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Abstract 
Human immunodeficiency virus (HIV) is a worldwide problem, with more than 34 million 
people infected with HIV/AIDS in 2011. At the end of 2011, in Nigeria, an estimated 
3.7% of the adult population were living with HIV/AIDS. HIV services in Nigeria are 
secondary-care led, involving multidisciplinary teams and access to free antiretroviral. 
However, evaluations of service provision from both patient and healthcare professional 
perspectives, especially, pharmacists in Nigeria have never been conducted, and are 
the aims of this research. 
This study involved grounded theory methodology, using In-depth semi-structured 
interviews with adults infected with HIV, pharmacists, and administrators involved in the 
management and care of those patients at Maitama District Hospital in Abuja. HIV 
pharmacists working for the NHS in the UK were interviewed for comparative purposes. 
Thirty-five patients were interviewed. Five concepts were identified that influenced how 
they accessed hospital services after diagnosis. These include faith in God and 
antiretroviral, social issues with emphasis on HIV stigma and discrimination, patient 
journeys at the hospital with delays and repeat visits, obstacles such as ARV 
unavailability and their expectations. Also, five concepts were identified from the 
pharmacists’ interviews which include clinical service, impressions of service provided, 
social issues the patients encountered, the obstacles faced with clinical service 
provided and expectations for improvement. Ten patients were shadowed on their clinic 
days to observe the patient journey articulated. Furthermore, the administrators 
interviewed re-affirmed the opinions of the patients and pharmacists about many 
patients attending HIV clinic, few staff attending to patients, medicines unavailability, 
especially ARV drugs, and lack of working space for staff. Delays, few 
pharmacists/many patients and shortage of ART as barriers to service provision 
ii 
 
emerged as dominant themes across the three groups of interviewees in Nigeria. Also, 
it has been found that there is a wide gap between HIV patients’ hospital management 
in the UK and Nigeria as regards availability of antiretroviral, staff strength, number of 
patients in attendance on clinic days and weekly clinic days. 
Pharmacy was found to have a substantial role in the management of HIV/AID patients 
but it appears from this study that service improvements, both human and material 
resources are needed. Twenty three recommendations, which are further synthesised 
into six potential areas, are made, which, if implemented, would dramatically improve 
the service provision for HIV/AIDS patients at Maitama District Hospital. 
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1. CHAPTER ONE - INTRODUCTION 
1.0 Introduction 
This chapter will briefly discuss the discovery, proliferation, pathophysiology and 
treatment of HIV/AIDS, highlighting its prevalence and effect on the African continent, 
particularly Nigeria. It will further introduce Nigeria, the country of study in this thesis, to 
enable the reader to understand some of the cultural, political and economic influences 
that will have a bearing on the findings of this work. 
1.1 Overview of HIV Epidemic  
The human immunodeficiency virus (HIV) which causes acquired immune deficiency 
syndrome (AIDS) is one of the most destructive epidemics the world has ever witnessed 
[1,2] making it one of the most important public health disasters in the world [3,4], Sub-
Saharan Africa (SSA), is particularly affected and where the impact of HIV has been 
most severe [5,6]. 
1.1.1 HIV/AIDS 
HIV, a retrovirus was identified as the causative agent for the development of AIDS in 
1983 [2,7], and was first described in a report from the United States (US) Centers for 
Disease Control (CDC) in 1981 [7,8]. Awareness of HIV started with a report, published 
in 1981 in the Morbidity and Mortality Weekly Report, of a rare type of pneumonia 
caused by Pneumocystis jiroveci (Pneumocystis carinii), as well as other unusual 
infections in five young homosexual men in Los Angeles, California. This was the 
earliest documented occurrence of AIDS as reported. 
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1.1.1.1 Origin of HIV  
HIV is assumed to have entered the human population through cross-species 
transmission from wild chimpanzees and sooty mangabeys (Old World monkeys) in 
Africa [9,10]. In HIV-infected patients, T-lymphocytes replicate rapidly and either destroy 
or impair cells in the immune system [11,12]. Hence, HIV infection leads to a severe 
reduction in the number of T-helper cells available to help fight disease and if not 
treated, becomes chronic and progressive leading to development of AIDS [13,14]. 
1.1.1.2 Transmission and Risk Factors 
HIV can be passed from person-to-person by way of sexual fluids, blood and breast milk 
[15,16]; the main channel for the spread of HIV infection being through sexual exposure 
[17,18]. Although the first identified cases of AIDS were in homosexuals in the US and 
Europe [19,20], heterosexual contact is the main route of transmission in areas of 
highest HIV prevalence [17,20]. Most adults living with HIV are women [21,22]; possibly 
linked to anatomical factors [23] and in Africa, to social and cultural issues [24,25] such 
as polygamy [26]. However, a number of studies have identified that certain groups are 
particularly affected including sex workers, long distant truck drivers, TB patients, 
patients with other sexually-transmitted diseases (STDs), injecting drug users and 
children born to HIV-infected mothers [22,27,28]. Another source of transmission of HIV 
is the cyclic use of non-sterile instruments in hospital settings and by traditional healers 
for circumcisions, tribal or body marks (tattoos) and talisman’s incisions [29,30]. 
1.1.1.3 Manifestation of HIV 
1.1.1.3.1 Opportunistic Infections  
After living with HIV infection for a prolonged period of time without medical treatment, 
most patients become vulnerable to other infections, termed HIV-related opportunistic 
3 
 
infections (OIs) because of the opportunity offered by the patient’s weakened immune 
system [31,32]. Some of the most common HIV-related OIs and diseases are bacterial 
infections, such as tuberculosis and septicaemia, fungal infections, such as  
Pneumocystis jirovecii pneumonia and candidiasis, malignancies such as Kaposi's 
sarcoma and Lymphoma and protozoal infections, such as toxoplasmosis and 
leishmaniasis [32]. 
1.1.1.4 Classification of HIV Infection 
Generally, HIV infection is categorised into four stages namely: 
• Primary infection; 
• Clinically asymptomatic infection; 
• Symptomatic HIV infection; and, 
• Progression from HIV to AIDS. 
In addition, the World Health Organisation (WHO) has developed a clinical staging 
structure for HIV infection [33]. This 4-stage structure relies more on clinical signs and 
symptoms rather than laboratory evaluation. The developed clinical staging structure 
has also been used in resource-constrained areas where laboratory testing is not 
available [33].  
1.1.1.4.1 Primary Infection Stage  
The time period from initial HIV infection to the development of an antibody response 
detectable by standard tests is known as primary HIV infection [34]. The acute viral 
syndrome of primary HIV infection, also known as sero-conversion illness, appears 
within days to weeks following exposure to HIV [35]. It is characterised by a large 
amount of HIV in the peripheral blood; hence, the immune system responds to the virus 
by producing HIV antibodies and cytotoxic lymphocytes. The most common symptom 
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presented is fever but other symptoms included fatigue, lymphadenopathy, weight loss, 
abdominal pain, oral candidiasis, anorexia and rash [36]. A study by Adedigba and co-
workers has shown that oral candidiasis is a common oral manifestation of HIV in 
Nigeria [37]. However, Blattner and co-workers have reported that tuberculosis is the 
most common throughout West Africa [25].  
1.1.1.4.2 Clinically Asymptomatic Stage 
During this phase, the majority of HIV positive patients are clinically asymptomatic 
(although, there may be swollen glands) in spite of the widespread immunological 
changes due to rapid viral replication [38]. Research has shown that HIV is not dormant 
during this stage, but is very active in the lymph nodes [39]. The level of HIV in the 
peripheral blood is very low, however, people remain infectious and HIV antibodies are 
detectable in the blood. Antibody tests will show a positive result and this stage can last 
for more than ten weeks [36]. This is WHO stage I. 
1.1.1.4.3 Symptomatic Infection Stage 
HIV symptoms develop and worsen as the immune system deteriorates due to the 
emergence of OIs [14]. This stage of HIV infection is often characterised by multi-
system disease and infections can occur in almost all body systems. The lymph nodes 
and many other tissues become damaged due to years of viral activity [33]. During this 
phase, HIV mutates and becomes more pathogenic, leading to more T-helper cell 
destruction; cells that cannot be replaced. Although treatment of specific infection or 
cancer is often carried out at this stage, the underlying cause of patient deterioration is 
the action of HIV on the immune system. Reduction of the viral load is the best therapy 
at this stage [40]. This phase is WHO stage II or III depending on OIs seen. 
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1.1.1.4.4 Progression from HIV to AIDS 
A patient is diagnosed with AIDS when his or her immune system is too weak to fight off 
further infections [14]. A diagnosis of AIDS is eventually made when an individual 
manifests one or more of a number of serious OIs or cancers such as Pneumocystis 
jirovecii pneumonia, Kaposi sarcoma, cytomegalovirus infection, extra pulmonary 
cryptococcosis including meningitis. It can take 10-15 years for an HIV infected person 
to develop AIDS [33]. This phase is WHO stage IV. 
1.2 Global Prevalence of HIV/AIDS 
The number of people living with HIV increased from around 8 million in 1990 to around 
34 million by the end of 2011 [6]. According to the WHO, over 60 million people have 
been infected with HIV [41] and approximately, 30 million people have died of AIDS 
since the first case was reported in 1981 [4]. In 2011, an estimated 2.5 million people 
were newly infected and there were 1.7 million AIDS-related deaths [6]. Over the last 30 
years, there has been a huge global effort from governments and the scientific 
community in improving patient education and developing new medicines [4,42]. This 
has seen the number of people diagnosed with HIV/AIDs slow as shown below (Figure 
1.1) [43]. 
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Figure 1.1: HIV/AIDS Global Trends 
 
 
Source: AVERT.org, 2013 
 
1.2.1 Effect of HIV/AIDS in Sub-Saharan Africa 
Sub-Saharan Africa (SSA) is most affected [4,44]. Currently more than 23 million people 
of the estimated 34 million people infected with HIV/AIDs live in this region, equating to 
an adult prevalence rate of 4.9% (Table 1.1) [6]. For example, in 2011, 1.8 million 
people acquired the virus and an estimated 1.2 million died of HIV-related illnesses; 
approximately, 70% of global deaths [6].  
At the end of 2010, there were countries in SSA where more than one tenth of the adult 
population aged 15-49 was infected with HIV [45]. Although the rate of new HIV 
infections has decreased, the total number of people living with HIV continues to rise 
[46]. 
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Table 1.1: Global HIV and AIDS Statistics, 2011 
Regions  People living 
with HIV 
Percentage of 
adults (15 ‒ 49 
years ) with 
HIV/AIDS 
prevalence  
People newly 
infected with 
HIV 
Deaths due 
to AIDS 
Sub-Saharan 
Africa 
23.5 million 4.9% 1.8 million 
 
1.2 million 
South and 
South-East 
Asia 
4.0 million 0.3% 280 000 
 
250 000 
Eastern Europe 
and Central 
Asia 
1.4 million 1.0% 140 000 
 
92 000 
Latin America 1.4 million 0.4% 83 000 
 
54 000 
North America 1.4 million 0.6% 51 000 
 
21 000 
Western and 
Central Europe 
900 000 0.2% 30 000   7000 
 
East Asia  830 000 0.1% 89 000 
 
 59 000 
Middle East 
and North 
Africa 
300 000 0.2% 37 000 
 
 23 000 
Caribbean 230 000 1.0% 12 000 
 
 10 000 
Oceania 53 000 0.3%   2 900 
 
  1300 
TOTAL  34.0 million 0.8% 2.5 million 1.7 million 
 
Source: UNAIDS, 2012 
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1.2.2 HIV Therapies 
Medicine treatments for HIV target the viral enzymes (integrase, protease and reverse 
transcriptase) necessary for HIV replication and cell entry stages are termed 
antiretroviral therapy (ART) [4]. The aim of ART is to reduce the viral load in the body; 
this in turn reduces OIs and frequency of illness and boost up the immune system 
[16,47]. Overtime the HIV virus has developed resistance to these agents resulting in 
the need for multiple medicine combinations to achieve good clinical outcomes [48]. 
Taking two or more ART at a time is called combination antiretroviral therapy (CART) 
and taking a combination of three or more is known as highly active antiretroviral 
therapy (HAART) [16]. 
Advances in ART and treatment combinations have shifted HIV from being a terminal 
condition to one that can now be managed as a chronic problem [48,49]. Thus, people 
living with HIV/AIDS (PLHA) are now living longer [48] although it has been reported 
that there are two new HIV cases diagnosed for every person placed on ART [46]. For 
ART to be effective, high levels of patient adherence are needed since poor adherence 
is also associated with the development of drug resistance [48,50]. 
1.2.2.1 Global Antiretroviral Adherence Interventions 
Poor adherence to ART has been reported as causing virologic failure, (when ART fails 
to reduce a patient viral load to less than 200 copies/mL) [51,52] drug resistance, 
frequent morbidity, increased health costs and ultimately, mortality [53]. Sherr et al [51] 
examined the United Kingdom (UK) patient self reported ART non-adherence. Survey 
data were matched with routine treatment and virology data. The authors found that 
non-adherence reduced with age, which was reported more by people born outside the 
UK or black patients; poor adherence in black patients has also been reported 
elsewhere [54-56]. Other studies have also identified, amongst others, disclosure 
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[57,58], stigma [58], forgetfulness in ART taking [58] and cultural norms [59,60] as  
obstacles to ART adherence. 
1.2.2.1.1 Other Adherence Intervention Methods  
Telephone adherence counselling and electronic drug monitoring have been found to be 
effective in improving ART adherence [61-63]. Pellowski and Kalichman [64] reviewed 
the literature and found that most studies focused on medication adherence, used 
different technologies to deliver the intervention including short message service (SMS) 
or text messaging, cell phones and computers. da Costa et al [65] assessed whether a 
warning system based on mobile SMS messages increased the adherence of HIV-
infected Brazilian women to antiretroviral (ARV) drug-based treatment regimens and 
their impressions and satisfaction with respect to incoming messages. The authors 
found that self-reported adherence indicated that 11 out of 13 participants remained 
compliant in the control group (adherence exceeding 95%), whereas all eight 
participants in the intervention group remained compliant. In contrast, the counting pills 
method indicated that the number of compliant participants was five for the control 
group and four for the intervention group. Microelectronic monitoring indicated that six 
participants in the control group were adherent during the entire four-month period 
compared to six participants in the intervention group. Those participants who received 
the SMS for less than four months, (eight participants in the intervention group and 
three patients) nine believed that the SMS messages aided them in treatment 
adherence, and 10 responded that they would like to continue receiving SMS messages 
[65]. Finocchario-Kessler et al [66] developed, piloted and evaluated pictorial images to 
communicate the importance of consistent dose timing and the concept of drug 
resistance to HIV patients. Adherence knowledge did not differ at baseline, however, at 
48 weeks, intervention participants’ demonstrated significantly increased knowledge 
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compared to controls. Also, the counsellors reported that the tools were well-received, 
and most participants felt the counselling helped them adhere to their medications. Allen 
et al [67] identified counselling focused attention to alcohol users and drugs with 
reduced side effects may improve ART adherence, and prevent the development of 
drug resistance. Also, Allen et al [68] acknowledged that to slow the Caribbean HIV 
epidemic, there was need to support programmes for the socioeconomic empowerment 
of PLHA. Wasti et al [69] reported that supportive environment, accessible treatment, 
clear instructions about regimens, and regimens tailored to individual patients' lifestyles 
were factors identified which influenced adherence amongst patients on ART and care 
providers in Nepal. 
1.2.2.1.2 Systematic Reviews on Antiretroviral Adherence 
Some systematic reviews of the literature on ART adherence have been carried by 
researchers, for example, Al-Dakkak et al [70] systematically, reviewed the literature 
involving adult HIV-infected patients aged 16 years and above. The authors reported an 
odds ratio for factors affecting adherence to ART to assess the impact of specific 
treatment related adverse events (AEs). They found that adherence to ART was lower 
in patients with non-specific AEs than in patients who did not experience AEs. Also, 
patients with specific AEs such as fatigue, confusion, taste disturbances and nausea 
were less likely to adhere to ART compared to patients without the AEs. While Nachega 
et al [71] systematically, reviewed the literature to estimate ART adherence rates during 
pregnancy and postpartum. The authors found 14 studies were from the US, six from 
Kenya, five from South Africa and Zambia each respectively. They found that only 
73.5% of pregnant women achieved optimal ART adherence and thus, reaching 
adequate ART adherence levels was a challenge in pregnancy, especially during the 
postpartum period. 
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Barnighausen et al [72] reviewed the literature on experimental evidence as regards 
interventions to reduce HIV prevalence, increase treatment as prevention (TasP) which 
requires high rates of HIV testing, and ART uptake, retention, and adherence, which 
was not, achieved in general populations in SSA. They found two randomised controlled 
trials (RCT) on HIV testing investigated an intervention in general populations and the 
other examined interventions in selected groups such as employees, or individuals 
attending public-sector facilities for services. One RCT demonstrated that nurse-
managed ART led to the same retention rates as physician-managed ART, but failed to 
show how to increase retention to the rates required for successful Tasp. Although the 
evidence on ART adherence was strongest, several RCTs demonstrated the 
effectiveness of cognitive and behavioural interventions. Thus, contradictory results in 
different settings suggest that the exact intervention content is crucial for success. 
Similarly, Hill and Kavookjian [73] reviewed the literature to identify studies analysing 
the effect of a motivational interviewing intervention on HAART adherence, to examine 
the relationship and identify gaps in the literature. Three of the five studies reviewed, 
showed a significant increase in adherence rates, two studies reported a significant 
decrease in viral load, and one study showed an increase in CD4 cell count as a result 
of the intervention. Also, Obiako and Muktar [74] reviewed the literature to examine the 
problems and challenges that affected the treatment of HIV infection in resource poor 
countries such as Nigeria. They found that previous studies showed that the advent of 
HAART has reduced morbidity and mortality among PLHA. However, in poor resource 
countries, HAART has been associated with many challenges such as; poor 
infrastructural base for the control programmes, irregular or non availability of drugs, 
poor drug adherence, co-morbidities and OIs, drug toxicities, drug-food and drug-drug 
interactions, laboratory monitoring of viral load, CD4 cell counts, full blood counts, 
electrolytes, kidney and liver functions. 
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1.2.2.2 Pharmacy Involvement in ART Adherence 
The role of pharmacy and pharmacists in HIV provision, and specifically the role in 
patient ART adherence is poorly researched. Work has been conducted to look at levels 
of adherence and patient understanding of ART. Badia et al [75] investigated how HIV 
patients took therapy and assessed adherence using the simplified medication 
adherence questionnaire adherence test; for which 40% of patients were deemed non-
adherent. Work by Bisson et al [76] showed that a pharmacy refill adherence 
assessments could be used in place of CD4 counts to detect virologic failure. 
Watermeyer and Penn [77] assessed patient understanding around ART dosage 
instructions and Govender et al [78] demonstrated that a pharmacist-led intervention 
programme increased patient knowledge on ART. 
1.2.2.3 Pharmacy and Pharmacists Management of HIV Patients 
Several studies have explored the contribution of pharmacists in HIV outpatient clinic 
setting for example, Henderson et al [79], Ma et al [80], Heelon et al [81], March et al 
[82], Castillo et al [83], Carcelero et al [84], Levy et al [85], Horberg et al [86], Govender 
et al [78], Watermeyer and Penn [77] and community pharmacies for example, 
Cocohoba et al [87,88], Hirsch et al [89,90], Rosenquist et al [91]. Although, HIV/AIDS is 
a huge concern in Africa, most studies published were conducted in the US [79-82,86-
91], Canada [83] Europe [84], Australia [85] and few in Africa [77,78]. 
According to Watermeyer and Penn [92], pharmacists have important roles to provide 
information, education and counselling to encourage adherence to ARV treatment 
regimens. Similarly, as described by Scott et al [93], pharmacists’ roles have developed 
from inpatient infectious diseases training clinical pharmacists, recommending therapies 
for OIs seen in the hospital, to clinical pharmacists who received specialised training in 
the treatment of PLHA in the outpatient unit. 
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Pharmacist’s primary contributions to HIV service provision have been found, among 
others, to include patients’ medication adherence counselling and education on dosing 
intervals, review of patients’ medical records in order to identify medication errors and 
possibilities for ARV adjustment [80,94] and dispensing of ARV drugs and tools for 
adherence improvement such as pill boxes [79], refill reminders, dose adjustment for 
renal or hepatic impairment, and monitoring for ARV adverse effects and drug 
interactions [80,82,85,90]. 
Effects of pharmacist contribution to HIV management included increase in clinic 
appointments being kept, improved quality of life [91], reduced ARV side effects [82] 
frequent hospital visits, more number of hospital days, emergency department visits 
[86], reduced pill burden [87], and improved daily dosing frequency adherence [80]. 
Several research findings [79,80,82,86,95] showed pharmacist contribution was 
associated with significant viral load reductions and increased CD4 cells count. 
1.2.2.3.1 Global Perspectives of Pharmacy and Pharmacists Management of 
HIV Patients 
A study carried out in the US, University of Colorado Referral Hospital, where 
pharmacists discussed with patients reasons for nonadherence and potential ways to 
overcome barriers, which included the use of pill boxes, appropriate management of 
ART side effects. They educated patients on the importance of adherence in preventing 
poor clinical outcomes associated with increases in viral load, and a pharmacy staff 
telephoned each patient refill reminders monthly. The authors found 25% of patients 
had  more than 95% adherence after referral to the pharmacist-managed clinic [79]. 
Carcelero et al [84] in Barcelonan hospital, found ART-related errors affected more than 
one-in-five patients. The most common causes of error were contraindications or not 
recommended drug–drug combinations and dose-related errors which were confirmed 
when pharmacists reviewed and identified those errors. Similarly, Heelon et al [81] in 
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the US, reported that the duration of prescribing errors was decreased when a clinical 
pharmacist who monitored patients prescribed HAART intervened to resolve the errors. 
Also, Ma et al [80] at Kaiser Permanente in the US, acknowledged that HIV clinical 
pharmacists may play an important role in reducing pill burden and dosing frequency, 
increasing medication adherence, and improving clinical outcomes through 
recommendations for ARV regimen changes. Similarly, Hirsch et al [90] found that 
18.2% more patients receiving ARVs from pilot Medi-Cal pharmacies, which had HIV 
trained pharmacists, had an adherence of 80%–120% in comparison to those not 
enrolled in this programme. Castillo et al [83] at the British Columbia in Canada, found 
that 14.7% more patients who obtained service from AIDS tertiary care hospital 
pharmacies had more than 90% adherence compared to those with off-site pharmacies 
and to physicians' offices. Levy et al [85] at an ambulatory care clinic in a hospital in 
Melbourne, Australia reported that participants missed 1.2 fewer doses 7 days after a 
pharmacist provided adherence education. March et al [82] in a County Hospital, 
California, US, reviewed the data from prospective observational study of a pharmacist 
managed drug optimisation clinic and made 253 interventions in 34 patients. The 
authors asserted that HIV pharmacists utilised patient education, addition of a 
medication, dosage adjustment, discontinuation of a medication, and interpretation of 
viral resistance tests to show significant improvement from baseline in patients’ CD4 cell 
counts, viral loads and drug-related toxicities. 
1.2.2.3.2 Sub-Saharan African Perspectives on Pharmacy and Pharmacists 
Management of HIV Patients 
To confirm the impact of pharmacist care on ART adherence in South Africa, a study by 
Govender et al [78] found that pharmacists’ intervention, through patients’ education, 
had a positive impact on HIV infected patients’ HIV and AIDS knowledge of the disease 
and ART usage and storage. Similarly, Watermeyer and Penn [77] in an ARV pharmacy 
15 
 
in South Africa, acknowledged how pharmacists confirmed patients’ understandings, 
whereby, the pharmacists initiated patients understanding of ARV dosage instructions 
through patients’ responses, both verbal and non-verbal responses which enabled the 
pharmacists to identify misunderstandings and or initiated clarification cycles. The 
authors found the patients appeared to have had better understanding of ART usage 
[77]. 
1.2.2.3.3 Systematic Reviews on Pharmacy and Pharmacists Management 
of HIV Patients  
McMahon et al [96] reviewed the literature to evaluate pharmacy adherence measures 
(PAM), which included virological and other clinical outcomes, efficacy compared with 
other adherence measures, and factors to consider when selecting a PAM to monitor 
adherence. The authors found that PAM estimates can be used by pharmacists and 
other health care providers to promote ART adherence. Although the literature on 
pharmacist directed interventions is limited, pharmacy based adherence interventions 
have successfully combined adherence education, tailoring regimens to patient 
lifestyles, and the management of adverse drug reactions (ADRs), resulting in improved 
adherence with virological and immunological response. Similarly, Saberi et al [97] 
reviewed the literature to assess the impact of HIV pharmacists on HIV clinical 
outcomes and found the involvement of HIV pharmacists was associated with 
statistically significant adherence improvements and positive impact on viral 
suppression in the majority of studies. 
Also, Nkansah et al [98] reviewed the literature which focussed on services provided by 
outpatient pharmacists in community or ambulatory care settings to examine the effect 
of outpatient pharmacists' non-dispensing roles on patient and health professional 
outcomes. They found only one study reviewed, which compared pharmacist services 
with other health professional services. However, most studies reviewed, supported the 
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role of pharmacists in medication and therapeutic management, patient counselling, and 
educating health care professionals' (HCPs) with the goal of improving patient care and 
clinical outcomes. 
From the review of these literatures above, one can deduce that there has not been any 
study carried out in Nigeria, to date on pharmacists or pharmacies management of HIV 
patients. 
1.2.3 Management of HIV/AIDS in Sub-Saharan Africa with 
emphasise on Service Provision and Adherence 
Unsurprisingly, many studies have been carried out in SSA, especially from Southern 
Africa [99-102] that have investigated HIV care, ranging from healthcare staff attitudes 
to patient adherence. For example, a 2010 systematic review by Fox et al [101] 
determined patient retention in ART programmes. This review showed that 
approximately 65% of patients were still retained on programmes 3 years after initiation 
of ART [101]. Peltzer et al [102] in a South African study found that at 6 months follow 
up from ART initiation, over 70% of patients were adherent in their medicine taking. A 
Zambian study by Nozaki et al [103] highlighted patients commonly held false beliefs 
about ART that affected ART adherence, whilst Hardon et al [104] established that 
adherence was affected by costs associated with patients’ care which included lost 
wages and transport. 
1.2.3.1 Factors Facilitating ART Adherence 
Certain factors have emerged to explain improved ART adherence. The important 
factors which support patients’ continuing ART adherence established by Fried et al 
[100] included social and economic support by individuals, role models and networks as 
well as positive experiences within the healthcare system and of the treatment itself. 
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Whilst Watt et al [105] identified five factors that explained excellent ART adherence 
which included experienced improvements in their health after starting ART to support 
their confidence in the medication and motivated them to adhere, their perceived need 
to be able to meet their family responsibilities motivated respondents to stay healthy. 
They also developed specific strategies to remember to take pills, where they routinized 
pill-taking by linking it with daily activities or events, material and emotional support 
received from others and trust in the advice and instructions of their health care 
providers, who regularly emphasised adherence. Ware et al [106] explained adherence 
success in SSA through an ethnographic study where the authors found that individuals 
taking ART regularly, overcome economic obstacles to ART adherence through a 
number of deliberate strategies aimed at prioritizing adherence. Such that the patients 
borrowed and begged for transport money and made choices to allocate resources in 
favour of treatment. Resources and helps were then made available by treatment 
partners, other family members, friends and HCPs, whereby, helpers expected 
adherence and made their expectations known, creating a responsibility on the part of 
patients to adhere. Consequently, patients adhered to promote good will on the part of 
helpers; thereby ensuring help will be available when future needs arise. Also, Sanjobo 
et al [107] explored patients and HCPs perceived barriers and facilitators to patients' 
adherence to ART and found feeling better, prospects of living longer, family support, 
information about ART, support for income-generating activities, disclosure of HIV 
status, prayers and transport support as facilitators of ART adherence. Whilst Murray et 
al [108] identified values of church or marriage as motivating factors that affected the 
ability and willingness of patients to take life-saving medicine for a long period of time. 
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1.2.3.2 Barriers to ART Adherence 
Likewise, barriers to ART adherence have also been identified. Fried et al [100] 
identified patients’ main challenges to effective ART adherence as patients' difficult life 
circumstances, particularly, those related to poverty for example transport and food 
costs and health system constraints, such as perceived lack of compassion and 
flexibility by healthcare workers. Hardon et al [104] identified setting specific constraints 
to adherence, which included transport expenditures, registration and user fees at the 
private health facilities. Also, lost wages due to long waiting times at the clinics, side 
effects and hunger in the initial treatment phase were identified. Furthermore, Van Tam 
et al [58] established that patients found it hard to take their drugs when they were 
among people to whom they have not disclosed their HIV status, such as co-workers 
and friends. Also, Sanjobo et al [107] identified lack of communication and information 
about ART, inadequate time during consultations, lack of follow-up and counselling, 
forgetfulness, stigma, discrimination and disclosure of HIV status, lack of confidentiality 
in the treatment centres, and lack of nutritional support as barriers to ART adherence. 
Weiser et al [109] found financial constraints, stigma, travel and side effects as main 
barriers to adherence. Whilst Murray et al [108] found refusal of HIV treatment based on 
illness beliefs, mental and behavioural health, for example depression and or 
interpersonal challenges, stigma, side effects and hunger. Potchoo et al [110] reported 
forgetting, travel, cost of treatment and side effects as the main factors of missing at 
least once a dose intake. Badahdah and Pedersen [111] interviewed 27 HIV infected 
Egyptian women who had been on ART for at least three months and identified fear of 
stigma, financial constraints, characteristics of ART, social support and reliance on faith 
as factors that influenced patients' adherence to HIV medications. The authors stated 
that despite the numbers of adherence inhibiting factors, most of the patients 
interviewed were motivated to achieve complete adherence to ART.   
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1.2.3.3 Effect of Faith on HIV/AIDS Care 
Nozaki et al [112] found that more than half of 389 ART patients held at least one false 
belief about ART effectiveness, side effects, or the consequences of ART non-retention 
or non-adherence despite thorough pre-ART counselling. Such beliefs included pastors 
can cure HIV infection through prayer and ART can be stopped without harmful effects 
while taking immune-boosting herbs, which were likely to reduce patients’ ART 
adherence and retention. Similarly, Maman et al [113] established how HIV infected 
women, who were pregnant or had recently given birth, described how they relied upon 
their faith and turned to church leaders when they were diagnosed with HIV. The 
women used prayer to overcome the initial shock, sadness and anger of learning their 
HIV diagnosis. They turned to their church leaders to help them prepare for disclosing 
their diagnosis to others, including their partners. Church leaders were also important 
targets for disclosure by some women. Women's faith played an important role in their 
long-term coping strategies. With acceptance of their infection as a path chosen by 
God, and believing that God has the power to cure their infection, comforted and 
provided them with hope. Also, Zou et al [114] explored associations between religious 
beliefs and HIV stigma, disclosure, and attitudes toward ART and found that HIV stigma 
is strongly linked with religious beliefs such as the belief that HIV is a punishment from 
God or that PLHA have not lived righteously. Most of these respondents said that they 
would disclose their HIV status to their pastor or congregation if they became infected. 
Although, most respondents believed that prayer could cure HIV, almost all said that 
they would begin ART if they became HIV infected and refusal of ART was associated 
with lack of secondary education and knowledge about ARV. 
Similarly, Tocco [115] found in Northern Nigeria that passages from Islamic books were 
regularly cited by both HIV/AIDS patients and HCPs when talking about the belief that 
Allah (Islamic name of God) sends a cure to human beings for every disease. Roura et 
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al [116] investigated faith leaders (FLs) and traditional healers (THs) attitudes towards 
ART and FLs were reported to be often opposing medical treatment with many believing 
in traditional healing. The authors reported that praying for the sick was a common 
practice. Being HIV positive was often seen as a punishment from God and a 
consequence of sin. As sinning could result from the work of Satan, forgiveness was 
possible, and reconciliation with God deemed as essential for a reprieve. While prayers 
could cure HIV completely, ART use was not discouraged by the FLs as God had only a 
part to play. 
1.2.3.4 Effect of Knowledge on Adherence 
Potchoo et al [110] assessed knowledge of adult patients and compared them with their 
ART adherence level. The authors found more than half of the patients knew the name 
of ART prescribed and all patients had a good knowledge of treatment schedule. The 
average adherence rate was 89.8% of the total doses prescribed while over half of the 
patients had an adherence rate of 95% or above. Hegazi et al [117] similarly assessed 
the relationship between patients' literacy and education to ART adherence and found 
formally educated patients were significantly more likely to achieve low viral load. 
1.2.3.5 HIV Status Disclosure and Gender Issues  
Shamos et al [118] identified high levels of felt stigma in all settings, though, fewer than 
anticipated accounts of expressed stigma in family, work, and neighbourhood settings. 
Also, the amount and characteristics of felt and expressed stigma and social support 
differed based on gender, as women often experienced more felt and enacted stigma 
than men and had less definite financial or emotional support. Anglewicz and 
Chintsanya [119] found that HIV status disclosure was relatively common among rural 
Malawians, where most of them have shared their status with a spouse and many 
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disclose to others in the community, still, there were differences in disclosure patterns 
by HIV status and gender. Women, who perceived greater HIV/AIDS stigma are less 
likely to disclose HIV status to a spouse, and men who were worried about HIV infection 
from extramarital partners were less likely to disclose their HIV status to a spouse. Also, 
the authors found that self-reports of HIV-positive men were of questionable reliability. 
Deribe et al [120] established that most patients disclosed their result to at least one 
person and their partner. However, some disclosures were delayed while some did not 
know their partner's HIV status. Among those who did not disclose, more than half of 
them gave their reason as fear of negative reaction from their partner, though, few of 
those who eventually disclosed reported any negative reaction from the partner and 
most reported that their partners supportively reacted to their disclosure. Dageid et al 
[121] found that 20 out of 23 men interviewed disclosed their HIV status to one or more 
persons, with partners and siblings being the preferred confidants. Disclosure was 
dependent on the acceptance of HIV status, perceived support, healthy relationships 
with others, HIV counselling and participation in educational and training activities. 
While those who did not disclosed stated that it was as a result of stigma, fear of 
rejection, discrimination, a lack of healthy relationships with others and lack of access to 
suitable disclosure strategies. Negative perceptions of HIV and controlling ideas of 
masculinity hindered men from disclosing and seeking health services. 
1.2.4 Nigerian Studies relating to HIV/AIDS 
1.2.4.1 Facilitators and Barriers of ART Adherence  
Charurat et al [122] reviewed clinic records of adult patients initiating ART and 
evaluated non-adherence through calculated pharmacy refill rates. They identified 
factors associated with left to follow up (LTFU) and non-adherence, which included only 
primary education, baseline CD4 counts more than 350 or less than 100 compared to 
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baseline CD4 counts of 100–200. Also, younger than 35 years, travelled more than 2 
hours to the clinic, ART duration of more than 6 months, with CD4 counts of more than 
200 at ART initiation. Whilst being female, post-secondary education, and initiating 
treatment with zidovudine containing or tenofovir containing regimens were associated 
with decreased LTFU. However, disclosure of HIV status to spouse or family and 
treatment with tenofovir containing regimens were associated with better adherence. 
Uzochukwu et al [123] found that all participants understood the need to take ARV 
drugs throughout their lives; the involved expenses, the need for periodic testing, the 
probability that complications would develop, cost of transportation to treatment site and 
the daily treatment regimen. However, the authors found that 75% of those patients 
were not fully adherent to their drug regimen. Their reasons for non-adherence included 
side effects, non-availability of drugs at treatment site, forgetting to carry drugs during 
the day, fear of social rejection, treatment being a reminder of HIV status, and selling of 
own drugs to those unable to enrol in the projects. Being female, under 35 years, single, 
and having higher educational status were significantly associated with non-adherence. 
Similarly, Alakija et al [124] found that older age and males associated well with 
adherence, thus, adherence among the young age and females needs strengthening. 
While Erah and Arute [125] found that adherence was dependent on adverse effects 
and educational level of patients and also identified that poor financial status, lack of 
confidentiality, occupational factors and stigma were the major reasons cited for 
nonadherence. Okoli and Cleary [126] found that high cost of transport, stigma and long 
waiting hours were found to be main barriers to ART services usage, though, patients 
usually spent under four hours at the clinic during their monthly appointments. The use 
of personal savings and financial support from relatives were the main means to access 
treatment. While transport costs were a chief concern among the poorest, well to do 
ones were more concerned about stigma and discrimination. 
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Shaahu et al [127] found that availability of ARV and ability to afford regular visits to the 
clinic among other factors, positively influenced adherence to HAART among PLHA. 
Also, a recent diagnosis of HIV made less than 3 years prior to the study period was 
also significantly associated with adherence to HAART. Olowookere et al [128] found 
that about a third of patients reportedly missed their medication because of fasting. 
Also, patients who felt healthy or forgot to take their drugs and those not willing to 
disclose their HIV status were associated with low adherence. However, Habib et al 
[129] found in another study that adherence and drug taking frequency appear 
uncompromised in fasting HIV patients. Similarly, Yakasai et al [130] investigated once-
daily and compared to twice-daily dosed ritonovir boosted lopinavir with fixed-dose 
tenofovir-emtricitabine once-daily among 17 stable fasting patients in Nigeria. The 
authors found that effectiveness; safety and tolerability of the ARV appeared unaffected 
by the changes as there were no changes in adherence. 
1.2.4.2 Health Care Professionals Knowledge and Roles in HIV/AIDS 
In 2006, Idigbe et al [131] evaluated HCPs training programme in Nigeria, examined 
their knowledge and skills gained with providing ART. The authors found that 13 out of 
15 treatment centres had ART adherence counselling structures in place and 
pharmacists were involved in the adherence counselling of patients. Similarly, in 2009, 
Zungu et al [132] investigated the availability of national ART guidelines (NATG) and 
their utilisation through self-administered questionnaire by HCPs from five treatment 
centres in Abuja, Nigeria. The authors found that out of 97 HCPs who participated in the 
study, 21 were unaware of the existence of the NATG in their treatment centres. About 
50 reported that they did not have access to the NATG as opposed to 47 who had 
access to the guidelines. Furthermore, 16 of the participants confirmed that they had 
access to an institutional copy of the NATG whilst 14 indicated that they had individual 
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copies and only three stated that they had individual copies and access to the hospital 
copy as well. Regarding utilisation of the NATG, 40 rarely used them, 32 never used 
them and only 25 often used them. The most frequent use of the NATG was among 
pharmacists compared to the least frequent use amongst nurses. 
Oyeyemi et al [133] reported low levels of knowledge and poor attitudes towards PLHA 
amongst Nigerian nurses. Attitudes appeared to be influenced by the nurse's speciality, 
rank, prior education and experience with patients with HIVAIDS and also, the 
responding nurses showed low levels of ease in giving care to those patients. Also, 
Oyeyemi et al [134] found in another study that the Nigerian physiotherapists showed 
unsatisfactory knowledge about AIDS, harboured negative attitude towards PLHA, and 
some were unwilling to provide care for PLHA. Previous experience of caring for PLHA 
influenced their attitude, and modest but positive relationships were found between 
knowledge and attitude and between attitude and willingness. 
Umeh et al [135] found a reasonable level of knowledge among all HCPs, with the 
highest level of knowledge among the doctors and the lowest among laboratory 
workers. There was a significant gender difference in the level of knowledge with less 
females but the data suggested that knowledge did not differ by hospital settings. There 
were generally, negative feelings and views about the care of PLHA among the 
professionals, these views being worst at the community health centres and best at the 
government hospitals. The greatest source of information for the majority of HCPs was 
health talks or seminars, and those respondents who got their information from school 
scored the highest on general knowledge of HIV/AIDS.  
Azodo et al [136] assessed the role of dentists in the prevention of HIV transmission in 
Nigeria and found HIV education by dentists was ranked as poor, as less than a quarter 
of respondents regularly educated patients on HIV in the clinic. The authors reported 
that only a few dentists were involved in public enlightenment programme on HIV in the 
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preceding 12 months. Most of the respondents reported a willingness to treat HIV-
infected patients while observing universal precautions. Good infection barrier practices 
were adopted by most of them, and disposable cartridges for local anaesthetic agents 
and dental needles were not reused. Autoclaving was the most widely used sterilization 
method, but less than half of the respondents knew how to ascertain whether 
sterilization was effective. 
1.3 Nigeria – An Overview 
1.3.1 History and Geographical Location 
Nigeria is named after the largest river in West Africa, and Africa’s third longest river, 
the Niger River [137,138]. Nigeria gained independence from the UK on 1st October 
1960 and was officially named the Federal Republic of Nigeria on 1st October 1963 
[139]. Nigeria is situated between the Gulf of Guinea to the South, Benin to the West, 
Cameroon to the East, and Niger and Chad to the North (Figure 1.2) [140]. The country 
extends from latitude 4 to 14 degrees North and from longitudes 2 to15 degrees East. It 
has an area of 923,768 square kilometres, which includes about 13,000 square 
kilometres of water [141]. Nigeria observes Nigeria Standard Time, which is Greenwich 
Mean Time plus one hour. 
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Figure 1.2: Location of Nigeria in West Africa 
 
 
Source: WHO, 2009 
 
1.3.2 Terrain  
1.3.2.1 Rivers 
Nigeria’s principal rivers are the Niger–Benue and the Chad. The Niger River flows 
4,184 kilometres from Guinea through Mali, Niger, Benin, and Nigeria before emptying 
into the Gulf of Guinea. The Benue River, the Niger’s largest tributary, flows 1,400 
kilometres from Cameroon into Nigeria, where it empties into the Niger River [142]. The 
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Chad River is made up of several tributaries that merge into the Yobe River, which then 
flows along the border with Niger before reaching Lake Chad [143]. 
1.3.2.2 Topography  
Nigeria's most extensive geographical features are the valleys of the Niger and Benue 
Rivers, which merge into each other [144] and form a "Y" shaped confluence at Lokoja 
in Kogi state [145]. Other notable features include Chappal Waddi Mountain, in Taraba 
state, which is 2,419 metres high, making it the highest point in the country [146]. The 
elevational pattern of most of Nigeria consists of a gradual rise from the coastal plains 
to the Northern savannah regions, generally reaching an elevation of 600 to 700 metres. 
At higher altitudes, broad stepped plateau reaching more than 1,200 metres in 
elevation, are found in areas of the Jos, Plateau [146].        
1.3.2.3 Rainforest 
Nigeria has lost about 47.5% of its total forest between 1990 and 2010 through logging, 
bush burnings, agriculture, urbanisation, industrialisation and high population growth 
[147]. In an attempt to preserve the remaining forest, the government set up the Cross 
River National Park in 1991 [148], which is Nigeria’s largest remaining area of rainforest 
and is home to a wide diversity of fauna, many of which are endangered, and include 
gorillas, leopards, chimpanzees, elephants and monkeys [149]. 
1.3.2.4 Climate 
The climate in Nigeria varies geographically: the north is dry; the central belt is humid 
and the south has typically equatorial weather [150]. Wet seasons are associated with 
South West monsoon winds, while dry seasons are associated with North East winds 
from the Sahara Desert [151]. The rainy season extends from March to November with 
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the heaviest rainfall usually recorded in August [150]. Nigeria’s temperature is generally 
high year round but it can fall to as low as 13°C during the coldest months of the year, 
which are between December and February. Mean maximum temperatures are 32°C to 
41°C [150].  
1.3.3 Population 
Nigeria is a multi-ethnic country, encompassing over 250 ethnic groups, the major 
groups being Hausa/Fulani (28%), Yoruba (21%), and Igbo (19%) [152]. It is the most 
populous country in sub-Saharan Africa, having an estimated population greater than 
140 million: the latest census (2006) reporting six cities with populations greater than 1 
million; Lagos being the most populous with a population greater than eight million 
[153]. The official language of Nigeria is English; however, there are over 250 native 
languages, the most common of which are Hausa, Ibo and Yoruba, corresponding with 
the major ethnic groups [154]. 
1.3.4 Political History   
The political history of Nigeria can be traced back to the 16th century, when the Songhai 
Empire in Northern Nigeria stretched from the Senegal and Gambia rivers, in the far 
West, and included part of Hausa land in the East. At the same time, the Sayfawa 
Dynasty conquered the Kanem-Bornu Empire, and extended its control Westward to the 
Hausa cities that were not under Songhai rule. To an extent, Northern Nigeria was part 
of one, or other, of these empires for over a hundred years, until the Sayfawa Dynasty 
conquered the region in 1590 and ruled for the next 200 years [137]. This tribal partition 
of land continued into the early twentieth century until the nation state of Nigeria was 
established by the British in 1914 [155]. 
29 
 
After Nigeria confirmed independence from Britain, Dr Nnamdi Benjamin Azikiwe was 
chosen as the first indigenous civilian president, and commander in chief of the armed 
forces in 1963 [137]. Over the subsequent 50 years, Nigeria has seen a number of 
coups, resulting in military rule for at least 30 of these 50 years [156] 
Recently, Dr Goodluck Ebele Jonathan, who inherited the Nigerian presidency on May 
6th 2010 following the death of his predecessor President Umaru Yar'Adua, won 
elections in April 2011 and became the 14th president of Nigeria for a four-year term 
[157]. 
1.3.5 Political Structure 
Prior to Nigeria gaining independence, it was a federation of three regions 
(administrative units governed as semi-autonomous regions), namely Eastern, Northern 
and Western [137]; shortly after independence, two areas in the Western region were 
detached to form a Mid-Western region, thus forming four administrative regions [137]. 
Following the military coup of 1966, these regions were replaced by 12 states, which 
were expanded to nineteen in 1976 and to thirty by 1991 [155]. Today, there are 36 
states with a Federal Capital Territory (FCT) in Abuja (the capital city since 1991) and 
774 local government areas (LGAs) [153]. The states have been established based on 
geographic proximity and ethnicity. In addition, for administrative and other political 
purposes, Nigeria is also subdivided into six geopolitical zones: North-West; North-East; 
North-Central; South-West; South-East; and South-South (Figure 1. 3) [158]. 
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Figure 1.3: Map of Nigeria showing the Geopolitical Zones 
 
 
 
Source: WHO, 2009 
1.3.6 Government Structure and Constitution 
Nigeria is based on a Federal system; a president having executive powers, and elected 
upper and lower legislative chambers comprising a Senate and a House of 
Representatives [152]. Each of the 36 states is governed by an elected Governor, 
Executive Council (including commissioners) and House of Assembly [159]. Nigeria’s 
current constitution, which is the fourth since independence, came into force on May 
29th 1999, and is the supreme law of the country [155]. The constitution allows for a 
separation of powers among the three branches of government; an executive, an 
elected legislature and an independent judiciary, even though the executive, and/or the 
president, have much more power compared to the other two groups. The constitution 
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affirms personal freedom and a secular state, however, it allows Muslims to abide by 
Sharia (Islamic law) [160]. 
1.3.7 Religion 
Nigeria’s population is split primarily between Islam (approximately 50%) and 
Christianity (40%), with about 10% of the population adhering to traditional beliefs. 
Muslims constitute the majority in the north and Christians are the majority in the south 
[154]. 
1.3.8 Economy 
Nigeria is rich in natural resources, not only oil, but also natural gas, tin, iron ore, coal, 
limestone, lead and zinc [161]. Prior to the discovery of oil in Nigeria, the economy 
depended mainly on agriculture, which provided for foreign export and for local 
consumption. However, since the early 1980’s, oil production has contributed more than 
75% of the gross domestic product (GDP) of Nigeria [162]. 
1.3.9 Education 
There are three basic educational systems in Nigeria; the indigenous system, the 
Qur’anic (Islamic) schools, and formal Western educational institutions [163].  
The traditional (indigenous) system of education starts from infancy by immediate family 
members, mainly to shape the character of individuals [164]. The Islamic educational 
system exists mainly in Northern Nigeria, and most children attend Qur’anic schools 
from the age of five, where they learn the Qur’an. Qur’anic education entails learning to 
read and write in Arabic and some children go on to specialise in religious studies, 
though most children who enrol in Qur’anic schools, subsequently enrol in Western 
schools [163]. 
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The formal Western education system consists of six years of primary school, starting 
from age of 6 years [165], three years of junior secondary school, three years of senior 
secondary school, and four years of university education leading to a bachelor’s degree.  
In 2006, adult literacy was reported to be 57% in Nigeria [163]. Nigeria provides free, 
government-supported education, but attendance is not compulsory at any level [166], 
and certain groups such as nomads and the handicapped are underserved [167]. 
1.4 Healthcare System 
Healthcare in Nigeria is based on a mixture of orthodox (Western) medicine and 
alternative medicinal practice [168]. Orthodox medical care is available from three 
sources, namely: government, private and charitable (Christian missionary facilities 
such as the Church of Christ in Nigeria and the Roman Catholic secretariat of Nigeria, 
PEPFAR) sources [169]. 
1.4.1 State (Public) Healthcare Services 
The Nigerian national healthcare system provides three tiers of healthcare; primary, 
secondary and tertiary [170], based on the three-tier government system. They are the 
responsibility of the Federal, State and Local Government authorities respectively [171]. 
Similarly, the administrative structure of healthcare in Nigeria is based on three levels of 
health administration, namely the Federal Ministry of Health (FMoH), which is the 
tertiary level, the State Ministry of Health (SMoH), which is the secondary level, and 
Local Government Health Departments (LGHD) which is the primary level; the FMoH 
being the overall health policy making body [172]. Each of these administrative levels 
finances their healthcare services mainly from the Federal government annual 
allocations to each sector and from local internal revenue generation [171]. 
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Ideally, referral from medical doctors should be the link between these three healthcare 
tiers [171], but Nigeria has a poor and dysfunctional primary healthcare (PHC) 
foundation in favour of hospital care [173]. Primary health centres are supposed to be 
the point of first contact for patients, but patients often will have attended a tertiary 
health centre without any referral from a medical doctor [174]. This can lead to 
congestion in the secondary and tertiary health facilities with conditions that should be 
managed via PHCs. However, tertiary organisations also provide some PHC services 
through their general outpatient departments, which further complicates patient access 
to healthcare services [174].  
The primary responsibilities of the PHCs are to provide basic health services, such as 
health education, family planning, childhood immunisation, control of locally endemic 
diseases including non-communicable diseases, provision of essential drugs and 
treatment of minor injuries and ailments [173]. Generally, highly specialised services 
such as fertility clinics, intensive care units, mental health facilities and kidney dialysis 
centres are accessed at secondary and tertiary levels [171]. This therefore tends to 
exclude those living in rural areas, as these centres are located in urban areas [175]. 
The Nigerian government operates teaching hospitals and federal medical centres, 
state ministries of health, local government departments of health, general hospitals and 
primary health centres and posts (Figure 1.4) [175]. 
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Figure 1.4: Nigeria Health System Structure 
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1.4.1.1 Payment under State Healthcare 
Patients attending government hospitals are expected to pay for their healthcare [176] 
with the exception of consultation fees. This includes their hospital registration cards, 
medicines, stay whilst in hospital and any laboratory services required [177]. 
1.4.1.2 National Health Insurance Scheme 
Nigeria introduced a national health insurance scheme (NHIS) in June 2005 [178]. 
Registration by each person then covers the spouse and up to four children under the 
age of 18 years [178]. Every participant contributes 5% of their basic salary each month 
and employers contribute 10% of the total cost [175,178]. 
1.4.2 Private Healthcare Services 
Private healthcare is available at both a formal level (pharmacy shops, hospitals, 
laboratories) and an informal level [177]; drug hawkers carrying and selling medicines in 
baskets; injection doctors (unqualified people who move from house to house, or shop 
to shop, with injectable medicines to inject for fees) and finally, visits to spiritual healers 
[168]. Also, there are medicine stores, where individuals can purchase simple over-the-
counter drugs for the treatment of common illnesses [179]. 
Formal places of healthcare delivery may be registered, regulated, premises (e.g. 
hospitals) while the informal ones are unregulated [180] although, these informal service 
providers are not acknowledged within the formal health service. Those who mostly 
utilise informal health services are poor people, and rural dwellers, who use them by 
choice, or necessity, due to beliefs and practices, lack of awareness, cost or ease of 
access [181]. 
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1.4.3 Lay Healthcare 
There are several options for patients who wish to access healthcare. These include 
self-medication at a medicine store, community pharmacy, drug hawkers, a visit to a 
traditional healer, or a visit to a private or public hospital [182]. General Practitioner 
(GP) surgeries, as available in the UK, are not available. 
The first point of contact is usually to speak to a close family member, a reliable friend 
or a neighbour, and to ask for advice on self-diagnosis and/or which medicines to use. 
This person will often supply, or recommend, medicines to the patient. However, if the 
condition persists, the patient will make a choice of where to visit next among the places 
mentioned above for further help. 
Thus, the practice of self-care is common in Nigeria [183] and often involves seeking 
advice or treatment from a traditional healer, rather than using government-run (public) 
health services [184]. 
In general, the educated and rich take the option of accessing community pharmacies, 
or private hospitals, as the first choice in preference to government-run hospitals, as 
they offer a faster service. However, people living in rural areas, who tend to be the 
poorer and less well educated, think of herbal or folk antidotes as first line treatment 
[185]. Their second alternative is usually medicine stores, where orthodox 
pharmaceutical products are sold on a retail basis without having any formally trained 
(legal) pharmacist involved [180]. In this situation, the vendor in charge of the store may 
supply any product, based on the patient’s ability to pay [179]. 
A further complication for many rural dwellers lies in the fact that many are convinced 
that illness must have been the handiwork of their enemies, just as every evil deed is 
credited to the devil. There is nothing ‘normal’ about ill health to a layperson in Nigeria. 
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1.4.4 Social Deprivation 
Although Nigeria generates high revenues from crude oil, there is still a very high rate of 
poverty due to poor governance [156,186] and the country ranked 156th out of 187 on 
the United Nations Human Development Index (HDI) in 2011 [187]. Nigeria’s economic 
growth has not improved the welfare of the majority of the population [158]. For 
example, in 2007, only 72% of urban residents and 49% of rural residents, had access 
to safe drinking water, which was unreliable and of poor quality; just 48% of urban 
residents and 30% of rural residents had access to adequate sanitation [188]. 
Furthermore, many Nigerians devote one to three hours of their day to the task of 
collecting water for domestic use. Similarly, the stability of the electricity supply is 
extremely unreliable [156]. 
1.4.5 Epidemiology of Major Diseases 
In 2009, the life expectancy for males was estimated to be 53 years and 54 years for 
females [189]. Furthermore, Nigeria has one of the highest child mortality rates (86 per 
1000 live births in 2007) and maternal mortality rates (800 per 100, 000 births in 2007) 
in the world [158]. 
Malaria is a major health problem in Nigeria and is the main cause of morbidity and 
mortality in infants, young children and pregnant women [179]. Furthermore, half of the 
Nigerian population experience one episode of malaria per year, whilst children under-
five experience two to four malarial attacks each year [190]. Other highly prevalent 
diseases in Nigeria include poliomyelitis, hypertension, tuberculosis (TB), Guinea worm, 
pneumonia, measles, gonorrhoea, typhoid and chicken pox [171]. 
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1.5 HIV/AIDS in Nigeria 
1.5.1 Identification of HIV in Nigeria  
HIV was first detected in Nigeria in a sexually active 13-year-old girl in 1985 and 
reported in 1986 [191]. Subsequently, some commercial sex workers tested positive for 
HIV [192]. From then onwards, AID (layperson’s word for AIDS) has become a 
household phrase in some parts of Nigeria. When someone suddenly falls sick in 
Nigeria, every neighbour who has heard about it would want to be sure that the 
sickness was not associated with HIV, because being infected with HIV/AIDS is 
perceived as a death sentence [193,194]. Furthermore, most deaths resulting from brief 
illnesses are suspected by non-HCPs to be HIV/AIDS-related.  
At the end of 2011, in Nigeria, an estimated 3.7% of the adult population were living with 
HIV/AIDS [195], thus, HIV/AIDS is one of the most significant public health problems in 
Nigeria [122]. Nigeria is second only to South Africa in terms of the number of persons 
living with HIV/AIDS [6] and it was reported that the population of Nigeria accounted for 
about 10% of the global HIV burden [196]. HIV is highest in young women and men in 
their most productive years [192,197] and at the end of 2010, among the 30-34 years 
age group. The HIV trends in HIV/AIDS prevalence in Nigeria at the end of 2010 is 
shown below (Figure 1.5) [191]. Nigeria’s HIV prevalence appears to have stabilised 
over the past 11 years, sliding from 5.8% in 2001 to 4.1% in 2010 among the general 
population. HIV/AIDS prevalence increased steadily from 1.6% to 5.8% in the period 
between 1991 to 2001 until 2003 when the first downward was recorded at 5.0%. That 
could be attributed to efforts made by the National Agency for the Control of AIDS 
(NACA) lunched in 2002 by the Nigerian government. NACA was mandated to 
coordinate the overall HIV/AIDS response, control the spread of HIV/AIDS through 
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advocacy, information, education campaigns and break down barriers to HIV 
prevention. It also focuses on the treatment and care of PLHA [126]. 
  
Figure 1.5: Trends in HIV/AIDS Prevalence in Nigeria, 1991-2010 
 
 
Source: NACA, 2012 
 
At the end of 2010, HIV/AIDS prevalence was highest in urban areas, and the North 
Central zone, particularly Benue State [191]. There is significant variation in HIV 
prevalence among regions, states and localities (Figure 1.6) [169]. At the regional level, 
HIV prevalence ranges from 2% in the South-West up to 7% in the South-South. 
Prevalence at state level ranges from 1% in Ekiti state in the South West zone to 10.6% 
in Benue state in the North-Central [191]. While the lowest rates are reported mainly in 
the North-West states of Katsina, Kebbi and Jigawa, North-East state of Bauchi and 
South-West state of Ekiti, with prevalence rates of 2.0% or less. The large population of 
Lagos state had a prevalence rate of  5.1% and there is no state in Nigeria that is not 
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affected by HIV/AIDS [191]. More than 80% of HIV transmission in Nigeria is through 
heterosexual sex and the populations at higher risk of HIV infection are sex workers 
(25%); men who have sex with men (MSM, 17%) and injecting drug users (IDUs, 4%). 
Some of the main factors responsible for the high rate of HIV/AIDS in Nigeria are high 
illiteracy, sexually transmitted infections (STIs), poverty, low condom use and general 
lack of perceived personal risk [191]. 
Also, there are a number of possible explanations for the regional diversity, e.g. the 
lower rates in the North may be linked to higher rates of male circumcision, less or none 
alcohol consumption in the largely Muslim populations and women constraint [193,198]. 
Whilst areas of high prevalence in the North-Central may be associated with a higher 
prevalence of sex workers from the region which, was partly due to marginalisation, 
coupled with culture and low levels of education resulting in low condom use [199]. The 
impact of HIV/AIDS in Nigeria results in a reduction in life expectancy, a decrease in the 
size of the workforce and an increase in the number of orphans. This ultimately imposes 
a massive strain on the healthcare system, which further weakens an already weak 
system [135,184]. 
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Figure 1.6: Map of Regional Distribution of HIV Infection in Nigeria, 2010 
 
 
 
Source: Ezegbe and Stephenson, 2012 
1.5.2 Conflicting Cultural Practices in Nigeria   
Nigeria has a male-dominated society, where women are viewed as inferior to men, and 
their traditional role is to care for their children and the home [199,200], early marriages 
and polygamy [201]. Furthermore, in Nigerian society, a wife is not protected; being 
unable to prevent her husband from taking other wives, or having extra-marital affairs. 
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Since most Nigerian women are not educated, some social and cultural practices such 
as ‘they are to be seen and not heard’ increases their vulnerability to HIV infection. 
1.6 Rationale for this Study 
Whilst some studies have explored HIV/AIDS roles, knowledge, beliefs and practice in 
Nigeria among different HCPs, for example, dentists [136], nurses [133,135,202], 
medical doctors [134,203], laboratory scientists [135], physiotherapists [134], no study 
known to the researchers has explored the pharmacists’ role in delivering care to adults 
in Nigeria who are infected with HIV. 
Furthermore, pharmacists are the drug custodians and experts in medicines and, in 
Nigeria; they are normally the last HCPs the patient sees before being discharged from 
hospital as regards medicine usage. 
1.6.1 Gap in the Literature  
There is a gap identified in the literature about roles of pharmacies and pharmacists in 
the management of HIV/AIDS patients in Nigeria. It is clearly evident that pharmacists 
have roles in the management of HIV/AIDS patients akin to other HCPs in Nigeria as 
Idigbe et al [131] confirmed that pharmacists were involved in ART adherence 
counselling. Similarly, Zungu et al [132] found that pharmacists made use of the NATG 
more frequently compared to the least users, the nurses. However, pharmacy roles in 
the management of HIV patients have not been explored in the literature. Thus, in order 
to be able to elucidate the roles of pharmacies and pharmacists in Nigeria, there is a 
need to find out the experiences of patients during their visits to the HIV clinic. 
Consequently, generic questions about patients’ experiences at a HIV clinic in Nigeria 
will be utilised to search for generic roles of pharmacies and pharmacists’ impact on 
these patients’ management. 
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1.6.2 Aims of the Study 
This study aims to explore the service provided by hospital staff, with emphasis on the 
pharmacy provision, for adult HIV patients attending an outpatients’ clinic at Maitama 
District Hospital (MDH). 
1.6.2.1 Why Maitama District Hospital is selected for this Study 
Maitama District Hospital is one of the major government hospitals in Abuja that is 
expected to provide the best general medical services and particularly, HIV/AIDS 
services for patients due to its proximity to the office of the president of Nigeria (State 
House). Also, people seeking for medical services at MDH come from every state in 
Nigeria, Thus, every tribe in Nigeria is fairly represented amongst patients in attendance 
at MDH. Hence, the researcher thought that about the best practice for providing 
HIV/AIDS services for outpatients in government District hospitals in Abuja should be at 
MDH as precedence for other prototype hospitals in Abuja.  
1.6.3 Research Questions 
This study seeks to elicit the contribution that pharmacy may make to the management 
of HIV/AIDS patients at MDH, in Abuja, Nigeria. In the light of a paucity of data at this 
site, and in line with the principles of grounded theory (GT), it was thought appropriate 
by the researcher to elicit at a fundamental level the perceptions of patients, as to the 
management of their HIV/AIDS by the hospital; the factors that govern their perceptions 
and expectations and, finally, the views of pharmacists and hospital management as to 
the quality of the service provided. Thus, two major research questions were addressed; 
these being: 
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1. What are the patient perceptions concerning the management of their HIV/AIDS at 
MDH? 
2. What are the perceived barriers to the treatment of adults infected with HIV at MDH? 
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2. CHAPTER TWO - METHODOLOGY 
2.0 Introduction  
This chapter reviews the planning and implementation of this study, and explains the 
rationale for the use of grounded theory (GT). It discusses the procedure by which the 
research was conducted with a justification for the chosen approach. It addresses the 
research methods adopted for capturing data required to achieve the research aims. 
Qualitative research methodology is applied in this study to understand participants’ 
experience as regards HIV service provisions in Nigeria and subsequently, identify 
pharmacies’ roles in the management of HIV/AIDS patients in Nigeria. Furthermore, the 
research is exploratory and descriptive in nature, which will assist in understanding 
emerging issues that are related to management of HIV/AIDS in Nigeria. 
2.1 Statement of Research Questions 
Informed by the literature reviewed in the previous chapter, the research questions of 
this study are as follows: 
1. What are the patient perceptions concerning the management of their HIV/AIDS at 
MDH? 
2. What are the perceived barriers to the treatment of adults infected with HIV at MDH? 
2.1.1 Research Paradigms, Conceptual or Theoretical Framework 
Bunniss and Kelly [204] defined paradigms as sets of beliefs and practices, which 
researchers hold on to as norms of inquiry within different research fields. Also, 
Bordage [205] stated that conceptual or theoretical frameworks are like lighthouses and 
lenses, which clarifies and magnifies comparisons of research studies. Furthermore, 
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Bordage [205] defined conceptual frameworks as ways of thinking or studying about a 
problem or portraying how complex things do happen the way they do. The author 
further stated that emphasise on various variables and their ultimate results and 
overlaps are influenced by different frameworks [205]. Rees and Monrouxe [206] stated 
that researchers consistently express and adopt philosophical beliefs whilst they carry 
out research enquires whether acknowledged clearly or implicitly. Thus, the approach a 
researcher takes, whatever its form, reflects a position taken methodically to justify the 
philosophical ideas in the research and issues of ontology and epistemology [207]. 
Similarly, Bunniss and Kelly [204] maintained that the researcher’s ontological, 
epistemological and methodological views, all affect the methodology adopted, which  
also influences the research methods applied in the research. Thus, Mills et al [208] 
emphasised on the researchers contentment with the choice of GT methodology, 
identification of ontological and epistemological position from the beginning, which will 
enhance their beliefs in the study methods. 
2.1.1.1 Ontological Stance 
According to Bunniss and Kelly [204], ontology is the branch of philosophy which 
concerns the nature of fundamental existence in the world and is a view about the 
nature of social reality [209]. The researcher may deem the social world as being 
composed of recognisable objects and processes, e.g. the physical world or as the 
product of the perceptions and actions of people [207]. One of at least two contrasting 
views may be taken regarding social reality, objectivism or constructivism [204]. 
Ontological perceptions of qualitative study are generally subjectivism or constructivism 
whilst that of quantitative study is objectivism [209]. 
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2.1.1.2 Epistemological Stance 
According to Petty et al [209], epistemology is the means by which researchers acquire 
knowledge about reality and the assumptions or approaches taken towards the study of 
social reality. A number of contrasting views may be taken, including positivism and 
interpretivism [209]. Bunniss and Kelly [204] acknowledged that a positivist view agrees 
with an objectivist ontology, and takes the position that social reality can be studied 
objectively by the researcher and the researcher is deemed as being capable of 
studying the social world without influencing it. Epistemological perception of qualitative 
study is generally interpretivism whilst that of quantitative study is positivism [209].  
2.1.1.3 This Study Philosophical Paradigm 
This study research questions were generated and informed by the researcher’s 
ontological and epistemological stance since research questions and their 
implementations cannot be separated from the researcher’s ontological assumptions 
[207]. The epistemological stance is broadly established in interpretivism, also referred 
to as constructivism or naturalistic [209]. Petty et al [209] stated that interpretivism 
assumes that generally, understanding of the world is sought by people, as meaning or 
reality is not naturally present in objects or social situations, it has to be constructed or 
created by entities. Similarly, Bunniss and Kelly [204] stated that epistemologically, 
interpretivism recognises knowledge and its understanding as subjective such that there 
are multiple, diverse interpretations of reality and thus, no one definitive way of knowing. 
Furthermore, Bryman [207] stated that approaches to obtain people’s subjective 
meaning behind their behaviours are needed because people, as research objects of 
social science are different from those in natural science. In other words, interpretivism 
recognises a difference between natural reality and social reality and hence, requires 
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the use of different methods in social science studies compared to natural science 
studies which are dominated by positivism. 
2.1.1.4 Methodology 
Petty et al [210] defined methodology as a strategy or plan of enquiry that guides a set 
of procedures in studying social reality. As Bunniss and Kelly [204] stated, ‘methodology 
is most often used to refer to an applied approach to a particular issue’. Whilst methods 
are systematic orderly techniques taken towards data gathering and analysis to build 
knowledge [210]. 
2.1.1.5 Factors Influencing the Choice of Methodology 
Methodologically, this study was primarily guided by a dearth of research-based 
literature to inform the area under investigation; specifically the role(s) of pharmacies 
and pharmacists in the management of HIV/AIDS patients in Nigeria, interpretation of 
the available literature and an approach to new knowledge in a natural setting. 
2.1.2 Research Process 
Generally, research may be categorised into two main classes, quantitative or 
qualitative, based on the type of research question and study to be undertaken [209]. 
Qualitative research can be described as a more inductive process whereas quantitative 
research is more deductive in nature [211]. The inductive approach is more explanatory 
and exploratory in nature, whereby data are collected, themes and concepts are 
identified and, eventually, hypotheses and theories are formulated [207]. This approach 
works from the specific to the more general [212], whereas the deductive approach, 
associated with quantitative research, is more confirmatory in nature; starting with a 
theme of interest, which is narrowed down to defined assumptions (hypotheses) [213]. 
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The theme of interest is further shaped with data collection to test the hypotheses 
leading to confirmation or contradiction of the initial ideas [207].  
2.1.2.1 Quantitative Research 
Quantitative research is concerned with how many, how much, how often, and to what 
extent [212]. It uses direct observation and experiment to acquire data (positivist, 
scientific empiricism), with narrow limits of observable facts, and often omits 
researcher’s opinions [209]. A positivist stance assumes that there exists an obvious 
certainty irrespective of the research development [204]. Quantitative research is mostly 
confirmatory and thus differences between data collected and hypothesis testing are 
usually investigated systematically and are subject to verification and repetition [209]. 
2.1.2.2 Qualitative Research 
Qualitative research is any research that produces findings not arrived at by statistical 
procedures or other means of quantification such as survey methods, laboratory 
experiments and mathematical modelling [212]. Qualitative data are subject to 
researcher’s interpretation, and are usually collected in natural settings [209]. This 
methodology is suited to finding the meaning people attribute to their experiences, 
circumstances and situations [211]. This may be through what they say and/or their 
behaviour [209]. Furthermore, the researcher becomes the medium through which data 
are collected [212]. In qualitative research, three kinds of primary data collection may be 
identified, namely; interviews, observations and document analysis [211]. 
2.1.2.2.1 Rationale for Adopting a Qualitative over Quantitative Research 
Methodology in this Study 
The choice and decision to use a qualitative method for this research was led by a 
desire to explore participants’ perceptions of the service offered at the hospital under 
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study (see section 1.6.1). This was based on the fact that the population under study 
have not been investigated previously, as there was a dearth of literature on service 
provision at the site (see section 3.4.1). The study therefore required an open, 
exploratory methodology. In addition, although data may be useful to others in 
formulating opinion, the findings were not intended to be for grand or statistical 
generalization. However, it does aim to achieve fuzzy generalization due to its theory 
seeking nature. Fuzzy generalization is a qualitative measure which says or claims that 
there is a possibility that what was found in one study could be found in similar 
situations elsewhere [214]. Furthermore, a study of this nature, which started without 
any preconceptions, needed to be flexible in order to generate ideas to be formed into 
hypotheses [212]. 
2.1.2.3 Types of Qualitative Approach 
According to Petty et al [210], there are five main qualitative research approaches, 
which are: 
1. The Biography (Narrative research); 
2. Case Study; 
3. Ethnography; 
4. Phenomenology; and,  
5. Grounded Theory. 
2.1.2.3.1 Biography 
Biography is a study of a single individual and his or her experiences [212]. The 
researcher investigates the life of one individual, often collecting data primarily through 
interviews and documents of many types e.g., diaries, family histories and letters [210]. 
It is particularly useful for writing comprehensive story about an individual, for example, 
51 
 
to develop and magnify political and powerful image of a politician over potential 
contenders [214]. A wide variety of information needs to be collected from and about the 
subject of the biography by the researcher. In addition, it is important that a clear 
understanding of historical and background material is known to position the subject 
matter within the larger trends within society or culture [214]. As Bell [214] emphasised, 
it needs good and thorough structure of the story, an element of analysis and 
development of themes for the final version. 
2.1.2.3.2 Case Study  
A case study is a detailed investigation of a specific individual, groups or institutions. It 
can also be used in specific situations, for example about decision making, planning for 
the future, completing process, or administrative changes [215]. To an extent, it is 
unstructured information, and is usually applied in political sciences, sociology, and 
many other social sciences [207]. The main difference between case studies and other 
qualitative methodologies is that the focus of attention is the individual case and not the 
whole population of cases [210]. A variety of data collection methods are employed in 
case study research which include interviews, observations, documents analysis and 
archival records which leads to a wider extent of data collection and may project the 
phenomena under study larger than in real world [210]. Denscombe [216] affirmed that 
the use of the case study can either be carried out as a follow up to a previous finding 
when it describes what is happening in a case study settings and can also precede a 
finding when it identifies and explains the causes of events, processes or relationships 
within a setting. Though Bell [214] emphasised that most case studies are carried out as 
free-standing studies.  
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2.1.2.3.3 Ethnography 
Ethnography attempts to describe and interpret a social-cultural system, highly rooted in 
the study of human beings from cultural aspects and sociology [210]. Ethnography is 
useful when social conditions, attitudes, roles of people and interpersonal relationships 
are explored according to the set down cultural practices [211]. It is usually carried out 
using observations and interviews to collect data, though as Bell [214] points out, many 
methods such as mapping, charting, interaction analysis, historical records and 
documents are applied. An ethnographic study may require extended periods of time 
collecting data because in the research environment, an ethnographer may need to be 
integrated into the culture for first person observation [210]. There is no limit of what will 
be observed for better understanding and thus, no real ending point in an ethnographic 
study and the focus of the findings are more descriptive than statistical [207]. 
2.1.2.3.4 Phenomenology 
Phenomenology is considered a philosophical perspective as well as an approach to 
qualitative methodology [210]. It has a long history in several social research disciplines 
including psychology, sociology and social work [212]. The phenomenologist wants to 
understand how the world appears to others and often, phenomenology has been used 
to describe residents lived experiences [211]. Phenomenology explores the common 
meaning of experience of an observable occurrence for several individuals. Thus, the 
researcher conducts interviews in order to describe the general experiences of several 
participants who witnessed the events to a central (focal) meaning of all the happenings 
[217]. As Petty et al [210] argued, to grasp and identify a phenomenon, the 
phenomenologist need to reduce the experiences of persons with a phenomenon to an 
acceptable focal descriptive idea which, can later be employed, to inform, improve, 
support or challenge policy and action. 
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2.1.2.3.5 Grounded Theory 
Grounded theory (GT) begins with a research situation and the researcher’s aim is 
usually to understand what is happening, and how participants manage their situations 
[208]. Sbaraini et al [218] acknowledged that GT has become popular in areas of 
sociology, nursing, education, psychology, and other social science. According to 
Corbin and Strauss [219], ‘a grounded theory design is a systematic qualitative 
procedure used to generate a theory that explains at a broad conceptual level, a 
process, an action or interaction about a substantive topic. Rees and Monrouxe [206] 
defined theory as ‘a set of statements or principles devised to explain a group of facts or 
phenomena, especially one that has been repeatedly tested or is widely accepted and 
can be used to make predictions about natural phenomena’. 
First of all, the aim of GT is to enable researchers to generate novel realistic theories 
rather than testing theoretical hypotheses or developing rich descriptions of particular 
phenomena [218]. As Hanson et al [211] explained, theory generation is the ultimate 
goal of GT studies so that higher level of understanding that is “grounded” in or derived 
from a systematic analysis of data is developed, whereby, the theory emerges through a 
close and careful analysis of the data. This is exactly in accordance with the aim of this 
research, which is to explore the service provided by hospital staff, with emphasis on 
the pharmacy provision, for adult HIV patients attending an outpatients’ clinic at MDH. 
Also, the literature review showed that there is a gap in the literature on roles of 
pharmacies and pharmacists in the management of HIV patients in Nigeria which further 
highlights the need for this research and hence, the appropriateness of GT approach to 
address this gap in the literature. 
GT is founded on an iterative, inductive and deductive cycle where theory is allowed to 
emerge directly from data and tested against the real world [212,214,220]. As Hanson 
et al [211] stated, to create a theory that can be further tested in GT, the researcher 
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need to listens, observes, and be submerged in data. Data moves from the specific to 
the more general theory. It does not test a hypothesis. It sets out to find what theory 
accounts for the research situation, an action research [212]. The aim, as Glaser stated, 
‘is to discover the theory implicit in the data’ [221]. 
2.1.2.3.6 Rationale for using Grounded Theory in this Study 
Different approaches to exploring the research questions were considered, and the 
advantages and disadvantages of each taken into consideration. An early decision was 
taken that an inductive approach would be most suitable for this kind of research. This 
means that concepts, hypotheses and generalisations will emerge or are derived from 
the data, as opposed to deduction where data is collected to test a predetermined 
theory or hypothesis [209]. The decision to take this approach was relatively easy, as 
there is no prior knowledge about the contribution of pharmacy to the management of 
HIV patients at MDH, Abuja, and the development of hypotheses or specific theory 
would involve an extent of speculation. This decision naturally led the study to a more 
qualitative design. 
Although qualitative methodologies can be used to test hypotheses, they are usually 
associated with the development of concepts that can assist in understanding social 
phenomena in natural settings, and these qualitative methodologies place emphasis on 
experiences, meanings and views of participants [211]. This type of approach would 
provide a starting point for further, perhaps more quantitative work. Indeed qualitative 
research can be a prerequisite of good quantitative research, especially in areas that 
have received little previous investigation, as it facilitates the follow up of initial findings 
[211]. 
Thus, an iterative, cyclical, GT approach to data collection will be employed in this study 
[210,211,221]. The practical emphasis of GT raises its predominance in the research 
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world, contributes to its value and thus, being one of the most popular research 
approaches in the world [222]. As Birks and Mills [222] argued, practice or human 
interaction and what is practical or pragmatic philosophy are the main concerns of GT 
study. These qualities of GT shape the research aim in the field and on explaining 
relationships between various elements of a phenomenon within a specific context. 
Also, these research qualities make GT so popular with studies on perceptions and 
interpersonal relationships [218]. Petty et al [210] confirmed this view by stressing the 
importance of the process of individual actions and interactions within perceptions in 
GT. 
2.1.2.3.7 Hypothesis Emergence and Acceptable Data in Grounded Theory 
The main difference between GT and other research methodologies is that it is explicitly 
emergent [218]. GT does not test a hypothesis but sets out to find what theory accounts 
for the research situation as it is [210]. Mills et al [208] argued that the explanatory 
power of GT reveal issues for people such that there is identification and application of 
theory in their own lives. GT is mostly carried out through observation, conversation 
(focus groups) and interview [210]. There are usually two acceptable sources for data in 
GT studies which are first person observations and face-to-face interviews [223]. 
2.1.2.3.8 Different Styles of Grounded Theory 
Various authors have come up with different types of GT, for example;   
1. Original version of GT by Glaser and Strauss, 1967 [224] 
2. Glaserian GT [225] 
3. Corbin and Strauss version of GT [219] 
4. Constructivist GT by Charmaz, 2006 [226] 
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Glaser’s approach to GT is traditional and purist, which is open-minded towards the 
research strategy [227]. Thus, theory building or generation is not interfered with in any 
way by the researchers’ preconceptions, but has to evolve directly from the data. The 
Strauss and Corbin approach is more practical or realistic, with a more structured view 
towards theory building, which specifies the use of rational and guiding principles. The 
researcher is encouraged to mix GT with other methodologies, and to apply 
researcher’s perspectives and prior knowledge to the topic where appropriate [219]. 
Charmaz has developed a modified GT, with a constructivist interpretation, which 
agrees more with the original concepts of Glaser and Strauss rather than those of 
Strauss and Corbin [221]. 
2.1.2.3.9 Principles of Grounded Theory 
There are four essential yardsticks for GT: 
1. Fit; 
2. Work; 
3. Relevance; and, 
4. Modifiability. 
Glaser suggested the main criteria for judging the adequacy of the emerging theory: 
‘that it fits the situation; and that it works, that it helps the people in the situation to make 
sense of their experience and to manage the situation better [224]. 
2.1.2.3.10 Style of Grounded Theory Applied in this Study 
Since the discovery of GT by Glaser and Strauss [224], many researchers have 
modified and improved on it in all aspects of action research, especially that carried out 
in naturally setting; for example, Bryant and Charmaz [221], Clarke, 2009 [228]; Corbin 
& Strauss, 2008 [219], Charmaz, 2006 [226]. On exploring several of the authors in the 
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field, Charmaz’s approach to GT was considered to be most suitable for this study 
[226]. Charmaz [226] bases her version on constructivist assumptions and abductive 
reasoning, while continuing to adhere to the structured analytical approach and constant 
comparison contained in earlier versions. Charmaz’s [226] explanation of constructivist 
GT provided several additional valuable tools that this study has attempted to integrate. 
2.1.2.4 Justification for Using Grounded Theory 
The open-ended questions in this study are about HIV/AIDS service provision at MDH, 
which will allow the interviewees to express their views about living with HIV, and/or 
clinical services provision for HIV/AIDS patients. Also, their responses will be recorded 
with a voice recorder along with manual jottings (including body language) to record the 
interviewees’ responses. Consequently, GT will allow the researcher to establish 
interviewees’ perspectives for improving the service provision and systems, in a manner 
which will be meaningful and valuable to them. Also, roles of pharmacies and 
pharmacists in the management of HIV patients in Nigeria will be established from data 
collected about experiences and views of HIV patients receiving services at a HIV clinic 
at MDH, that is, theory will be generated from data as it relates to GT principles. The 
fact that GT is used to generate theory makes it the best choice to generate ‘theory’ as 
to the role of pharmacy in the management of these patients – a strong reason for using 
GT rather than any of the other methodologies described above. 
2.1.3 Sampling 
This study will use a purposive sampling technique. Purposive sampling [211], (also 
known as theoretical sampling in GT) [223] is a non-random sampling method used in 
qualitative research to strategically select a limited number of participants that have 
particular characteristics, so that their in-depth information will give optimal insight into 
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the area under investigation. Thus, the purposive sampling technique of GT makes it a 
valid and effective methodology in terms of theory development and establishment 
[218]. Rather than deciding sample size before data collection and analysis, the 
theoretical sampling method uses findings from initial data collection and analysis to 
inform further sampling and data collection [218]. It requires the researcher to collect 
data and analyse them simultaneously so that he or she can make the decision for 
further sampling and refine the theory being developed [221]. This particular process, as 
Mills et al [208] stated, sets up a clear boundary between the categories and helps 
researchers identify the properties of categories, relevant context, specific conditions for 
a particular phenomenon and subsequent outcomes. As far as this study is concerned, 
purposive sampling would assist and guide to identify attributes of pharmacist roles at 
an HIV clinic, the pharmacists views about the service they provide, the barriers 
associated with their roles and consequently, their expectations. Therefore, only 
patients and staff who have experiences about HIV/AIDS clinical service provision will 
be chosen for the study. 
2.1.4 Data collection 
The data collection techniques considered for this study included observation, focus 
groups and in-depth interviews [210]. It would not be appropriate to use an 
observational technique in this study, as the thought processes of the subjects cannot 
be observed [212]. Focus groups are unstructured, or semi-structured interviews, with 
small groups of people, who interact with each other and with the group leader [210]. 
This technique can produce extremely valuable data about people’s experiences and 
opinions as the group dynamics produce a discussion whereby ideas are shared and 
new ideas are produced. However, there are two main disadvantages to the use of this 
technique in relation to this study. First, conducting focus group interviews with a busy 
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and understaffed profession, such as hospital pharmacists is difficult to achieve. 
Secondly, problems arise with the topic of discussion itself; HIV is a sensitive issue, and 
patients/pharmacists may not wish to express themselves in front of others. Therefore, 
the technique that seemed most appropriate for this study was chosen to be semi 
structured in-depth interviews. One to one interviews will be employed to collect data for 
the GT study in this research. Interview is more direct, more flexible and theoretically, 
able to collect more data when compared to other data collection methods such as 
observation and questionnaire [212].  
2.1.5 Interviews 
According to Kvale and Brinkmann [229], an interview is literally, an inter-change of 
views between two persons conversing about a theme of familiar interest - a specific 
kind of conversation with a purpose. Where the researcher tries to understand 
something from the subjects point of view and to uncover the meanings of their 
experiences and get to know the interviewees better [211]. 
2.1.5.1 Types of Qualitative Interviews 
There are three main types of qualitative interviews namely: 
1. Structured; 
2. Semi-structured; and,  
3. Unstructured. 
2.1.5.1.1 Structured Interviews 
This technique involves use of questions in a standardised manner, administering 
structured questionnaires and fixed responses to which the participants respond [229]. 
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2.1.5.1.2 Semi-structured Interviews 
This technique has loosely predetermined open-ended questions from the beginning 
[210]. However, the order of questioning and wordings can be changed depending on 
what the interviewer wants to pursue. It can be used if the interviewer knows the topic 
well [229]. 
2.1.5.1.3 Unstructured (In-depth) Interviews 
This technique aims to develop ideas and hypothesis rather than mere collection of data 
and uses prompts and probes for elaboration on the focal point [212]. This type of 
interview has one main fundamental principal; that the participant’s perception on the 
particular topic should unfold as the participant views it, not as the researcher views it 
[210]. There are a number of advantages of this technique. First, it avoids imposing the 
researcher’s prior assumptions, such as is done when developing a structured interview 
schedule. The dynamic of the interview allows for discovery of the participants own 
meanings. These can be clarified by the interviewer during the interview and this also 
means that questions can be altered to fit in with the participants own understanding 
and meanings. Secondly, a less standardised and less rigid interview schedule ensures 
that questioning is appropriate to the participant and the particular interview situation. 
Thirdly, the interview questions are open ended and this encourages the discovery of 
new concepts and ideas unforeseen by the researcher. Interesting issues or ideas that 
may arise during an interview can then be followed up. This whole approach can then 
produce findings of high validity [229].  
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2.2 Methodological Issues 
2.2.1 Data Analysis 
Data analysis will be approached using thematic analysis as stated by Petty et al [210], 
thematic analysis is a commonly used analytic method in qualitative research. Also, 
according to Hanson et al [211], qualitative data analysis is considered as occurring in 
three passes as shown below (Figure 2.1). Thematic analysis is a rigorous and 
systematic means of describing and quantifying textual data [230], a method of analysis 
which enhance understanding of data through fracturing and refining of words into fewer 
concepts which eventually leads to similar focal meanings [218]. Also, Braun and Clarke 
[231] stated that thematic analysis, also referred to as discourse analysis and content 
analysis is a method for identifying, organising, describing, analysing, interpreting and  
reporting themes in data. It is also a means of reproducing significant deduction from 
data as it relates to the area of interest, with the purpose of better knowledge 
generation, new perceptions, depiction of facts and, ultimately, a pragmatic guide to a 
way forward [232]. The aim is to achieve a reduced but general description of the 
phenomenon, and consequentially, concepts or categories describing the phenomenon 
are obtained [212]. Usually, the purpose of the concepts or categories is to build up a 
model, conceptual system, conceptual map or categories. The researcher has a choice 
of using concept or category, based on the purpose of the study [214] and in this study, 
concept will be applied since the subject of interest is about service provision and 
participants’ views. 
According to Petty et al [210], thematic analysis involves the researcher reading and re-
reading the interview transcripts and field notes, in order to assign preliminary codes; 
then reflecting on these as further interviews are conducted, transcribed and coded. As 
Hanson et al [211] stated, codes are words that act as labels for important concepts, 
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which emerge as data analysis progresses and are completely grounded in the original 
data. The researcher then attempts to identify any themes, or ideas, based on the 
coded interview data and field notes. For the purpose of this research, themes are the 
strings of commonalities that depict the obvious meaning of diverse experiences which 
emerged during data analysis [211]. Also, for the purpose of this research, concepts are 
the groups of similar ideas (themes) put together to inform the general research ideas 
[211]. This approach allows for flexibility and rigour in the research design, as there will 
be continuous coding and analysis of the data [218]. This will permit the follow up of 
individual themes in the subsequent interviews and data can be collected in order to 
strengthen previous findings until a point of data saturation is reached. Data saturation 
is the point at which no new knowledge or themes are achieved with more data 
collection [218]. It will also allow for direct comparison to previous data [233] (constant 
comparison method). This whole process can lead to the iterative confirmation and 
refinement of ideas and concepts generated by the study [211]. This approach is suited 
to the exploration of undeveloped areas such as roles of pharmacies and pharmacists in 
the management of HIV patients in Nigeria as it allows flexibility and openness to new 
ideas. 
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Figure 2.1: Qualitative Data Analysis  
 
 
  
 
 
 
 
 
 
 
 
 
 
Source: Hanson et al, 2011 
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in a certain manner. For example, interviewees may feel like they are being tested 
[215]. To deal with this effect, the researcher will make the interviewee feel at ease and 
will reflect on her effect on the interviewees’ responses throughout the study. Conscious 
bias can be controlled by avoiding leading questions and phrasing questions using the 
interviewees own and body language [207]. 
2.2.3 Validity 
A good way of ensuring validity is to produce an audit trail [211]. A full record of 
activities while carrying out the study will be kept, including a record of transcripts, field 
notes, details of coding and data analysis. This will reduce researcher bias and can be 
reflected on by both the researcher and the researcher’s supervisors. As part of the 
overall approach to data analysis, the concepts will be continuously revised and refined 
until general ideas are found, and will strengthen the validity of any claims or ideas 
emerging from the findings [221]. 
2.2.4 Ethics 
According to the Cambridge advanced learner's dictionary [234], ethics are moral 
beliefs and rules about right and wrong, and are the guidelines set down to inform 
researchers of their responsibility towards their subjects and their sensibilities [218]. An 
ethical study should address the ‘Golden Question’ that the researcher should not 
subject their subjects to any process or procedure to which they, themselves, would not 
wish to be subjected. 
Hence, research ethics address the areas of the informed consent and confidentialities 
of the individuals to be interviewed, questioned or observed. Also, the questions to be 
asked, where and how they are to be presented during any study must all be included. 
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Agreements must be established about the uses of data collected and any subsequent 
data analysis must be agreed [214]. 
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3. CHAPTER THREE - METHODS 
3.0 Introduction 
This chapter looks at the confidentiality of participants recruited, setting and ethical 
considerations for this study, participants included in the study, and summary of 
narratives of how the study was conducted. The following section describes the 
methods used in this study to collect, analyse, and report data. 
3.1 Confidentiality 
As in any ethical study, participants in this study were assured of voluntary participation, 
both verbally and through the participants’ study leaflets (Appendix 4.2, 4.4.2), that 
participants could withdraw at any time and confidentiality was protected. All responses 
were anonymised before analysis, and special care was taken not to reveal possibly, 
identifying details of participants. All data will be treated as strictly confidential. To 
ensure this, all identifying features of the participants will be removed from the data 
during transcription. The study will respect all patient confidentiality, and participants will 
be asked not to mention patients by name. However, if any details of patients are 
inadvertently given by participants during interviews, they will not be included in the 
transcripts. The only people to have access to data are the researcher and her 
supervisors. All data, such as interview transcripts, voice recorder, and contact details 
will be stored in a locked filing cabinet and any computer files will be password 
protected. All data will be kept for a maximum period of 5 years after the study has been 
completed to allow for the writing up of relevant papers. After such time, the voice 
recorder and other data will be destroyed. The analysis of data will be performed by the 
researcher and will take place in appropriate, secure, research surroundings. 
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3.2 Informed Consent 
Participants (patients) will be selected according to the study's sampling strategy (see 
section 2.1.3) at the MDH on their clinic days. Participants will then be asked for 
appropriate time when they will be interviewed at a place reserved by the principal 
researcher within the hospital on their clinic days. Once this has been attained a 
consent form will be given (or read and explained to the ones who cannot read) to them 
along with a participant information sheet. Any further questions the participants may 
have will be answered face to face by the principal researcher. The participant will be 
allowed to decide whether to take part in the study and they will be made aware that 
they can withdraw from the study at any time. The signed consent form will be collected 
immediately before the interview. Similarly, the pharmacist’s participants will be 
recruited at ARV pharmacy unit (APU) when they are on duty or via telephone when 
they are out of the hospital premise. They will then be asked for the appropriate time 
and place within the hospital for the interview. The pharmacists will be given the 
participant (pharmacist) information sheet and consent form. They will also be allowed 
to decide whether to take part in the study and they will be made aware that they can 
withdraw from the study at any time. Interviews will commence only after each 
participant agreed to participate and the signed consent form will be collected prior to 
the interview. 
3.3 Pilot Study 
It is strongly advised that interviewers are trained in the technique of in-depth 
interviewing, before they go into the research field. Therefore, the researcher read 
books on research interviews, for example, Kvale and Brinkmann [229], Robson [212], 
Bell [214], and Bryman [207]. Also, the researcher conducted mock interviews with five 
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Nigerian students studying at the University of Wolverhampton (UoW). Analysis of mock 
interview transcripts was also performed at the UoW to allow the researcher to 
understand the process involved from transcription to thematic analysis. This process 
was facilitated by an external researcher, who has extensive experience with qualitative 
analysis. Especially valuable was the chance to experiment with the computerised 
qualitative analysis software package, NVivo. A course was attended by the researcher 
within the University on the subject of computerised qualitative data analysis. 
These interviews provided the researcher with some practice of conducting interviews 
and also an opportunity to run through the procedures employed for transcribing and 
analysing qualitative data. However, the questions that were used were not the same as 
the actual interview questions used in Nigeria since the students were not the intended 
participants, though it enabled the real questions to be properly phrased as necessary. 
It was realised by the researcher that a clear understanding of what the interviewee 
wishes to be recorded, either by voice recorder or on paper should be established prior 
to the interview. No major changes were made to the interview schedule itself but the 
manner in which the interview was to be introduced was certainly modified so as to 
make it less formal. 
3.4 Setting  
The study was carried out at MDH, Abuja, Nigeria and at four NHS hospitals in the West 
Midlands of the UK. Abuja is a city of over 1.4 million [153] people and is divided into 
districts which include Asokoro, Central area, Garki, Maitama and Wuse. Maitama 
District is to the North of the city. Abuja was chosen for this study as its population 
represents all tribes in Nigeria [153] and it is one of the cities in Nigeria that has highest 
number of PLHA ( Figure 1.6) 
69 
 
3.4.1 Maitama District Hospital 
Maitama District Hospital (Figure 3.1) is the largest government-owned hospital in the 
Maitama District of Abuja. It is a 60-bedded hospital occupying a two-storey building. 
The ground floor contains record offices where all new patients obtain their cards, 
outpatients consulting rooms (adults and children), accident and emergency ward, 
antenatal clinic, immunisation unit, optometry, laboratory, x-ray unit, and outpatient 
pharmacy. Outpatient HIV/AIDS patients are attended to by staff members on the 
ground floor and the antiretroviral pharmacy unit (APU) is located adjacent to the main 
hospital building. The first floor of the hospital accommodates all in-patients, including 
children, adult males and females and VIP wards. Also found on the first floor are the in-
patient pharmacy, surgical theatre, labour, post-natal and surgical wards. On the 
second floor are predominantly administrative offices and record archives. 
Figure 3.1: Upper Front View Photograph of Maitama District Hospital, Abuja, 
Nigeria, taken on 30th July 2010  
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3.4.2 NHS Hospitals 
For purposes of comparison, HIV/AIDS pharmacists at four NHS hospitals within the 
West Midlands were also interviewed; these were:  
• New Cross Hospital (NCH); 
• Birmingham Heartlands Hospital (BHH); 
• Selly Oak Hospital (SOH); and, 
• Walsall Manor Hospital (WMH). 
3.5 Ethical Issues 
Since the subject of this research had to do with patients and their sensitive behaviours, 
the researcher sought and received ethical approval from the appropriate authorities. 
These were:  
• Maitama District Hospital Research Ethics Committee (Appendix 1); 
• University of Wolverhampton’s Behavioural Sciences Ethics Committee (BSEC); and   
• Federal Capital Territory Health Research Ethics Committee (Appendix 3). 
3.6 Sampling 
This study used a purposive sampling technique, which is a non-random method of 
sampling; participants being chosen for their knowledge and experience of the topic. 
Hanson et al [211] defined purposive sampling as a sampling method used in qualitative 
research to select a limited number of participants, strategically, so that their in-depth 
information will give optimal insight into the issue under study. A quantitative sampling 
strategy, such as systematic random selection [212] was not selected as the intention of 
the research is not the statistical generalisability of results, but rather an exploration and 
description of a complex and interesting phenomenon. Since the questions for the 
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interviewees had to do with experiences of the HIV/AIDS service provided at MDH, 
patients newly diagnosed who had not previously attend the HIV/AIDS clinic were not 
selected for interview. Similarly, hospital pharmacists who did not attend to HIV/AIDS 
patients were not asked for their opinions. 
Since the researcher is not a registered Pharmacist in the UK, a snowball technique 
was used to recruit UK pharmacists to the study; seeded from a senior contact at New 
Cross hospital. According to Petty et al [210], snowball sampling is a form of non-
random sampling in which the researcher identifies an individual as an appropriate 
participant, then the participant is asked to identify other potential participants and there 
is a repeat of the procedure until sufficient data is collected. 
3.7 Recruitment of Participants  
3.7.1 Interviews 
Patients were recruited to the study at the point where they entered the waiting area for 
the HIV/AIDS clinic at MDH. Potential recruits were given an introductory letter by the 
researcher (Appendix 4.1) together with details of the study, and of their rights to 
confidentiality and withdrawal from the study and a consent Form (Appendices 4.2 and 
4.3). Patients who confirmed their consent to take part in the study were recruited for 
interview. 
Pharmacists at MDH who were working in the HIV/AIDS clinic were approached directly 
to participate in the study. As with patients, they were provided with details of the study 
and asked to sign a consent Form before being interviewed. 
Due to the small number of management personnel at MDH, hospital managers were 
approached on an individual basis to take part in the study. Consent Form and 
guarantees of confidentiality were given. 
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In the UK, pharmacists were identified by the snowballing technique described in 
section 3.6 and, again approached directly to participate in the study. 
3.7.2  Patient Journey 
Again, patients were recruited to the study at the point where they entered the waiting 
area for the HIV/AIDS clinic at MDH. Potential recruits were given an introductory letter 
by the researcher (Appendix 4.1) together with details of the study, and of their rights to 
confidentiality and withdrawal from the study and a Consent Form (Appendices 4.2 and 
5.3). Patients who confirmed their consent to take part in the study were then observed 
throughout their stay at MDH. 
3.8 Study Protocols 
At MDH, three groups of personnel were invited to speak about their views pertinent to 
their perceptions of, and/or management of HIV/AIDS at the hospital. In the UK, 
pharmacists were invited to share their views on the management of HIV/AIDS in their 
hospital. The groups approached were: 
• Patients attending the HIV/AIDS clinic at MDH (Phase I and Phase II); 
• Pharmacists working in the HIV/AIDS clinic at MDH; 
• Management personnel at the MDH; and  
• NHS HIV pharmacists. 
In all cases, individual in-depth interviews were carried out, using the appropriate prime 
questions (Appendices 4.4, 4.4.3, 5.2, and 5.5) and any necessary prompts, and the 
interviews recorded using a recorder (Sony ICD B500). Interview transcripts were 
prepared and analysed by a process of re-iterative thematic data analysis, and based 
on the principles of GT, to identify themes and concepts that could be used to 
73 
 
characterise the interviewees’ thoughts and views. Where appropriate, interviews were 
continued until the interviewer perceived that data saturation had been achieved. 
3.8.1 The Need for Pidgin English and Prompts concerning Faith 
in Phase II Interview Questions 
Following analysis of the first group of patient interviews (Phase I), two factors emerged 
that necessitated further follow up and these are:  
1. A number of restrictions to expressions were identified by the researcher, centring 
on patient understanding of the prime questions and the language used by both the 
interviewer and the interviewee. 
2. The influence of a concept of ‟faith” which, impacted very strongly on the patient 
perception of HIV/AIDS service provision at MDH. Therefore, prompts with 
emphasise on faith were designed. 
Thus, an additional set of patient interviews were undertaken (Phase II), using an 
enhanced approach with prompts; in an attempt to overcome any perceived barriers to 
effective communication. Data achieved from these Phase II interviews allowed the 
researcher to examine and identify any further themes derived from these patients that 
may have been inhibited in the Phase I study, thus giving an expanded insight into 
patients’ views. 
3.8.1.1 Patient Interviews (Phase I)  
Twenty-five patient interviews were conducted in October 2009 with five patients’ 
interviews at each meeting. Identifiable concepts began to emerge at the fifth interview, 
and these were subsequently explored in further interviews. Category saturation was 
achieved at the twentieth interview. However, in order to ensure that data saturation 
was complete, interviewing was continued until the twenty-fifth patient. 
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3.8.1.2 Patient Interviews (Phase II)  
Ten patients were interviewed for the second phase of interviews and the questions had 
prompts, which were based on themes obtained from the Phase I patient interviews. 
Similar themes to those obtained from the first phase of patient interviews emerged 
from the second phase of patient interviews, and the interviews were terminated after 
ten patients due to data saturation. 
3.8.1.3 Pharmacists at MDH  
Ten hospital pharmacists were interviewed. 
3.8.1.4 Management Personnel at MDH 
Interviews were carried out with two medical record officers who were overseeing 
registration process for all HIV/AIDS patients at MDH. These interviews were written 
down since the interviewees did not want their voices to be recorded. 
Finally, the Senior Medical Officer in-charge of clinical service for HIV patients at the 
hospital was interviewed on HIV service provision.  
3.8.1.5  UK Pharmacists 
Interviews were carried out with four HIV/AIDS pharmacists in the UK. 
3.8.1.6 Patient Journeys 
In a parallel study, patients were observed during their visit to the HIV/AIDS clinic at 
MDH, in order to identify a ‘Patient Journey’ that described the physical activities of 
patients during their visit to the hospital clinic. Patients were identified individually at the 
start of their hospital appointment and details of their journey through their attendance 
at the HIV/AIDS clinic noted in order to identify any points of potential delay. 
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During the second phase of data collection, ten patients were shadowed at the hospital 
on their appointment days to confirm how HIV patients go through their day-to-day 
activities at that HIV hospital. Also, patient’s journeys emerged as a theme during the 
first phase of patients interviews. The shadowing was terminated after ten patients 
because the patients did not want to be followed around the hospital for their identity 
protection. The researcher followed each patient that was shadowed after consented to 
be followed from the outpatient waiting room until they were seen leaving the hospital 
through the main gate. 
3.9 Methodological Issues 
3.9.1 Reflexivity 
In qualitative research, it is important to be aware that the researcher will have biases, 
interests, values, experiences and characteristics that all affect the data collected and 
the researchers interpretations of the data [207]. In order to be reflexive, the researcher 
endeavoured to maintain an awareness of her impact on the study. As an aid to 
ensuring a degree of reflexivity, the researcher kept a research diary and made field 
notes during all interviews.  
The interviewer can both consciously and subconsciously, influence respondents to act 
in a certain way. If the interviewee appears to hold certain values the respondent can 
react in a socially desirable way [215]. The fact that the researcher is a pharmacist, and 
the identity was not concealed, had some effect on the interviewee. This may cause the 
interviewee to react to questioning in a certain manner. Interviewees may even feel like 
they are being tested [235]. To deal with those effects, the researcher made the 
interviewees feel at ease and reflected on her effect on the interviewees’ responses 
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throughout the study. Conscious biases were controlled by avoiding leading questions 
and phrasing questions using the interviewees own and body languages. 
3.9.2 Validity and Reliability 
A good way of ensuring validity and reliability is to produce an audit track [210]. A full 
record of activities while carrying out the study was kept, including a record of 
transcripts, field notes, details of coding and data analysis. Furthermore, the audit track 
reduced researcher’s bias and can always be reflected on by both the researcher and 
the researcher’s supervisors. As part of the overall approach to data analysis, examples 
were sought throughout the study, where prior findings are disconfirmed and are 
contrasted with. This approach is called negative case analysis [212] and will strengthen 
the validity of any claims or ideas emerging from the findings. 
3.9.3 Limitations of this Approach  
In addition to the limitations that have been previously discussed regarding the 
individual data collection methodologies, there is also another more general limitation of 
the study. Pharmacists and doctors are experts who are accustomed to having control 
and it seems natural that when placed in a situation such as an interview they will 
attempt to make sense of the research and apply their own agenda or theories of what 
the research is about. This behaviour is termed ‘demand characteristics’ [209] as the 
participant will often try to understand the aims and objectives of the study. That led to 
anxiousness on the part of the participants who often wants to confirm their beliefs of 
the purpose of research. This behaviour was exhibited during both interview phases.  
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3.10 Data Analysis 
As stated in Chapter 2, a thematic analysis in line with the GT approach to data analysis 
of pharmacist and patient interviews was undertaken. The principle of GT data 
collection and analysis is shown in Figure 3.2. 
Figure 3.2: Grounded Theory Data Collection and Analysis ‘Dance’ 
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Following ad verbatim transcription of interviews, manual data analysis was carried out 
by the researcher, reading and re-reading the interview transcripts and field notes in 
order to assign preliminary themes; then reflecting on these as further interviews were 
conducted, transcribed and coded. The researcher then identified themes or ideas 
based on the coded interview data and field notes. That approach allowed for flexibility 
and rigour, as there was continuous coding, and analysis of the data. That permitted the 
follow up of individual themes in the subsequent interviews and data was collected in 
order to strengthen previous findings or contrast with them. It also allowed for direct 
comparison to previous data (constant comparison method). That whole process led to 
the confirmation, refinement and rejection of ideas and the development of concepts 
generated by the study. 
For comparative purposes, a secondary process of data analysis was carried out on the 
Phase II patient interviews in order to ascertain whether, or not, computer-based 
analysis gave differing views on the development of concepts. 
3.11 Methodological Narratives 
The actual activities for this study started with a request letter, which was written to 
MDH Ethics Committee Chairman by Professor Rae Morgan, on behalf of this research 
team to request for the principal researcher to carry out this research at MDH. The MDH 
Research committee approved the request and replied with a letter to back it up 
(Appendix 1). The letter of approval to carry out this research at MDH Abuja from that 
committee was attached to the proposal to the BSEC as a proof of approval from the 
primary site to carry out this research. Following an approval from the BSEC, the 
principal researcher went to MDH to collect data for this research. 
On Tuesday 15/09/2009, at MDH, the principal researcher informed the hospital 
authority through a letter (Appendix 2) of her presence in the hospital for data collection 
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which was acknowledged. The researcher also met the hospital pharmacy chief 
pharmacist who introduced her to the focal pharmacist of APU, MDH. The focal 
pharmacist then took the researcher round the units that were directly involved with 
HIV/AIDS at MDH. The focal pharmacist also informed the researcher about the clinic 
days, which were Mondays for new patients and Wednesdays for repeat patients. 
Wednesday 16/09/2009, the researcher went to the HIV/AIDS outpatients’ waiting room 
where over 111 patients were already in attendance. The researcher recruited thirty 
HIV/AIDS patients, who were willing to take part in the study. A letter of invitation 
(Appendix 4.1) to take part in the research along with a patient participant information 
sheet and a consent form (Appendix 4.2 and 4.3 respectively) were given to the 30 
sampled patients at the HIV outpatients waiting area of MDH. The researcher explained 
to those who could not read individually the overall ideas of the study. At the end of that 
clinic day, those approached by the researcher were able to confirm when next they will 
be coming back to the hospital and attend the proposed interviews. 
Similarly, the researcher gave the focal pharmacist at the APU within MDH a letter of 
invitation (Appendix 4.1); along with a pharmacist participant information sheet and 
consent form (Appendix 4.4.2, and 4.3 respectively). The researcher equally talked her 
through the importance of the study and made it clear to her that all the pharmacists 
who have attended to HIV/AIDS patients were needed for interviews and probably for a 
focus group. The focal pharmacist then gave the researcher telephone numbers of all 
the pharmacists who had attended to HIV/AIDS patients at MDH. It must be stated here 
that it was very difficult to track more than two of this group of pharmacists down at 
once. 
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3.11.1 First Phase of Data Collections 
Analysis of the patients’ interviews and pharmacists’ interviews were carried out, 
themes and concepts emerged. Then following the pattern of patients responses, we 
(principal researcher and her research supervisors) decided to come up with prompts 
for each question for the patients. That was done specifically to find out if we could get 
any different views on their experiences from them. We were given the go ahead from 
the BSEC; hence the researcher went to Nigeria in June 2010 to carry out more 
interviews with the patients. Also, ‘patient journey’ was identified from the first phase of 
interviews as a core category and needed to be explored further in Nigeria. Hence, ten 
patients were shadowed within MDH to note how much time they spent at the hospital. 
Also, we agreed after the analysis of data from phase one that it was necessary to have 
a formal chat with a hospital administrator at MDH who knows details about clinical 
service provision for HIV/AIDS patients.  
3.11.2 Second Phase of Data Collections 
The researcher went to MDH on 24th June 2010 and informed the hospital authority of 
the researcher’s presence through a formal letter (Appendix 5.1) which was 
acknowledged to collect further data on the study from 28th June to 2nd August 2010. 
Ten patients were then interviewed for the second phase of interviews and the 
questions had prompts, which were based on themes obtained from the phase one 
patient interviews. Similar themes to the themes obtained from the first phase of patient 
interviews emerged from the second phase of patient interviews and the interviews had 
to be terminated after ten patients due to data saturation. 
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3.11.3 Patient’s Journey Observation 
During the second phase of data collection, ten patients were shadowed at the hospital 
on their appointment days to confirm how HIV patients go through their day to day 
activities at that HIV hospital. The researcher followed each patient from the outpatient 
waiting room until they were seen leaving the hospital through the main gate. 
3.11.4 Medical Record officers’ interview 
Two medical record staff, who were overseeing registration process for all HIV/AIDS 
patients at MDH, were interviewed during the second phase of the data collection 
process. The record officers’ interview was intended for one record officer but a second 
officer came into the venue of the interview and made relevant contribution. 
3.11.5 Senior Medical Officer’s Interview 
Furthermore, the Senior Medical Officer in-charge of clinical service for HIV patients at 
the hospital was expected to know everything or most things about HIV patients and 
service for them. Hence, he was interviewed on HIV service provision. 
After the analysis of all data collected from Nigeria, with no new theme coming up, then 
there was need to take a look at service provisions that UK HIV pharmacists provide for 
HIV/AIDS patients. This can help bring improvement to service provision in Nigeria. 
3.11.6 UK Pharmacist Interviews  
Formal discussions were held with NHS clinical pharmacists specialising in HIV care at 
four different hospitals after data collection from Nigeria. The discussions centred on 
management of HIV outpatients in West Midlands and the differences between Nigeria 
and West Midlands management of HIV outpatients were noted. 
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The diagram below describes steps taken to achieve data collection for this study 
(Figure 3.3). 
Figure 3.3: Data Collection Trail 
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83 
 
4. CHAPTER FOUR - STUDY ANALYSIS AND RESULTS 
4.0 Introduction 
This chapter focuses on the research results; analysis of the data and findings, which 
were collected from interviewees in a hospital in Abuja, Nigeria and four NHS hospitals 
in the UK. Also, observations of the patient journey on HIV clinic days at MDH to receive 
clinical services is reported. 
Each recorded interview was transcribed and each transcript was checked thoroughly 
against the voice recorder by reading and re-reading the text. Main ideas in every 
transcript were highlighted in green colour (Appendices 4.4.1, 4.4.4, 5.2.1, 5.5.1, and 
5.6.1) as the transcripts were being read which later on became useful and easier to 
organise into themes. Interestingly, different interviewees often used the same or similar 
words and phrases to express the same idea and those ideas made the research issues 
to become clearer and shaped the themes. 
Furthermore, from the transcribed text and based on the order which the questions were 
asked, relevant key words and statements from each interview were identified and 
written separately on Microsoft Excel. The words and or statements were then selected 
and appraised to form the themes. The process of organising and integrating narrative 
qualitative information according to emerging themes and concepts (ideas, concepts) 
was then followed [232,236]. Similar themes were then grouped together to form 
concepts and that helped to interpret the findings by attaching meaning and significance 
to the data analysis. 
The findings are presented in sections reflecting the interview questions and also 
corresponding with the concepts that were identified from the data collected. As stated 
previously, this is a qualitative study and therefore the majority of data in this chapter 
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are presented in a qualitative manner. Hence, readability of this qualitative report is 
enhanced by the inclusion of verbatim quote taken directly from individual interviews 
[237]. Furthermore, both phases of data collected for patients are grouped together in 
one section and also, pharmacist interviews in Nigeria and NHS pharmacist interviews 
are included in another section. 
Notably, after the manual analysis of all data collected, the second phase of patient 
interviews were also analysed with QSR-NVivo (Version 9) software [238], purposively 
to find out if more or different themes would emerge. NVivo, a qualitative data analysis 
(QDA) computer software package produced by QSR International, helps researchers 
to manage, shape, store, analyses and make sense of unstructured information mainly, 
large quantities of data as data can be coded into nodes, and it is a useful tool to link 
the data to emerging themes and concepts and then, develop the overall conclusion for 
the study [233]. However, it should be noted that Petty et al [210], Leech and 
Onwuegbuzie [233] and Hanson et al [211] argued that with qualitative research 
approach, the researcher is the main tool for data analysis, it does not replace the 
researcher’s role in analysing and interpreting qualitative data. Furthermore, Hanson et 
al [211] have emphasised that analytical software such as NVivo, which assist in the 
management of qualitative data, cannot replace the researcher’s appraisal and depth of 
understanding, though the software saves time, organises and visualises data. 
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4.1 Patient data 
4.1.1 Phase 1 Patient Interviews 
The following norms will be used in reporting the interview results: Italics are used to 
identify direct quotes or direct words spoken by the participant. Dots (…) indicate that 
the interviewee paused in the conversation during the discussion. Also, 5 minus signs (-
----) indicate that the interviewee made other statements in between the statements 
quoted. 
4.1.1.1 Demographic Data of Patient Interviewees 
In the first round of interviews, twenty-five interviews were conducted; fourteen were 
with male patients and eleven with female patients. The age of the respondents ranged 
from 21 to 59 years and the time since started ARV drugs ranged from 3 months to 
more than 30 months. Interviewees came from major suburb areas of Abuja city and 
some from other states in Nigeria. The demographic details of the interviewed patients 
for phase one interviews is summarised in Table 4.1. 
Table 4.1: Demographic Details of the Phase 1 Patient Interviewees 
 
Interviewee 
serial  
Number  
Sex, female (f) 
or male (m) 
Age in years Months since 
started ARV 
drugs 
Religious 
affiliation   
1 F 50 10 Christianity   
2 M 37 14 Christianity 
3 F 21 25 Christianity 
4 F  29  10 Christianity 
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5 M 47 30 Christianity 
6 F  29  5  Christianity 
7 M  40 20  Christianity 
8 M 39 5 Christianity 
9 M  33 3 Christianity 
10 F  36 3  Christianity 
11 F 38  3 Christianity 
12 M  43  18 Christianity 
13 M 40 8  Christianity 
14 F 32 10 Christianity 
15 F  36 18 Christianity 
16 M  33 11 Christianity 
17 M 37 10 Christianity 
18 M  36  7 Muslim  
19 F 33 23 Christianity 
20 F 28 23 Christianity 
21 F  28 29 Christianity 
22 M  36 31 Christianity 
23 M  35 21 Christianity 
24 M   23 27  Christianity 
25 M  59  3  Christianity 
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4.1.2 Concepts 
In this section, the findings from the analysis are presented as themes and concepts 
(Table 4.2). After outlining the predominant themes, five concepts emerged by grouping 
similar themes together, these being:  
• Faith; 
• Hospital Journeys; 
• Social Issues; 
• Obstacles; and 
• Expectations for service provision. 
Whilst every theme that emerged was important in the links to forming the concepts, 
only themes that emerged from at least three interviews will be backed up with direct 
quotes in this thesis. Direct quotes are presented in italics. Interviewees and interviewer 
have been labelled in shorthand. For example, patient 1 refers to first patient 
interviewed whilst patient 25 refers to the twenty-fifth patient interviewed. 
4.1.2.1 Faith 
4.1.2.1.1 Belief in God and ART 
Nineteen patients asserted that faith in God made them optimistic towards HIV infection, 
and 13 patients clearly affirmed their belief in ART. The patients also attested to the fact 
that their beliefs in God and ART alleviated the pains they were passing through and 
helped them to cope better with HIV infection as is quoted below. 
“When you have HIV you are a victim of HIV, you look miserable. You now believe that 
yours is finished, but today, we have hope because there is a drug that secure the life 
that keeps us moving ----- So I went to the Blessed Sacrament, I went and cried to my 
God. I told my God to give me the grace, the courage to bear the ----- To carry the cross 
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he has given me, because it is not my portion and can never be my portion for life.” 
(Female, Patient 6) 
‟You know…I felt that all hope was gone and I was not going to survive it since I have 
been hearing of it. And later …it was that day that I know that there is life drug, that the 
person that counsels will still counsel me and after sharing the drugs and by the grace 
of God I will be fine.” (Male, Patient 8) 
4.1.2.1.2 God can cure HIV infection 
Three patients confessed the belief that God can completely cure HIV infection while 
others wished for a permanent cure from the infection. 
‟Living with HIV is not a sickness in my side, is just a challenge…and the challenge that 
can be taken away at any time by God. So we keep on…one has to encourage himself, 
being a man anything that comes to you, you are equal to the tasks, God can just take it 
away from you anytime.” (Male, Patient 13) 
‟I heard a story where some people said that they will continue taking the ARV until 
certain time when their bloods get tested; the laboratory scientists could tell them that 
the patients do not have the virus again. That is God’s work…God is able to do 
anything….anything can happen. So my prayer is let this sickness be over, I am tired of 
the ARV (laughed) because ARV are not better things ----- Are not food but sickness 
makes someone to take them ----- If I want to come to the hospital, I hand over 
everything to God…I will say God these ARV that I’m taking…I know ARV solve this 
thing…I don’t trust ARV…is God that I put my trust. I prayed to God…I said God these 
ARV that I’m taking is not my portion, God should heal me so that I will stop these ARV 
----- To continue to pray for them (staff)…so that they will work more and more…to pray 
so that God will strengthen them so that they will not become tired -----God will 
strengthen them to save our lives.’’ (Female, patient 21) 
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4.1.2.1.3 Happiness 
Despite all risks that have been identified with HIV infection, ten interviewees affirmed 
that they were happy and had courage that they were alive with the infection since 
many people with HIV infection have died. 
‟Now that I have it, I’m happy to live with it, whatever I don’t bother myself, I don’t 
trouble myself, In fact if not em…my appointment day and when I’m to take my drugs, I 
hardly think about it, I just free myself as if nothing is effected at all.” (Male, Patient 7) 
‟Seeing the day, I’m happy because it is not my own making as I’m seeing the day. If I 
have to tell you the truth, the agony I passed through before you are seeing me today, 
I’m very happy; I have to appreciate God Himself.” (Male, patient 5) 
‟I don’t joke with my drugs, I take my drugs quick quick ----- When I’m among the living? 
What of those who are dead, what will they say, I should be happy.’’ (Male, Patient 13) 
4.1.2.2 Patient hospital journeys 
4.1.2.2.1 Delays 
Thirteen patients explicitly expressed their feelings about the delays experienced during 
their visits to the HIV clinic, particularly, as delays impinged on their ability to go about 
their daily activities, e.g. work. 
“Anytime I know I have appointment with the hospital, I will start having sleepless 
nights… let me tell you… let me be sincere. Actually, my appointment was last week, 
last week Wednesday. I was supposed to collect drugs that very day, by the time we 
finished from the doctor, when we got here; they said that they were looking for the keys 
to the store ----- So I was here till 2, I took permission from my boss in the office said 12, 
I should be in the office ----- I had to leave …let me go because of my job, without the 
job how will I live…they said we should eat well, feed well, take care of ourselves. 
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Without the job, how will I take care of myself, so I had to rush back.’’ (Female, patient 
15) 
‟For instance, when patients come, some may be asked to come six o’clock, they may 
come before 6:00 am in the morning. But before these people begin to attend to them, it 
will be 8:00 o’clock and these are people who work in the ministry, who work in the 
company and they have their private businesses. If you want to be excused for two or 
three hours in the office, having come here by six o’clock to be back by nine o’clock, he 
can never meet up appointment because the hospital opens by 8 or 9 and the 
appointment stated there is 7 am or 6 am even.” (Male, patient 17) 
4.1.2.2.2 Staff Uncaring Attitudes 
Eight patients also complained about staff uncaring attitudes toward patients especially 
as it appeared to relate to stress experienced whilst they waited for medical services. 
‟Where we book our appointment,----- Is it the PMM (patients’ management and 
monitoring) or whatever, I can’t remember…, is just one small office under the stairs 
there, where we book for our appointment dates in the dairies. There sometimes, when 
you come, they sort of treat people as if we are not human beings, you know.” (Male, 
patient 12) 
‟The issue is that some people (staff), you know the way some people used to do, some 
people at that place there, the card, the way they treat people is not fair.” (Male, patient 
16) 
‟See the staff members at the booking place; let the authority talk to them to be patient 
with us. Just like last year, I asked for something, that male staff just came to… insulted 
me that I should walk out. I just said I am an old woman and I asked him if he did not 
have a mother at home.” (Female, patient 1) 
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4.1.2.2.3 Good Service 
Four patients stated that the services provided by the MDH were good. 
“The services they are doing fine…they are doing fine ----- Yea, they are good…they 
are good.’’ (Male, patient 24) 
‟Yes, like I earlier said I will still give a little bit of curdles (credits) to the hospital 
because it is not easy…but I feel within this Abuja metropolis, I will rate them one of the 
best ----- because I have friends that are positive that have gone to other hospitals, from 
the way they complained, I felt lucky coming here ----- I even advise people to come 
here, people that are HIV positive to come here and receive treatment” (Male, patient 
23) 
‟The staff here have been so cooperative, they have been so okay, to me I have not 
had any ….bad experience with them so far. They have been good, they have been 
polite, they will not even show you that you are supposed to be like… They have 
inspired me; they have encouraged me to stay positive.” (Female, Patient 11)  
4.1.2.3 Social Issues 
4.1.2.3.1 Regular Attendance at the Hospital  
Patients visited the hospital due to initial poor health, sickness and or side effects of 
ART as stated by 22 patients. All these contributed to their frequent visits to the 
hospital. 
‟The sickness just appeared like a devilish…devilish something...it surprised me ----- 
You know, after sometime, we started having high body temperature…frequently then 
my husband said we should go and carry out laboratory investigation, so we all…when I 
carried out my laboratory investigation, he followed me to the hospital and did his own 
laboratory investigation too. We were told that we have HIV and then we started 
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collecting ARV...for years. When I started taking the ARV, I had headache, stomach 
pains and general body weakness. Everything is okay now but before now, I used to 
experience so many things like... I could not enjoy myself… could not cook.” (Female, 
patient 21) 
“I had no problem but I started experiencing pain whenever I stepped on some sides…I 
felt it all over my body… just as I heard on the radio that if one is on antiretroviral…there 
is any side effect…the person should continue to use it…” (Female, patient 1) 
‟The problem I have now is that they change my drug and is very much that I’m taking 
now. Each time I take, I must vomit; I don’t know why….and I have been on drugs for 
long. -----This very one has just come… the first one I’m given, there was no problem, 
while this very one, when I got home, I discovered it.” (Male, patient 2) 
‟Last year when I suspected I had this sickness, I was seriously sick, I lost my weight 
and I went to the hospital where laboratory investigation was done. -----I was at the 
hospital two months back, I complained to the doctors; they asked me to go the 
laboratory for further investigation for that problem. I did the laboratory 
investigation…returned the result of the investigation to the doctors, they prescribed 
drugs for me, yet my stomach is still disturbing.” (Female, patient 14) 
4.1.2.3.2 Thoughts about Living with HIV 
Eight patients expressed their thoughts about their living with HIV infection, and used 
words such as challenge, stress and psychological to described their perceptions. 
‟The issue is that Nigerians we stigmatise ourselves and that is the most difficult aspect 
of it as far as am concerned. We based issue of living with HIV, otherwise there is 
nothing about it, is just like any other ailment and I think HIV is not the worst. But once 
people know that you are HIV you know, because of the way they understand it, they 
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want to avoid you… the way they look at you as if may be you are a misfit, or you have 
misuse yourself. So that is the challenge as far as am concerned.” (Female, patient 20) 
‟Is not the delay per se, but you know the stress, you come and join queues, you have 
to wait and then waking up, you have to come earlier. Like my appointment day, I come 
latest 6:00 o’clock that is if I’m not early. I leave my house 5:00 o’clock and l stay in 
kubwa. May be, I will come and write number 40, before you finish from that side, before 
you finish the vital…, and see doctor… getting to this place again. Is not easy… the 
whole day is gone.” (Female, patient 15) 
“Psychologically, you will be having one feeling that you have an issue ----- You just 
look onto God that can... but no how... no how, you must take the drug and I will be able 
to keep to time as simple ----- I know the drug is doing its own homework and God is 
also doing His own work you understand, live is so sweet it depends on how you handle 
it.” (Male, patient 5) 
4.1.2.3.3 Loss of Hope 
Five patients stated that, following their diagnosis, there was loss of hope and an 
assumption that they were not going to survive with the virus because of what they had 
heard about HIV. 
“Living with HIV…for me living with HIV is just like living…You feel isolated…at the 
same time ----- I felt that all hope was gone and I was not going to survive it since I have 
been hearing of it” (Male, patient 8) 
‟Actually, I felt bad… in fact I was almost crying. When I left the hospital, I went home 
and locked myself somewhere… felt like committing suicide. Because I was just…was 
just picturing….picturing a lot of people that died around, you know, when I heard what 
happened to them that they tested positive or they were HIV positive or they had AIDS. 
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So I was just picturing them and I was like God, would I happen to die young? So I felt 
like committing suicide.” (Female, patient 15) 
“I said I wanted to die… I said I wanted to die…I said it was hypertension…I got 
hypertension by force…it was not easy…the thing I didn’t expect…I thought that it was 
fever, then I heard about this kind of thing ----- After the laboratory investigation and I 
was told that I have the HIV virus, I became like a broomstick (so slim) …I was always 
thinking about it such that whenever I ate or saw food, my stomach became filled up. I 
was always thinking… thinking and asking why…where did this thing came 
from…why?” (Female, patient 21) 
4.1.2.3.4 Stigma/Discrimination 
Five patients associated HIV infection with discrimination and stigma, in some cases 
directly leading to job loss. 
“Once people see that you have HIV, they look at you as a condemned human being 
already; sometimes they won’t want to share food with you, all these things. We face a 
lot of challenges several times ----- I find it a little bit difficult when I lost my job, thank 
God I have got a job which I will start this October, even though it is not my normal job 
but it is better. Because if you go to any offices now, they will say go to HIV test and this 
and that.” (Male, patient 2) 
‟Living with em…living with HIV viruses is not an easiest ways… no… why because you 
get frustrated errrh…you find people running away from you. The stigmatisation is still 
there even the government effort of trying to reduce it. Errrh…presently like me now, I’m 
jobless due to my…the…em status of HIV, so it’s not been easy, is not been easy at 
all.” (Male, patient 23) 
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‟The discrimination that comes with it, if not because of that I don’t think there is 
anything ----- May be these people that…may be some people they don’t know you …or 
they discover that you are positive,… that is it.” (Male, patient 9) 
4.1.2.3.5 Support from Family 
Five interviewees spoke about the support, both morally and materially received from 
their family after their diagnosis. 
"But we thank God we are among the living ----- I felt bad and I felt …errr…life was of 
no use to me. ----- Thank God I have a sister who stood by me all the while who played 
a motherly role to me and em…through her encouragement and everything I’m still 
living.” (Male, patient 23) 
‟Like now, I’m staying with one of my cousin after Apo…Apo village, Apo So I find it… 
sometimes I find it difficult to make it, but I believe God, I say God like this morning I 
was saying God how can I…today is the time I want to come and refill my this thing, 
thank God I have somebody that gave me money and I have to transport myself so that 
is.” (Male, Patient 16) 
4.1.2.3.6 Awareness of HIV 
Four patients with prior HIV awareness stated that they had good knowledge of HIV, 
from listening to HIV programmes on the radio, television and attending workshops. 
“I listen to the radio and television, I don’t miss it. I participate in many workshops on 
HIV without knowing that I’m a victim. So that have broaden my live, when the news got 
to me, it didn’t border me and I take it as part of live. That is me oooh, I don’t know of 
others.” (Male, patient 5) 
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‟Yes… yes prior to that time I had the awareness, from my sister and from … you know, 
news, books, I read a lot about it, I browse the internet about it, so it wasn’t really a 
shock.” (Female, Patient 20) 
4.1.2.4 Obstacles 
4.1.2.4.1 Many Patients/Few Staff 
Most patients identified issues relating to patients overcrowding with few staff; twelve 
patients acknowledged that the number of patients and few staff contributed to delays. 
‟What I have seen is that the load is too…much for this pharmacy, every day we will be 
seeing 100 plus, 200….at least us we are in that side we can be attending that side that 
Bwari general hospital instead of this place.” (Female, patient 3) 
‟The…the problem we have there is that the population is increasing everyday with 
the…. HIV positive people. So if you don’t leave your house in time there is every 
tendency you miss even by 6 o’clock you will still be in hospital.” (Male, patient 22) 
“Like me, I was here by 6 am ----- The staffs they are working and they are cooperating 
with us, but I think is the population ----- Sometimes we come; you know like we are 160 
and then, the doctors on seat is just two. So, you could imagine two people answering 
160.” (Male, patient 9) 
4.1.2.4.2 ART Shortage/Rationing 
There were concerns about incomplete dispensing of prescribed ARV drugs or ART 
shortage by three patients which constituted barriers to HIV service provision. 
"My drugs, sometimes the only problem I have here is that when… you may be asked to 
be given three months, may be, they will give you one month ----- I started with two 
weeks, after the two weeks, one month, at two months I was given drugs but now the 
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rate of the number they give is reducing. I don’t know whether is the population. I will 
not accuse them that it is their own fault, it may be the fault from the supply or is the 
population that murder the demand.” (Male, patient 13) 
‟When they send us to pharmacy to come and collect drugs, may be, they tell you that 
the drugs are insufficient but pharmacy will tell you to come and collect the remaining 
ones. I will come and collect. Like myself I was given drugs but not complete for the last 
three months, and they ask me to come before my appointment to come and collect.” 
(Male, patient 2) 
4.1.2.4.3 Patient Attitude/Favouritism 
Impatience amongst patients and preferential treatment being offered to some patients 
were identified by four patients that affected service provision. 
‟The problem is even with us the patients because we are not patient with ourselves 
and we don’t listen to the doctors when they ask us to do a particular thing, to do 
this…we know what we are supposed to do when we come but we won’t do it, so most 
a times we even behave like kids.” (Female, patient 20) 
“A times people feel that they are treating them with partiality, you know may be along 
the way, files will be mixed up unknowingly. You will see people vibrating, but when they 
discover that, those in charge will try to maintain it and listen to people and see where 
they can correct so that they will be peace.” (Female, patient 19) 
4.1.2.5 Expectations for Service Provision 
4.1.2.5.1 Employ More Staff 
The patients’ suggestions for improvement included employment of more staff to help 
reduce the number of patients in attendance on clinic days as stated by seven patients. 
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‟If they have the capacity at least, we will appreciate it ----- Eehm...More doctors …more 
doctors….more doctors, sometimes we come, you know like we are 160 and then, the 
doctors on seat is just two. So, you could imagine two people answering 160, so before 
they finish….so we were here that day before we left that day were 56 something 
….before we left here that day it should be around four o’clock…getting to four o’clock.” 
(Male, patient 9) 
“Me personally, naturally I don’t like hospital I cannot say hospital is good. Here is 
good… here is good, but something must bring you to a place. And for me I’m satisfied 
with what is given to me ----- May be, you should increase the number of doctors 
coming because a times like on Wednesdays, the patients are many and a times we 
have only two doctors working and everybody is waiting, and it takes time.” (Female, 
patient 11) 
‟We need more resources to be frankly speaking, more staff, adequate…more  
Staff, I… mean. Because sometimes we come to the hospital; we found that we are  
over 300 and, may be, three doctors attending to…” (Male, patient 23) 
4.1.2.5.2 Medicine Supply 
Six patients suggested that the provision of an adequate supply of ARV drugs would be 
a major step towards improving services. 
“The equipment like those drugs now, it just have to be enough. Like before when we 
come, they do give us drugs that took us for may be, two or three months. But like last 
time when we came, they said there was shortage of drugs somehow…they have to 
give us for one one month. But there is no time (stressed it) we come, they say no... no 
drugs, they only say, instead of giving us three months, they will give us one... one 
month because there is no enough drugs, so that the drug will go round" (Male, patient 
22) 
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‟So, I am praying that Mr President should give attention to Maitama District Hospital so 
that there will not be medicines out of stock, increase salary, and care for the hospital 
staff. If the President does not do like that, I will not be happy...I will not be happy 
because medicine is very important in this World. May God help us.” (Male, patient 18) 
4.1.2.5.3 Provide Adequate Accommodation 
Improvements to hospital facilities were suggested by three patients. 
“At the reception where we wait for the doctors, I think that place is really...whenever the 
crowd is much.  The place is em…choked up, as we come so many things associated 
with other illnesses such as cough, you know everybody is coughing and the 
place…there is no ventilation, personally when I come, I stay outside… until I know 
shortly they will call my name. So that place needs to be taken care of. If they can… 
may be extend the place… know what to do about it, is really awful. Some will be 
standing, some will be coughing, some will be sneezing and is not good for us.” 
(Female, patient 20) 
‟Umm…well the accommodation, where they receive patients is not enough. A times, 
we will be so crowded in that place and you see people hanging outside because they 
can’t be in. I think that is the one thing, if there is any improvement to be made.” 
(Female, patient 19) 
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Table 4.2: Themes and Concepts for Phase 1 Patient Interviews 
  
Concepts Contributing Themes  
Faith Faith in God (17), faith in antiretroviral (ARV) (13), 
optimism (1), pray for staff (1), happy (8), unhappy (1), 
gratitude to God (1), Holy Grail (3), courage (2), 
Social issues Poor health (13), sickness (5), discrimination (3), stigma 
(2), challenge (4), psychological issue (1), awareness of 
HIV (4), loss of hope (5), disclosure issues (2), loss of 
source of income or jobs (5), support from family (5), 
counsel (1), poverty (1), 
Patients’ hospital journey  Delays (13), uncaring staff (8), stress (3), stressful CD4 
cells count unit (2), laboratory investigation (5), good 
service (3), serving well (1), encouraging staff (1), 
orderliness in pharmacy (2), doctor’s counselling (1), 
Obstacles  ARV drugs ration/shortage (3), side effects of ARV 
drugs (4), unscheduled visit (2), work (5), few staff (3), 
many patients (9), preferential treatment (4), doctor’s 
attitude (1), patients’ impatience (4) ARV drugs 
constantly (1) 
Expectations Sufficient availability of ARV drugs (6), trim down visits 
to hospital (1), service closer to patients (1), improved 
accommodation for patients (3), more hospital staff (7), 
more volunteers (1), appeal to Nigerian president for 
HIV support (1), increase wages for staff (1), 
amendments at card room (2), HIV pharmacy needs 
amendment (1) 
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4.2 Phase 2 Data Collection 
4.2.1 Rationale for further Data Collection at MDH  
The necessity for a supplementary phase of data collection from patients (Phase 2) was 
conceived out of the concepts that emerged from the analysis of the first phase of data 
collection. ‘Patient journey’ emerged as a concept from analysis of phase one interviews 
and there was a perception that the use of Standard English could have limited the 
findings on patient experiences during the phase one interviews. Consequently, the 
questions were re-formulated in Pidgin English. 
Firstly, it was decided to have a closer look at the ‘journey’ patients undertook on clinic 
days to identify possible causes of delay and to help with data triangulation (Section 
4.3.5. the Patient Journey). A decision was taken to interview more patients with the 
same semi-structured questions but with more specific prompts, which were formulated 
based on patient responses during the first phase of data collection (Appendix 5.2). 
Furthermore, it was decided that management staff needed to be interviewed to find out 
their perception of the clinical service provided to HIV/AIDS patients at MDH.  
4.2.2 Phase 2 Patient Interviews 
Ten further patients were interviewed, six men and four women. 
4.2.2.1 Demographic Data of Second Phase Patient Interviewees 
The age of the interviewees ranged from 21 to 56 years, and the time since starting 
ARV drugs ranged from 3 to more than 36 months. Interviewees came from major 
suburb areas of Abuja city and some from other states in Nigeria. The demographic 
details of the interviewed patients for phase two interviews is summarised in Table 4.3. 
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Table 4.3: Demographic Details of the Phase 2 Patient Interviewees 
  
Interviewee 
serial  Number  
Sex, female 
(f) or male 
(m) 
Age in years Months since 
started ARV 
drugs 
Religious 
affiliation 
26 M  52 14  Christianity 
27 M  37  10  Christianity 
28 M 41 16  Christianity 
29 F  22 36  Christianity 
30  F  26 24 Muslim  
31 F  25 13  Christianity 
32 F  21  3  Christianity 
33 M  30  13  Christianity 
34 M  56  23  Muslim  
35 M  42  25  Christianity 
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4.2.3 Concepts 
In this patient result section, the findings from the analysis will be presented in concepts 
(Table 4.4). After determining the predominant themes, the same five concepts as seen 
in phase one patient interviews emerged, these being: 
• Faith; 
• Hospital Journeys; 
• Social Issues; 
• Obstacles; and 
• Expectations for service provision. 
Data is reported in the same manner as phase one patient interviews. It is worth noting 
that during the NVivo data analysis, it became clearer that themes which make up the 
five concepts do overlap all through, particularly, themes that made up Social Issues 
and Obstacles. However, the themes which overlapped are reported in one concept. 
4.2.3.1 Faith 
4.2.3.1.1 Belief in God and ART 
Like the first phase of patient interviews, every (all ten) patient in the second phase of 
interviews spoke about faith in God and ART which helped him or her to cope better 
with living with the infection. 
“This medicines before aaha…before I will took it, I do pray before taking the drug… 
may God help me to get healing because doctors do treat the body but God is 
err…healer, that is how I always said before I took the drugs. ----- I believe that it will 
work and is working ----- I always pray for them even the doctors that may God give 
them more knowledge so that one day they got…got the medicines to cure this 
infection.” (Male, patient 33) 
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‟That is why I tell you that wherever...anywhere you find yourself, thank God. According 
to Muslims, they say God gave gifts and God take ----- Who are we to challenge Him? 
Nobody can, which court do you want to take Him (God) to, He knows the place? That 
is what I’m telling you. Some people have cancer, you see it na, you see cancer with big 
man ----- I believe it is one thing that will take one’s life back to Him, whether by 
headache ...whether by cough, it is one death will take all of us back to Him, that is my 
own believe. I know it is my cross, I cannot blame anybody and I won’t blame my God.” 
(Male, patient 34) 
Also, six of them said that God can completely heal them of the infection and so, hoped 
for a complete cure from HIV. 
‟In any situation like that as I said, give God the Glory because He is the Alpha and the 
Omega….He is the creator of everything. He can say today HIV wipe away from the 
surface of the earth, it will definitely go ----- I pray to my God in the morning….in the 
evening, even in taking ordinary water, I say thank you for giving me that water. Then I 
don’t think I play with my God. My God is always a living and a creative God …He 
provides me with all my needs ----- I said no, my world will never end, it is just a 
challenge, I will take it, anytime God decides to take it away from me and I believe it will 
all go back.” (Male, patient 28) 
‟The drugs…in fact, I have seen improvement in my body seriously like em ….even I 
have come to believe that one day I will come for test where the virus will not be…. I am 
thinking that one day I will come for test where the virus will not be found again.” (Male, 
patient 27) 
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4.2.3.2 Patient Hospital Journey 
4.2.3.2.1 Caring Staff 
Every patient interviewed at this second phase, through similar or related wordings, said 
that most staff who attended to them behaved nicely to them. 
“They (staff) are nice; I can say they are nice; they are good to me…because the other 
woman (a staff) that was here before that was sometimes harsh; other people are not 
like her. I think she is no more here again, I don’t normally see her again. But as for 
these ones I see…both the doctors I see, they are nice -----There is nothing I don’t like 
about them.” (Female, patient 29) 
‟They (staff) are doing well…they are doing well ----- Well… (Looked at the ground and 
lowered her voice)…the only thing I want to say is that if you talk to them gently you 
understand, even if you are late, they will help you…you understand.” (Female, patient 
31) 
‟Well, they (staff) are really trying in this hospital….they are trying very well in this 
hospital. Like some of the supporters, they give attentions to we…..to we that live with 
virus. May be if you have any complaints, you go to them, some of them they take their 
time to listen to you to share your pains and to share your feelings with you. They don’t 
discriminate and they are… not partial.” (Female, patient 32) 
4.2.3.2.2 Good service 
Eight of the patients acknowledged that the service provided was good. 
‟The doctor himself will always advise me that those drugs are very good….they always 
encourage me so there is no fear, I have confidence….I always have confidence ----- 
The service is okay ----- Everything is okay ----- I like them because they keep 
encouraging….they receive us and encourage us.” (Male, patient 27) 
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‟I don’t have any fears because our doctors are treating us well….entertaining us and 
give us a good advice so I don’t have any other fear -----They are giving us a good 
treatment, very nice treatments ----- In fact there is nothing wrong about them to me, in 
fact I don’t know of others. If I ask them something, they will tell me how I will 
understand, they will teach me to do this or not to do that so I’m enjoying the way they 
are treating at me.” (Female, patient 30) 
Seven of the patients also appreciated how staff educated them generally, on HIV. 
‟As for now…before we start the drug they (staff) told us this is not for cure, it is to help 
you to build your immune system, to bring out… to make you…I didn’t remember it 
again. For my own understanding, is just to build you up, is not going to cure the 
sickness or the virus in you.” (Female, patient 29) 
‟I don’t have any fears oooh (tapped his lips) once they have already told us the 
guidelines ...and once you follow those tips; there will be no problem... you live your 
normal life.” (Male, patient 26) 
4.2.3.2.3 Uncaring Staff  
On the contrary, five patients particularly, through similar or related wordings stated that 
some staff were uncaring. 
‟Some of their staff are hot tempered and aggressive… sometimes. I don’t know if it is 
due to the kind of crowd they see or the stress ----- Well, the only thing I can point at 
that I don’t like about them is that sometimes…some of the nurses’ sha…like some of 
us that are new in the environment. May be, we come for like check our BP and weight 
like that, if they are weighing us and all that….a times they talk to you any how and may 
be, sometimes, they start frowning for… anyhow, that is just something that I don’t like 
about them.” (Female, patient 32) 
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“Like some people (staff) if you want to ask, if it is some questions you want to ask 
them, the way they will even put it to you...to even talk anything, is not there for 
you...will they even allow you talk?” (Male, patient 34) 
4.2.3.2.4 Delays 
Delays and spending long days when attending clinic were frequently experienced, with 
three patients stating they arrived at the hospital the night preceding their appointments 
to try and mitigate delays. 
‟I will leave home as early as 4:00 in the morning and before I reach here, it will be 
around to 5 or 4:30 and as then I will be like number fifty something or sixty something. 
And it will end up may be, me staying until...there was a time I leave this hospital around 
6:00 pm ----- I didn’t find it funny…sometimes I might cook my food very early, though I 
know they are trying but is just like leaving my house as that early and going back as 
that late, sometimes I said I don’t know why?” (Female, patient 29) 
‟Some people, (patients) they do not get time to stay in the hospital for long you 
understand…want to see doctor early and go back to work…some leave far…very far 
away, so sleep in the hospital you understand.” (Female, patient 31) 
‟Then from there...you see some people very annoying here. Somebody you are 
number 2 or number 3, then you see number 10 coming to...the...err... this pharmacy to 
collect medicines before you …because we don’t want to late, some people we come 
early...we book our names since last night so that…to enable us go early. You see 
somebody who come here in the morning...go before you, what is the essence of 
err...coming early?” (Male, patient 34) 
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4.2.3.3 Social Issues 
4.2.3.3.1 Support from Family Members 
Three patients acknowledged that patients who had support and encouragement from 
family members after their diagnosis fared better with the treatment. 
“I’m still with my elder sister. So when I came to the hospital, I did the test, I was the 
only one. Then I found out we are living together, if I did not tell her, definitely when I 
start these drugs, she will definitely know what these drugs are for. And I feel that if 
anything should happen to me, if I’m having malaria…I wouldn’t stand…because then 
she (sister) was working in the pharmacy; I always tell her ahah…I’m having this, she 
brought drugs for me. So I called her and said see oooh, I want to be stronger and I 
want you to help me because is just like if you don’t help me, no other person can help 
me. I went to the hospital and this is what they said, I am positive. Then she really really 
encouraged me, she said well, she works in pharmacy and amount of the people that 
buy those drugs… is that HIV is something that will not kill. So I should carry on with my 
life and just what she wants me to know is to be close to God. She really advised then 
that is why I think I should let her know.” (Female, patient 29) 
4.2.3.3.2 Regular Attendance at Clinic 
Due to initial poor health or sickness, patients regularly visited the clinic according to 
nine patients. 
‟You know, it is fever which first come, I now go to the doctor. You see, when I first 
notice the thing, every week, constant problem...fever...fever...fever everything fever ----
-The doctor now come say I should do test at heart to heart place. Now I said doctor, is 
it this thing that caused my fever everytime? He said yes, if I do it, then I start using the 
medicine and I will see the improvement. Truly, and as he said true, since when I 
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started using the medicines...I do before almost a month I do not see anything now, 
three...four months ----- but I don’t see the fever too much. But I still said it is dreadful 
for us....both my wife and one of my daughters carry it.-----If some people see me now --
---They said aah...your body is all coming -----There was a certain time, If you see me 
even my trouser then... I cannot wear them now.” (Male, patient 34) 
‟Actually since I have started taking my drugs, I’m now getting better more than before 
and I don’t used to do small small sickness like before because before I have never 
started taking my drugs, I used to found myself with small headache, stomach pains all 
over the body. But now that I have started taking my drugs, it take me a long time 
before I sick. And even though I sick, may be, is the problem of stress and when I sleep, 
I will find myself better.” (Female, patient 30) 
4.2.3.3.3 Thoughts about Living with HIV 
Eight patients described living with HIV through similar or related wordings as traumatic 
and a challenge. 
“Is very traumatic...hardly would a day go without at a point you feeling ...feeling so 
sorry why me? So the trauma is always there, even when you try to buckle up and say 
life goes on, but deep within you, err...is still there, you still feel it.” (Male, patient 35) 
‟My mum being a very local woman, she keep on encouraging me that I should not just 
bear it, that it is never a dead thing. She told me it is never a dead thing. My younger 
sister told me again that HIV is nothing that I should not take it and start thinking as if 
my world is end. I said no, my world will never end, it is just a challenge. ----- HIV 
infection as I have seen it, is as I earlier told you that is a challenge.” (Male, patient 28) 
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4.2.3.3.4 Death Sentence/Loss of Hope 
There was also loss of hope amongst patients following their diagnosis as stated by 
three patients, and HIV infection was viewed as a deadly disease. 
‟I was just looking at myself when I found out I am positive, I was really thinking that am 
I going to die. Then, I was like when did I start life, then after everything now, I found out 
that let me just be close to God and do so many things.” (Female, patient 29) 
‟It was like, if you were positive, you will just be waiting for when to die. So even the 
people who were to come and collect drugs, there was really no need...really no need 
(laughed) for...preparing a very good place for them (laughed) after all, they will soon 
die (laughed).  May be there is an understanding that they are not dying yet, so let us 
provide them something.” (Male, patient 35) 
4.2.3.3.5 Stigma/Discrimination 
Every patient interviewed in this phase employed word such as stigma, enmity, scandal, 
rumours, discrimination and hatred as responsible for their not disclosing their HIV 
status to other people. 
“At times…you know, most people they are still ignorant of it -----Yes, because…the 
reason why I have a fear of people knowing is that…you know in Nigeria here, like if 
people know you are HIV positive, they will just be carrying the rumour about it. 
Broadcasting it… pointing fingers at you. May be like in school now, friends you have 
been …they have been hanging around with you, they will start running away from you 
because they are ignorant of it that is the fear of not telling anybody.” (Female, patient 
32) 
‟Naturally of course you know that…there is a stigma attached to HIV whether you like it 
or not. And so err… there are certain things…they are some people that relate with you 
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freely, the moment they know err…that this man is positive, they might feel whether you 
have infected that because you are affected, so you just stay.” (Male, patient 35) 
‟Since I was tested, I did not disclose it to anybody especially my family members and 
friends apart from people I only met in the hospital here, I did not tell anybody, I keep it 
to myself. -----You know this kind of thing, I keep it to myself because when you tell 
people you do spread the news, due to explaining of the news, you will feel somehow. 
You will feel something…rejecting you…discrimination. So this thing, it do cause 
somebody to really get heart attack, thinking people are saying that you are like this and 
that. So I decided to keep it to myself so that I will make my life keep on going and 
everything will go on normal with me.” (Male, patient 33) 
4.2.3.4 Obstacles 
4.2.3.4.1 Many Patients 
Seven patients spoke about how many patients were at the clinic. 
‟The service is okay. Is only that the… numbers of em…sometimes…the number of 
patients are…we are many. So, we have to be patient with the service providers and 
are being happy for them ----- Well, I can say actually we have many patients, but the 
staffs have been trying their best according to the number of patients they have.” (Male, 
patient 27) 
‟Umm like…well may be doctors and the pharmacy, they are trying their best for us 
because we are more than 100 patients and they are attending us, so they are trying 
their best.” (Female, patient 30) 
‟Sometimes if you come, if people too much like Monday you understand, they will tell 
you if you have your drugs, you should go and come back, you understand. If people 
too much... like last time I come, people too much, they said if you have your drugs that 
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can take you till that day …can sustain you to that Monday, that you can come.” 
(Female, patient 31) 
4.2.3.4.2 ART Ration/Septrin® Out of Stock 
Most patients experienced medicine shortages at one point or the other, mainly in form 
of the ART being rationed which increased their visits to the clinic. 
“Apart from Septrin®, sometimes I do come here if they don’t have certain drugs; they 
tell me I should get it outside. Like these my drugs they have never had it before. I have 
never fell sick that they wrote another drug like that…since I started the drug I have 
been fine.’’ (Female, patient 29) 
“In some hospitals, they said like Septrin® they normally have it every day and they said 
you must use two Septrin® a day... but here na, if you ask them, they will tell you they 
don’t have.” (Male, patient 26) 
4.2.3.4.3 Inadequate Accommodation 
Patients spoke about the inadequate accommodation, for example, seating 
arrangements whilst patients waited to be attended, which was a source of concern for 
four patients.  
‟The canopy you place outside…before anytime we come, we are at DOTs (Directly 
Observed Therapy for the Treatment of Tuberculosis) section, they call us, and we line 
up under the sun ----- What we need now is seats; they should help us with seats so 
that embarrassment from DOTs side should not come to us anymore. This morning we 
pick seats from there to sit here, again they drove us off.” (Male, patient 28) 
‟Like before...before we come, when we reached here for drugs, there was no place to 
stay and collect the drugs...no place to stay and wait.” (Male, patient 35) 
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4.2.3.4.4 Patient Attitude 
Five of them spoke about annoying and impatient patients on clinic days, and insinuated 
that the patient problems at the hospital were caused by patients’ attitude. 
‟I stayed here sixteen days with my wife, I have never seen anyone (staff) in this 
hospital… I have never seen any embarrassment in the ward. Nobody embarrassed me 
any time we come, except to me, the patients because you cannot say all human beings 
do behave the way you want to behave you know. Some con man, start playing the kind 
of a game of come last, go quick. That is always the problem we always have within 
ourselves.” (Male, patient 28)    
4.2.3.5 Expectations 
4.2.3.5.1 Medicine Supply 
Four patients wished there would be adequate ART, Septrin® and other medicines, 
where ARV drugs should be formulated as once weekly or monthly doses and 
medicines that will last until next clinic appointment to help reduce patient visits to the 
clinic.  
‟The only improvement …what I always pray for, may be the drugs could be improved in 
a way that may be, you can take once in a week or once in a month or something like 
that…so that we can avoid too much of people coming every day for drugs.” (Male, 
patient 27) 
“If they can get all the necessary …like all this Septrin® …most of the people when used 
to complain that they don’t give them all the. Like on Wednesday now you know they 
will say …like this supporting group, you will hear a lot of things say come ooh... they no 
dey give us Septrin® again …make them dey provide am regularly.” (Male, patient 26) 
114 
 
‟Like when I have appointment in the hospital, they have to give us err…long time drugs 
that will take us to take our lectures.” (Female, patient 30) 
4.2.3.5.2 Increase Clinic Days 
Also, three interviewees wanted the present once weekly clinic, be increased to two or 
more. 
‟Is just only two days now, old patients have only one day and new patients only have 
one day----- if they can increase the day…improve the days, if they can add more, either 
to make it three days or two days more.” (Female, patient 29) 
“Like me, I’m a student, so, a times I used to get lectures, lessons, exams. Like when I 
have appointment in the hospital, they have to give us err…long time drugs that will take 
us to take our lectures and. You know, like now I have to collect my drugs…I’m here 
since 4:00 yesterday, I come for a booking, I now left for home…I came today morning.” 
(Female, patient 30) 
4.2.3.5.3 Employ More Hospital Staff 
Despite the fact that all patients at one point or other did speak about inadequate 
staffing, only two suggested for more staff employment to reduce long stays at the 
clinic. 
“Just staffing (raised his voice) because there are some times err…when we come, is 
like the staff are not enough, so they are stressed…err…it is because they are not 
enough that is why people pile up, it is when people pile up, they will be complaints 
when they are plenty. But if the staffs…the number of staff are increased, of course the 
waiting time will be reduced ----- There are delays but it still boils down I feel to 
hands…number of hands, if number of hands are enough, the crowd that waits here will 
not be there.” (Male, patient 35) 
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‟Improvement...eherr...you know the only thing...coming here...if it is three people that 
have been giving...attending to people here, may be they should them make it five 
because some of us err...as I tell you...some of us leave office err...without allowing 
them to know that this is what you come for. This thing has caused some people their 
job, you understand.” (Male, patient 34) 
4.2.3.5.4 Improve Accommodation for Patients 
Furthermore, three patients wanted better facilities. 
‟At least their (HIV patients) own thing should be done different, and they should keep 
them at a different department. They are not supposed to be at the entrance there, at 
the reception area there ----- Like you know, some people are shy…people that are 
coming for the… treatment and when they see somebody, they will first start...they will 
be looking for a way to hide themselves and all that. Is better they could remove them 
from that reception any way.” (Female, patient 32) 
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Table 4.4: Themes and Concepts for Phase 2 Patient Interviews  
 
Concepts  Themes  
Faith  Faith in God, faith in ART, God can cure HIV infection, permanent 
cure for HIV, live positive, be cheerful, Pray for staff 
Social issues Support, encouragement from family members, poverty, 
Disappointment in relationship due to HIV status, Disclosure 
issues or did not disclose HIV status to anyone, HIV could be 
punishment from God, HIV does not show on faces, HIV was like 
a death sentence, loss of hope, Ignorance,  Sickness, poor health, 
side effects, Stigma, enmity, scandal, rumours, discrimination, 
hatred, This thing, Traumatic, stressful, dreadful, miserable, 
challenging, frustrating, depressing, Valuable job time loss, Job 
loss 
Patient 
journeys  
Delays, HCPs education of patients on HIV, HIV service provision 
was okay & orderly, Impatient, hasty & annoying patient 
Night arrival at MDH, Staff resumed late for work, Staff were 
helpful, nice, good service, encouraging, trying their best, 
advising, attentive, unbiased, joyful & excited, Uncaring, biased, 
hot tempered, aggressive, spiteful & unapproachable staff, 
Appreciation of volunteers for HIV service provision 
Obstacles   Out of stock ART, Septrin® & other medicines, ART ration, 
Inadequate accommodation & seats for patients, Many patients & 
few staff, Negative effects of Nigerian government corruption on 
HIV service provision, not fully adherent to ART,  
Expectations  Employ more staff, provide adequate accommodation, seats for 
patients, Provide adequate ART, Septrin® and other  medicines, 
Make available once daily, weekly, monthly ART doses, Reduce 
patient visits to hospital, increase clinic days, Re-organisation is 
needed at MRU 
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4.3 Patient’s Journey 
Following initial analysis of the patient data obtained during phase one of this study, it 
was identified that the actual time-based experiences of patients may have had a 
bearing on the patient experience at MDH. The determination of ‘Patient Journeys’ 
reflect the patients’ experience during their visit to MDH from the time they arrived at the 
hospital until they finished receiving clinical services and left the hospital. Ten patients 
were shadowed (Table 4.5). 
Table 4.5: Demographic Data of Shadowed Patients 
 
Shadowed 
patient serial  
Number  
Sex, female (f) or 
male (m) 
Age in years Months since 
started ARV drugs 
1 F  34 36 
2 F  29 12 
3 F  44 8 
4 M  32 10 
5 M  37 7 
6 F  39 24 
7 M  52 35 
8 F  25 4 
9 M  40 9 
10 F  58 22 
 
4.3.1 General Observations of Patient Journeys  
4.3.1.1 Medical Records Unit (HIV/AIDS Section) 
On appointment day (or the previous evening), patients arrived and assembled at the 
HIV/AIDS outpatients reception and each patient wrote (those who could not write, 
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asked for assistance from others) each patient’s name individually into the attendance 
register along serial numbers already on the register. At about 07:00, staff from the 
medical records office, removed the first page of the register and arrange those 
patients’ folders (medical records) in the order entered onto the register. Then, at about 
08:00, medical record staff began to distribute individual patient’s folders based on the 
serial numbers in the day’s attendance register. However, at times, some patients did 
not receive their folders (normally, because the folders were misplaced or the patients 
were not scheduled for that clinic date). Unannounced patients did put their names on 
the attendance register; however, they could be attended to or turned away based on 
their reasons to be in attendance that clinic day. Subsequently, the second, third, fourth, 
and so on, pages were removed and same procedure repeated until the staff reached 
all patients (added extra scope for unannounced patients) who were expected for that 
day. 
4.3.1.2 Vital Signs Measurement Unit 
At about 09:00, each patient was called for vital signs (body weight, body temperature 
and blood pressure) measurement according to their serial numbers on the attendance 
register. Nurses from the heart to heart unit (which oversees pre- and post HIV testing 
counselling) measure the patients’ vital signs. The measured vital signs were recorded 
in each folder. Each folder was then collected from the patient whilst the patient moved 
to the waiting area to consult a doctor. The patients’ folders were collected by staff from 
the medical record’s unit (or volunteers) and taken to the doctor’s consulting rooms in 
bulk (in tens) and shared on each doctor’s table. On each clinic day, they were two to 
four doctors that attended to patients. 
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4.3.1.3 Doctor’s Consultation 
At about 10:00, the first patient on the day’s register was called into the doctor’s room 
for consultation and subsequently, other patients followed. Each patient consulted with 
doctors individually and the patients were directed to different units in the hospital based 
on individual patient’s medical needs. (For example see patient journey one) However, 
most went to the APU. The folders were again collected by medical record staff in bulk 
(in tens to thirties) and taken to the APU. However, some patients individually took their 
folders to APU after being attended to at other units prior to ARV drugs collection. 
4.3.1.4 ARV Pharmacy Unit  
At the end of each patient’s consultation with the doctor, patients prescribed ARV drugs 
(and or medicines for OIs) usually went to the APU and waited at the patient’s waiting 
area. The folders were left in the order, which medical record staff brought them. Then, 
the pharmacist (s) on duty called the names of individual patients in that order for 
patients to take their turn appropriately. Subsequently, each pharmacist picked the 
folder from the top, went through the medical records, called the patient into the APU, 
confirmed that that was the right patient (verified with patient’s personal appointment 
card) and asked the patient to sit down. Furthermore, the pharmacists asked the patient 
to confirm certain facts, informed him or her about changes or no changes to 
prescription, counselled and dispensed the prescriptions. 
After attending the APU, the patients went to confirm their next clinic appointment with a 
medical record staff who was stationed at the APU; the patients then left the hospital. 
4.3.1.1.1 Patient 1 
Patient 1 (Appendix 5.3.1.1) was a 34 year old female who had been on ARV drugs for 
36 months. She arrived at MDH at 17:00 on the evening preceding her clinic 
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appointment. She was not given her medical records as staff could not trace her 
medical records. She was called for vital signs measurement at 09:04, which was 
completed and recorded on a plain sheet of paper at 09:06 (time taken for vital signs 
measurement was 2 minutes). At 09:47, her medical records were retrieved and she 
was able to consult with a doctor at 10:00, which she completed at 10:10 (time taken for 
consultation with doctor was 10 minutes). Subsequently, she went to the labour ward for 
cervical cancer screening, and arrived at the APU at 10:41and completed her visit at 
10:55 (time spent at the APU was 14 minutes). She booked for next clinic appointment 
at 10:57 and left MDH at 11:05. 
4.3.1.1.2 Patient 2 
Patient 2 (Appendix 5.3.1.2) was a 29 year old female, who had been on ARV drugs for 
12 months. She also arrived at MDH at 17:00 of the evening preceding the day of her 
appointment. At 08:00 her medical records were given to her. She was called for vital 
signs measurements at 09:06 and her vital signs were measured at 09:08 (time taken 
for vital signs measurement was 2 minutes). She was called to consult a doctor at 10:30 
and completed consultation with the doctor at 10:38 (time taken to consult doctor was 8 
minutes). At 10:40, she arrived at the APU and completed her visit at 10:47 (time spent 
at the APU was 7 minutes). She booked for next clinic appointment at 10:49 and left 
MDH at 10:52. 
4.3.1.1.3 Patient 3 
Patient 3 (Appendix 5.3.1.3) was a 44 year old female who had been on ARV drugs for 
eight months. She arrived at MDH at 07:45, without any prior appointment to see a 
doctor because she felt unwell. Her medical records were given to her at 09:30. She 
was called for vital signs measurement at 09:40 and that was completed at 09:43 (time 
taken for vital signs measurement was 3 minutes). She waited and consulted a doctor at 
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11:37 and that was completed at 11:50 (time taken for consultation with doctor was 13 
minutes). She went to APU at 11:55 and left the pharmacy at 12:07 (time spent at the 
APU was 12 minutes). She booked for next clinic appointment at 12:10 and left the 
hospital at 12:14. 
4.3.1.1.4 Patient 4 
Patient 4 (Appendix 5.3.1.4) was a 32 year old male who had been on ARV drugs for 
ten months. He arrived at MDH at 17:00 of the evening preceding his clinic day 
appointment. His medical records were given to him at 08:10 and he was called for vital 
signs measurement at 09:06, which was completed at 09:08 (time taken for vital signs 
measurement was 2 minutes). He waited and consulted a doctor at 10:10 and 
completed consultation at 10:18 (time taken to consult doctor was 8 minutes). He 
arrived at the APU at 10:20 and completed his visit at 11:46 (time spent at the APU was 
86 minutes). He booked for his next clinic appointment at 11:50 and left MDH at 11:56. 
4.3.1.1.5 Patient 5 
Patient 5 (Appendix 5.3.1.5) was a 37 year old male who had been on ARV drugs for 7 
months. He arrived at MDH at 05:00 and his medical records were given to him at 
08:11.  He was called for vital signs measurement at 09:08 and completed at 09:10 
(time taken for vital signs measurement was 2 minutes). He waited and consulted an 
HIV doctor at 11:10, which was completed at 11:20 (time taken to consult doctor was 10 
minutes). He arrived APU at 11:23 and completed his visit at 12:30 (time spent at the 
APU was 67 minutes). He booked for his next clinic appointment at 12:35 and left MDH 
at 12:40. 
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4.3.1.1.6 Patient 6 
Patient 6 (Appendix 5.3.1.6) was a 39 year old female who had been on ARV for 24 
months. She arrived at MDH at 05:00 and her medical records were given to her at 
08:16. She was called for vital signs measurement at 09:30 which were completed at 
09:35 (time taken for vital signs measurement was 5 minutes). She waited and 
consulted an HIV doctor at 11:00, which was completed at 11:10 (time taken to consult 
doctor was 10 minutes). She arrived at the APU at 11:22 and completed her visit at 
13:05 (time spent at the APU was 103 minutes). She booked for next clinic appoint at 
13:08 and left MDH at 13:12. 
4.3.1.1.7 Patient 7 
Patient 7 (Appendix 5.3.1.7) was a 52 year old male who had been on ARV for 35 
months. He arrived at MDH 05:00 and was given his medical records at 08:16. He was 
called for vital signs measurement at 09:30 and completed at 09:35 (time taken for vital 
signs measurement was 5 minutes). He then waited and consulted a doctor at 11:11, 
which was completed at 11:20 (time taken to consult doctor was 9 minutes). He arrived 
at the APU at 11:22 and completed his visit at 13:05 (time spent at the APU was 103 
minutes). He booked for his next clinic appointment at 13:10 and left MDH at 13:12. 
4.3.1.1.8 Patient 8 
Patient 8 (Appendix 5.3.1.8) was a 25 year old female who had been on ARV drugs for 
4 months. She arrived at MDH at 05:00 and was given her medical records at 08:17. 
She was called for vital signs measurement at 09:33 and this was completed at 09:37 
(time taken for vital signs measurement was 4 minutes). She waited and consulted a 
doctor at 11:22, which was completed at 11:30 (time taken to consult doctor was 8 
minutes). She arrived at the APU at 11:33 and completed her visit at 12:35 (time spent 
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at the APU was 62 minutes). She booked for her next clinic appointment at 12:37 and 
left MDH at 12:40. 
4.3.1.1.9 Patient 9 
Patient 9 (Appendix 5.3.1.9) was a 40 year old male who had been on ARV drugs for 9 
months. He arrived at MDH at 05:00 and was given his medical records at 08:20. He 
was called for vital signs measurement at 09:30 and these were completed at 09:32 
(time taken for vital signs measurement was 2 minutes). He waited and consulted an 
HIV doctor at 10:30, which was completed at 10:38 (time taken to consult doctor was 8 
minutes). He arrived at the APU at 10:40 and completed his visit at 12:50 (time spent at 
the APU was 130 minutes). He booked for his next clinic appointment at 12:55 and left 
MDH at 13:00.  
4.3.1.1.10 Patient 10 
Patient 10 (Appendix 5.3.1.10) was a 58 year old female who had been on ARV drugs 
for 22 months. She arrived at MDH at 07:30 and was given her medical records at 
08:30. She was called for vital signs measurement at 10:00 and completed at 10:04 
(time taken for vital signs measurement was 4 minutes). She waited and consulted a 
doctor at 12:00, which was completed at 12:08 (time taken to consult doctor was 8 
minutes). She arrived at the APU at 12:13 and completed her visit at 16:00 (time spent 
at the APU was 227 minutes). She booked for her next clinic appointment at 16:05 and 
left MDH at 16:07. 
4.3.2 Time Spent at Three Units 
The time spent to receive three clinical services; vital signs measurement at nurse’s 
station, consultation with doctors and ARV pharmacy service (time spent at APU 
includes waiting time from initial time of arrival to departure at the APU. Actual time 
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spent with the pharmacist was not recorded but the time recorded when shadowing was 
time of arrival to time of departure – therefore the majority of this time was waiting) on 
clinic days are shown on Table 4.6 and Figure 4.1. It was observed that patients spent 
between 4 and 19 hours (Table 4.7 and Figure 4.2) at the hospital to receive those 
services. 
 
Table 4.6: Time Ten Shadowed Patients Spent at Three HIV Units of MDH 
 
Patient  Time (minutes) 
for Vital signs 
measurement  
Time (minutes) 
for doctor’s 
consultation  
Time (minutes) 
spent at ARV 
pharmacy  
1 2 10 14  
2 2 8 7 
3 3 13 12 
4 2 8 86 
5 2 10 67 
6 5 10 103 
7 5 9 103 
8 4 8 62 
9 2 8 130 
10 4 8 227 
 
 
 
 
 
125 
 
Figure 4.1: Time spent at Three Units by each Patient Shadowed 
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Table 4.7: Observed Total Time spent at MDH by each of the Ten Patients 
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Patients Entry time into 
MDH  
Exit time from 
MDH   
Total time spent 
at MDH  
 1 17:00 previous day 11:05  18 hours 5 minutes 
 2 17:00 previous day 10:52 17 hours 52 
minutes 
 3 07:45  12:14 4 hours 31 minutes  
 4 17:00 previous day 11:56 18 hours 56 
minutes 
5 05:00 12:40 7 hours 40 minutes 
6 05:00  13:12 8 hours 12 minutes 
 7 05:00 13:12 8 hours 12 minutes 
 8 05:00 12:40 7 hours 40 minutes 
9 05:30 13:00 7 hours 30 minutes 
10 07:30  16:07 8 hours 37 minutes 
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Figure 4.2: Observed Patients’ Journey Entry and Exit Times 
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4.4 Nigerian Pharmacist Interviews 
Ten hospital pharmacists were interviewed during phase 1 interviews; five were female, 
and five were male. One was an intern (Trainee) pharmacist; three were volunteer 
pharmacists; and the remaining six were full-time permanent staff. 
The volunteer pharmacists were registered pharmacists in Nigeria who have completed 
training provided by Global HIV/AIDS Initiative Nigeria (GHAIN) to provide HIV/AIDS 
clinical services. Intern pharmacists are certified graduates of Bachelor of Pharmacy, 
provisionally registered with the Pharmacists Council of Nigeria, employed by the 
Ministry of Federal Capital Territory Administration (MFCTA) and posted to MDH to 
provide clinical pharmacy services for patients under supervision of a fully registered 
pharmacist, and gain more experiences. While the full time hospital pharmacists are the 
registered pharmacists in Nigeria duly employed by MFCTA and posted to MDH to 
provide clinical pharmacy services for patients. All the pharmacists interviewed for this 
study had additional training to enable them provide clinical service for HIV/AIDS 
patients, and, had worked in the APU. 
4.4.1 Concepts   
From the analysis of the pharmacists’ interviews, five concepts emerged from the main 
themes identified (Table 4.8). The themes are fairly grouped into five concepts which 
include: 
• Clinical Service Delivery; 
• Impression of Clinical Services provided; 
• Social Issues associated with HIV/AIDS; 
• Obstacles which obstructed or could hinder patients’ compliance to ART; and 
• Pharmacist Expectations which will enhance clinical service provisions. 
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Themes which have been talked about by at least two pharmacists or more will be 
backed up with direct quotes. 
4.4.1.1 Clinical Service Delivery 
The pharmacists described the services they provided for the patients at MDH. The 
main clinical services the pharmacists spoke about include counselling after verification 
of patient’s details, grouping them and screening of prescriptions. They counselled and 
educated patients on the need to know what medicines they were taking, and be 
absolutely adherent to their ART to avoid viral resistance to ART. The patients were 
also educated on how to take ART with emphasis on the timing intervals between doses 
(since ART efficacy is time dependent). This is encapsulated by the sixth pharmacist 
interviewed and is quoted below. 
“We counsel the patients because the whole essence of ARTs, antiretroviral therapy is 
to make sure that this patient is assessed and classified. We have WHO classifications 
like stages 1,2,3,4, we also have immunological assessments which tells you of the 
CD4 count. So once the person is eligible for ARTs or ARV treatment, the patient is 
placed on it, we have to make sure the patient understands that these drugs as at today 
will have to be taken almost for life. Some people come and said okay what if I take this 
drug for one year, two years and my CD4 count comes up to 800, can I stop taking it? I 
heard my friend told me…we have to make them understand that there is no such thing 
as starting and stopping the ARVs. And these drugs are not like your normal drugs you 
can take em… in Nigeria people, say take one three times a day, take one in the 
morning whenever you remember, take one in the afternoon whenever you remember, 
and one in the night whenever you remember. But make them know that these are time 
dependent drugs, drugs that the administration is time dependent, mostly is 12 hourly or 
24 hourly. So if you take these drugs by 8 o’clock if you have to set up an alarm…to 
130 
 
make sure you take by…if you took the first dose by 8:00 am in the morning.” (Male, 
pharmacist 6) 
4.4.1.2 Impression of Clinical Services Provided  
4.4.1.2.1 Satisfactory Service 
The pharmacists spoke about how they perceived the services provided. All, to an 
extent felt satisfied with the service provision, though working at APU came with 
challenges and chaos when considering the environment and number of many patients 
attended to by few staff. 
‟I felt that the level of healthcare provided for patients are satisfactory…are very 
satisfactory. Though we …we discovered that the ratio of patients to pharmacists are 
actually very high so because of that as we contain that factor we may not really have 
enough time to sit down with the patients to give them detail counselling and may be 
that part of their drugs. In the midst of that pressure, pharmacists still take time to sit 
their patients down and give them the necessary counselling and care.” (Male, 
pharmacist 2) 
“My view is that you know…is just simply the same thing everywhere em… you know in 
Nigeria, the problem we are having is inadequate staffing that is the only problem. 
Sometimes you see yourself…Those that are working in the clinic, sometimes, they 
work even up to 11 in the night dispensing drugs to patients, counselling them and all 
the pharmaceutical services we render to them. So that’s it…is a little hectic that’s all ---
-- You can’t just leave some of the patients you know, knowing fully well that if you don’t 
give them their drugs. Some of them come with their drugs almost…already finished 
and you can’t just tell them to go and come back because you are battling with 
resistance if you know the implication. If you don’t give the patients their drugs for 
some…just for a few days, you know resistance can set in, so we try to clear the log in 
131 
 
everybody to make sure we attend to everybody that came for the day.” (Male, 
pharmacist 3) 
They also felt that patients were more comfortable discussing their issues, including 
personal issues, with the pharmacists when compared with other staff. 
‟Generally, I think we are all doing a great job because we are under a lot of stress… 
One, we have too many patients and then we don’t have enough staff you understand. 
And first of all we have to get to know the patients, should I say individually that kind of 
stuff ----- They don’t feel as comfortable with the doctors as the pharmacists. What they 
cannot tell the doctors, they usually tell the pharmacists, they come here searching for 
me because I don’t sit down here; peeping and looking, madam I’m looking for you.” 
(Female, pharmacist 9) 
4.4.1.2.2 ART High Compliance 
The pharmacists stated that compliance to ART was high, as patients reported that they 
took their ART as prescribed. This is summed up below. 
“Compliance is 100%...compliance is 100%...the only problem we are having; I would 
have said, is this rationalise, but none of them goes out of their drugs. No one knows 
what will happen if the government…since the government is not even actually 
responding, the people that are responding are most of these NGOs.” (Male, pharmacist 
4) 
‟Compliance in Nigeria is very high and also people want to live, and you see…is in this 
case you see that you know people …nobody wants to die… Ask them are you taking 
your drugs, yes, I’m taking it. If you really want to prove it, ask them, they will tell you 
how they are taking it. So occasionally, they miss their drugs, is not out of 
context…some of them actually miss one or two doses in a month. Well, we counsel 
them don’t miss again and they say yes.’' (Male, pharmacist 3) 
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‟I can even reveal to tell you that success rate is above 70 because I have found people 
who have been on this programme and their CD4 count has steadily been on the 
increase in the last six months. I know somebody who came in, he was like 48 and 
today he is 118, to be frank, I’m not sure of the figure. And I saw someone, I wasn’t 
attached to this unit when the person started, the person started ARVs about one and 
half years ago and today, her CD4 count is over 800, when she started she was 147, so 
we have such stories you know.” (Male, pharmacist 6)  
4.4.1.3 Social Issues Associated with HIV/AIDS 
4.4.1.3.1 Stigma 
The pharmacists noticed that most patients were ashamed of associating themselves 
with ART, as patients took the tablets out of their packs before they left the hospital. 
 “A lot of them (patients) still…because of this stigma that is attached to HIV. A lot of 
them do not still come out openly to take their drugs, they tend to take their drugs in 
secret, they…do not embrace their drugs the way em…they embrace other drugs. You 
discover that they hid these drugs, before they could even leave the premises you see 
them removing the drugs from their packs and throwing the packs away. So they always 
try to hide the drugs and by so doing they tend not to know the drugs. They don’t know 
the names of the drugs they are taking and at the same time in the process of doing that 
you discover that they are mixing the drugs. They are mixing the dosages, instead of 
taking aaaa…combivir, in the process of hiding it, they are taking the wrong thing, if they 
are supposed to take once a day, they will end up taking it twice a day.ʼʼ (Male, 
pharmacist 2) 
‟When you even give them (patients) the drugs, they are somewhat, ashamed to carry 
the drugs about, so you see them even before leaving the hospital premises. They 
remove the drugs, remove the label and everything so that people won’t be able to 
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identify what they are holding or when it is time for them to take, people will not know. 
Some will even open the drugs, poured it inside dispensing envelope just to keep the 
identity of the drugs because they believe the environment will stigmatise them.” 
(Female, pharmacist 5) 
4.4.1.4 Obstacles 
The pharmacists spoke about barriers or obstacles which prevented them from carrying 
out their tasks thoroughly. 
4.4.1.4.1 Many Patients/Few Staff 
Pharmacists spoke of the volume of patients attending clinic days coupled with few 
staff. 
“The most difficulty is staff. We don’t have enough hands that is all, no enough hands 
and the patients are many -----When you talk of space, it affects the hospitals generally, 
and is in all our hospitals, there is a space constraint, you just manage what we have, 
that is all.” (Female, pharmacist 5) 
“They (patients) are so many, number one the issue of staff, we don’t have enough 
staff. If we had some…their staying time you know because from the time for you to see 
a patient to go through their…the folder to greet the patient, to counsel the patient takes 
time sometimes it takes up to 10 minutes. 10 minutes is a long time, if every patient that 
comes in …you are seeing somebody every…you are seeing one patient every 10 
minutes and you are seeing 100 and something, you can imagine how long it takes ----- 
If you come in the morning, you don’t close till very late, so is long they have to stay, 
they come from very far away places also.” (Female, pharmacist 7) 
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4.4.1.4.2 ART Rationing/Shortage 
Pharmacists said they had to ration ART since dispensing complete prescriptions over 
two months for each patient would amount to denying other patients ART that day. 
‟If the drugs are not enough we can ration the drug, if they say six months we can give 
three months. Record the person’s name say come back and I think that is basically, 
just it ----- A times we want the drugs to go round because sometimes we have to go to 
Wuse or somewhere, is not to give someone six months the other person comes and 
doesn’t get any.” (Female, pharmacist 9) 
‟Three months those days, we used to have problems we…the stock is limited and if we 
give one patient three months’ supply, we are really really going to have problems and if 
you could look outside, you will see about 50 or 30 people having their prescriptions not 
yet filled. So, what you do is to cut it down, you give the patient one month. Then, we 
have a book we call em… incomplete dispensed book, then we enter the patient in the 
incompletely dispensed book, note the amount we are giving him, the amount 
remaining. Three months prescribed, one month dispensed, two months left, no need to 
go to the physician, is now between us and the patient.” (Male, pharmacist 3) 
4.4.1.4.3 Working Environment 
Pharmacists spoke of difficulties at the APU, such as lack of air conditioners and 
computer software that frequently hindered their daily tasks. 
‟Another factor is the word in Nigeria about power I was speaking to a project partner in 
one of the meetings we had, when I met him and I said why is it that we are not…all our 
data entry are not computerised on real time…are not done on real time and he 
explained and I can understand because sometimes when you are working there is no 
light ----- Maitama is far better than so many sites in the suburbs and outskirts of the 
city. When you leave a city like Abuja, you can imagine what goes on there, so the light 
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and the electricity problems is…is nationwide and is not only peculiar to HIV or ARV 
pharmacy ----- Space is a problem then the software’s, even though the NGOs are 
ready to supply them but we need more computers and software’s and real time data 
entry or so.” (Male, pharmacist 6) 
‟A times when you are working…the working environment… you have been to that our 
place, I remember it was sallah day, all the whole air conditioners have packed off and 
the heat was so much. I had to open with one hand, I was fanning myself and was 
sweating, is not too ideal.” (Female, pharmacist 9) 
4.4.1.4.4 Patient Attitude 
According to the pharmacists, the patients were mostly in a hurry to take their leave 
from the clinic. Patient attitude was attributed to the fact that most patients did not take 
appropriate permission from their workplaces to be at the clinic and so, wanted to return 
back to their work before they were found out. 
‟And again, some of them (patients) sneak out of office to come and pick these drugs 
too, they can be here and they are receiving phone calls too. So, if you are trying to 
offer pharmaceutical services, which to us, is almost compulsory because you just don’t 
handle over the drugs because these drugs they have guidelines; you have to check out 
for prescription errors first, you have to counsel the patients, register their IDs, the 
patient’s name, the pharmacist’s ID, then you write out all the details of the ART 
regimes given to the patient. This information tells you how many patients are on 
particular drugs and you can make provisions for such drugs accordingly. At times these 
things, they may not have time for it and they can actually boil and say what they want 
to say. And you as a trained healthcare professional or healthcare provider, is just one 
of those things in the line of your duty, you just do your best and make sure you put the 
situation under control.” (Male, pharmacist 6) 
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“When you look at their (patients) behavioural attitude everything, you know. A times, 
we have had patients that they will just turn like…they will just look at you as if the 
services you are giving is not even important, they just want to get their drugs and get 
out of the place. So we still talk to them, bring them down, may be somebody offended 
them somewhere, may be personally from their house, may be their husband or their 
wife, sometimes transfer of aggression. We let them know that the services we are 
about providing …is very very important…is the most important because if they don’t 
adhere…don’t get counselling …you know adherence is very very important. Because if 
they are missing just like two or three doses in a month that is in fact something will 
happen in their systems, so we need to let them realise it.’’ (Male, pharmacist 8) 
4.4.1.5 Pharmacist Expectations 
4.4.1.5.1 Employ more Pharmacists  
The pharmacists expected the authorities to employ more pharmacists, to update their 
training to provide improved HIV services and to assign them to permanent positions at 
APU. 
‟They can employ more pharmacists, so that we will be able to spend quality time with 
the patients. We have to hurry, so that we can finish on time. As at last week, I think 
they finished around 7:00 pm and you know once you start getting tired, the quality of 
service you offered will be reduced because the enthusiasm will not be there again. You 
are just eager to let the patient go, so you won’t have time to really talk to the patients 
and counsel him, which is what we are supposed to do, we are supposed to be 
counselling the patients, not just give them drug, one morning one evening bye bye, go, 
we have to counsel.” (Female, pharmacist 1) 
“Personnel ----- that is one of the challenges we are having because a times to attend to 
patients on their clinic days Mondays and Wednesdays so busy and considering the 
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number of pharmacists at the ARV is not easy. Because a times a em…what about two 
or three should be handling, you alone will be handling. A times we close very late you 
know, normally we suppose to close at about 3:00 o’clock but we find ourselves closing 
around 7, 8 in the evening, you know ----- If more personnel can be recruited. More 
pharmacists can be deployed to ARV clinic to facilitate how the work …to reduce the 
stress on pharmacists is very very important.” (Male, pharmacist 8) 
“I think we should have permanently… There are no a….Mrs Akande can be pulled out 
of that place tomorrow, she is the one that is there currently, you see there is no 
continuity…somebody like Aisha now that had gone on training…Aisha…Pharm. Aisha 
was trained specifically by Ghain and she is the focal person here in Maitama hospital, 
she is now in the store, now she has been pulled from the ARV clinic to pharmacy store 
because there are no permanent staff in ARV pharmacy, so my suggestion is that 
government should put some permanent staff there you know that this man is even 
trained. This man is there, this man is coordinating activities at the ARV clinic, when 
internees come, this man will put them through; this is what you do, you supervise them 
(other pharmacists).” (Male, pharmacist 3) 
4.4.1.5.2 Regular Medicine supply 
They also wished for greater availability of ART and other medicines. 
“We need enough drugs, adequate availability of the drugs; it will even help them if we 
have…patients that are already stabilised. If we can provide for them three… three 
months course of therapy, it will now reduced the… time the patient comes to the 
hospital.” (Male, pharmacist 4) 
‟The government should try to make the drugs…have more drugs regularly.” (Female, 
pharmacist 9) 
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4.4.1.5.3 Working Environment 
They were strongly of the opinion that the non-conducive working environment could be 
improved by the provision of more space for patients and increased storage facilities to 
keep the ART drugs and necessary equipment. 
‟I will say…that a bigger space can be set for the pharmacy too. Our Storage conditions 
you understand what I’m saying, we need adequate storage facilities for the drugs, you 
understand what I’m saying because…you know, ideally our drugs should be arranged 
on the shelves not on cartons on the floor. We don’t have where to arrange them, we 
don’t have top shelves. You go in there; you can go and see for yourself. You see the 
drugs in the cartons on the floor there, actually we are dispensing directly from the 
cartons whereas we are supposed to dispense from the shelf.” (Male, pharmacist 3) 
“The working areas, there should be more space for working so that all the drugs you 
can just stretch your hands and get them.” (Female, pharmacist 1) 
Some pharmacists also expressed the opinion that volunteer pharmacists should be 
paid stipends. 
“This issue of staffing like these volunteers sometimes they are not being paid 
especially the pharmacists they don’t give them stipends. I don’t know what they say 
they give the doctors but they don’t give the pharmacists, sometimes they come here 
they are tired.” (Female, pharmacist 9) 
‟Then we (pharmacists) wouldn’t mind if there is any …if there is any incentive for the 
pharmacists working over there (APU) because they used to work extra hours without 
any compensations, if it is to boost their morals.” (Male, pharmacist 8) 
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Table 4.8: Themes and Concepts for Nigerian Pharmacist Interviews 
 
Concepts  Contributing Themes  
Clinical service  delivery Fact finding (2) family's HIV status (3), knowledge of 
ARV drugs (4), complaints/side effects (5), confide in 
somebody (1) provide one on one clinical service (1), 
counselling (5), drug resistance (3), pharmaceutical 
care service (4), prescriptions vetting (5), matching 
each patient to individual folders (3), liaise with medical 
doctors and  teamwork (3) dispensing/refilling (4), CD4 
cells count (1), emphasis on dosing frequency (3), 
WHO classification guidelines (1), register patients (1), 
patient education on ARV drugs compliance (1), 
document ARV drugs (1),  
Impressions Satisfactory service (2), trained for the job (1), highly 
service & great job (2), ARV drugs high compliance (2), 
reduced death rate (1), joy (1), success rate (1), 
pharmacists could provide more service (1) 
Social issues  Increased public awareness (1), Stigma (4), ignorance 
(2), NGOs support for HIV (3), tracking HIV patients (1) 
Obstacles  Concealment of ARV drugs by patients (2), challenging 
work  (1), sympathy (6), more work load for 
pharmacists (1), many patients (7), few 
staff/pharmacists (10), time factor (1), ARV drugs out of 
stock (7), ARV drugs ration (4),  patients do not know 
their ARV drugs (2), patients hurry out of hospital (4), 
HIV patient’s attitudes (3), ARV drugs low compliance 
(1), non- conducive working environment (3), small 
working space (5), delays (1), high complications (1), 
patients spreading HIV (2) more infected HIV patients 
(1),  ARV drugs for life (1), language barrier (1), 
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electricity outages (1) delays due to many patients (1),  
Expectations  for 
improvement 
More input from pharmacists (1), more public 
awareness on HIV/AIDS (1), employ more 
staff/pharmacists (9), regular ARV drugs supply (3), 
adequate working environment (5), enough working 
tools (1), permanent HIV pharmacists (1), HIV laws to 
protect HIV negative persons (1), software for data 
entry (1), electricity (1), retrain more pharmacists for 
HIV service (1), increase clinic days (1), decrease clinic 
patient numbers (1), staff incentives (3), language 
translator (1), patients’ genuine feedback about service 
provided (1) 
 
4.5 NHS HIV Pharmacist Interviews 
For a comparison, NHS HIV specialist pharmacists were interviewed at four different 
hospitals in the UK after data collection from Nigeria. The discussion centred on the role 
they played in the management of HIV/AIDS outpatients. 
4.5.1 Concepts 
After the analysis of NHS HIV pharmacist interviews, five concepts emerged from the 
main themes identified (Table 4.9) which were based on their spoken and body 
language as written in the transcripts. Like the Nigerian pharmacist interviews, the 
themes are fairly grouped into: 
• Clinical Service Delivery; 
• Impression of Clinical Services provided; 
• Social Issues associated with HIV/AIDS; 
• Obstacles which hindered or could hinder patients’ compliance to ART; and 
141 
 
• Pharmacist Expectations, which will enhance clinical service provisions. 
4.5.1.1 Clinical Service Delivery 
The pharmacists said the clinical services they provided include; assessing patients 
prior to classifying them, attending to every patient, one on one basis, medicines’ history 
taking, educating and counselling on ART adherence, helping patients with choosing 
their ART, checking ART with each patient and advising patients on side effects of ART 
amongst others. 
“We have got two groups of patients; one is…your new patient and one is…err 
treatment naïve and inexperienced patient, yea. When the new patient comes in, they 
will see the health adviser…they will see the consultant…they will see the nurse…they 
will see the pharmacist. My role is to give them as much information about what HIV 
treatment pathways is, you know…use the HIV ibase patient booklet, explained to them 
the journey of the disease state. The journey of the medication, how it works, what 
monitoring is required, what to expect…the importance of monitoring…everything is 
explained in a one hour appointment ----- We are extracting basic drug history from that 
patient; previous drug history, co-morbidities, allergies, life history, family history, the 
social-sexual history is taking by the health adviser. The GPs will have their inputs…to 
the GPs through the consultants. All that is combined in the first visit, we give them 
information to take away to read and absorb and come back in a week later. That gives 
them a week to go back and reflect that they are ready to start treatment, okay. When 
they come back, by which time we may have the genotype resistance report come back 
which tells us which drug will be suitable and which won’t be suitable. Matching that with 
drug history taken by myself, we design a pathway of treatment of drug choice options 
based on the guidelines. We initiate the treatment at week one, as they come in, we 
decided. Already they have gone away, any question from last week conversation, they 
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said yes...no…they usually have a lot of questions to ask, as we clarify, reassure, we 
check their thinking and their understanding that takes a good half an hour.” (Male, 
pharmacist 4) 
‟So you know, we can only spend limited amount of time, but the doctors will go through 
medical things with the patients and err…we have basic things we would with these 
patients that come through. Checking the drugs with patient, checking any other 
medicines that they are taking for interactions, checking that they are taking the right 
thing and err…you know ----- Checking that they are taking with food or without food 
may be necessary ----- As soon as they start treatment, they will all come and see the 
pharmacist first for a session, which is a very special clinic…start clinic. We will spend 
four hours going through with the patient, everything to do with antiretroviral and 
adherence and the different treatment options.” (Female, pharmacist 3) 
Dispensing of ART was carried out at hospital pharmacies or contracted pharmacies 
such as Boots pharmacies and there was also home delivery of ART. 
“The medication is all dispensed through Boots pharmacy, which is close to the hospital. 
They do…err… they do all the outpatients dispensing, and filling of prescriptions for 
whole the hospital, they can also deliver to the patients within the catchment area. So is 
like a home delivery service and err…there is also …they can pick it up from the 
pharmacy that is near to their homes as well. So we try and make life easy as possible 
for the people, so if they come to clinic and is a long way and they don’t want to get and 
their medicines from the counter, there are other options for getting their pills.” (Female, 
pharmacist 3) 
‟Previously, we had patients whose prescriptions were sent to pharmacy, prepared and 
sent back here for collection. We stopped that service 12 months ago and what we are 
doing now, we have onsite dispensing here, we have a technician in the room next 
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door. We will issue a prescription at the beginning of the consultation, it will get 
dispensed by the technician, I will double check it and then go with the medication to the 
patient.” (Male, pharmacist 4) 
4.5.1.2 Impression of Clinical Services Provided 
4.5.1.2.1 Very Good Service  
The NHS HIV pharmacists described the service provided for the patients as good, very 
good, very integrated, beneficial and or invaluable, thus, they were satisfied with the 
service provision. They also said that the service involved a multidisciplinary teamwork 
approach in close proximity as regards care of patients whilst they were more doctors at 
the HIV clinic compared to pharmacists; this affected the time the pharmacist could 
spend with each patient as stated by the pharmacist with the BHH. 
“Here, the patients get a very good service, I think is a very integrated service that we 
provide, so is very much multi-disciplinary. Err...particularly in this hospital, so we very 
much work as a team. So, is being a patient’s...is not just the doctor level service which 
I think is important, you know… the clinical nurse specialist, the dietician, the 
pharmacist, occupational therapist, the social worker as well, everyone is got their part 
to play in helping, you know, to successfully treat the patient. I think that is quite 
important ----- I think if you compare HIV services to the outpatient service and the 
amount of time the patient gets here within clinic compared to… you know, any other 
general outpatient setting. They get a lot of time and they get a lot of input, which is 
really good for the patient. So you know, a patient here will have a whole half an hour 
with a doctor for each appointment and err -----The consequences of treatment not 
being successful, I think somewhere through that we can justify that -----The way that it 
works, within clinic time, any patient that sees the doctor, has a prescription will always 
come through to see the pharmacist ----- obviously we spend less time with the patient 
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compared to the doctor because you might have three or four doctors in clinic but just 
one pharmacist.” (Female, pharmacist 3) 
4.5.1.2.2 Many Clinic Days 
The pharmacist with the SOH spoke about when and how the clinics ran and how 
patient lists were drawn with regard to whom they needed to see; the clinics operate 
from Monday through Friday and include evening clinics. 
“In terms of pharmacists’ involvement, we currently have six clinics a week, potential 
seven clinics a week, Monday to Friday there is a clinic, Friday is a double clinic, 
morning and afternoon. There is adherence clinic on Wednesday afternoon and a clinic 
on Saturday morning. For instance if we highlight a patient who needs a lot of our time 
and we can’t schedule to see during the routine clinic, we can get them in on a 
Wednesday afternoon if they turn up. Scheduling is done via our appointment system. 
Every time a patient sees…comes into clinic to see a doctor, if they need medication, 
they will see me. If a patient needs to see only me, they approach our nursing staff and 
the nursing staff book appointment for them to see me ----- A patient is booked on a 
code to see me, so at the beginning of a clinic I picked up the sheet, I know exactly who 
is on the list… I can look out a patient who is here and needs my attention ----- If the 
patients are only to see me, then we can give them a set time, ordinarily, a lot of our 
patients understand that we have clinics running, that I can’t guaranteed that we see 
them at a particular time. The approach that I have with my patients is that I’m honest 
with them and they know if I can’t see them. (Male, pharmacist 2) 
4.5.1.2.3 Availability of ART 
The pharmacist with the NCH acknowledged that the hospital provided a good service 
in line with national treatment guidelines for HIV patients. Those HIV patients who 
presented with late stages of the infection were cared for by consultants. He also said 
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that the hospital stocked variety of ARV drugs regimens, which were readily available 
for the HIV patients. 
“I think is...a Good service and we‘ve got em...we’ve got about 400...between 300 and 
400 patients are on treatment. Usually err...we start treatment when their CD4 cell 
counts are around 350, so we monitor their CD4 cells count in line with our national 
treatment guidelines… BHIVA, we start treatment when their CD4 cells count fall below 
that 350. And the patients we have, they are on treatment when their CD4 cells count 
drop to that level ----- to have suppressed viral loads, which is the aim… of antiviral 
therapy. And because we have got a lot of quite different regime available, we can 
always find the regime. We do get some patients who present late, so we take the 
patient to the consultant… that they present late…so she is got cancer and em...then 
the patients are usually considered as consultant patient.”  (Male, Pharmacist 1) 
4.5.1.3 Social Issues associated with HIV/AIDS 
4.5.1.3.1 Disclosure Issues/Stigma 
Also, the pharmacist with the SOH identified that patients appeared to have problems 
regarding disclosure of their status (with lack of privacy where they live), patients in 
denial as their status and stigmatisation. 
‟We have as well is…housing, you probably think what has housing got to do with this? 
A lot of our patients are from abroad, they may be asylum seekers, they may be 
refugees. For them, is not just the matter of I can put my medication wherever I want in 
my house. They might just live within just one room in the house, and whom did they 
share that room with? They could be sharing that room with complete strangers, so for 
strangers to have a look at their tablets… medication, that ooh…they see that on the 
shelves, it does not take much to go on to Google, type the name of the drug, and 
straight away, the patient’s status is disclosed. Sometimes patients are concerned they 
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don’t want to be seen taking tablets or they having an association, they have 
psychological issues that em…I’m taking medication because I’m ill but I look fine and I 
feel cool, why should I take medication to treat symptoms that I don’t even have yet 
when the medication will cause me side effects. So there is a huge barrier like that. 
Other things that we have is, there is still a lot of stigma, patients don’t want to come to 
clinic, we have been in a situation where a patient has turned up to clinic, not even got 
to the stage where they will get to be with unitary where the nursing staff. They have 
looked down the corridor, seen all these faces, and are not keen on that, turned out and 
walked off before they are even being seen by the doctor. How can we sit them down, 
talk about the medication, get them to take the medication, and we can’t even get them 
to clinic, so that is that.” (Male, pharmacist 2) 
4.5.1.4 Obstacles 
4.5.1.4.1 Language 
The challenges the pharmacist with the SOH saw with regard to providing clinical 
service were centred around language barriers with his patients. 
“There are a number of difficulties; the commonest one I think is language… Now, we 
are fortunate in a sense that within a multidisciplinary team, we have people from 
different backgrounds, is quite multicultural, so they cover a lot of the languages. So we 
get a lot of French speakers from Africa, err…we get some of the other native speakers 
from Africa as well; we got Arabic speakers as well ----- Sometimes, we need to get a 
translator. Is difficult enough explaining things to a patient, but when you are explaining 
it to a third party, we are always conscious if something is being lost in translation. And 
you know…like a Chinese visitor, you sometimes questions if the patient really 
understands it, you do your best, is still about it.” (Male, pharmacist 2) 
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4.5.1.4.2 Time Management  
The pharmacist with the WMH identified difficulty with the clinical service provided as 
time management of staff, which could lead to patient delay with patients becoming 
inpatient. 
“Is the time, you know we have between 12 to 20 patients per clinic, which means we 
only have 20 to 40 minutes per person. If the nurse is going to do the bloods, the 
biochemistry, high blood pressure, doctor is going to see them, they may want to see 
the health adviser, then they gonna see me. And sometimes, they have to wait for me 
because I’m with someone else and that may take longer than 10 or 15 minutes 
because there is issues or concerns. So the patient is kept waiting and when I go to 
them they have been waiting for an hour before they see me because they come for 
their appointment 10 minutes earlier. They have spent about half an hour to 40 minutes 
with the rest of the team that is 50 minutes; they had to wait to come to me, then I 
spend another 20 minutes they could be here for an hour and half. And then is a 
turnaround in here, you can’t rush them because you have to be sure that when they 
leave, there is no other question or concern…they will comply with instructions and the 
results are getting the right directions. So the difficulty is managing time and the 
resources to do that. They can be impatient; you know…I have been waiting for 20 
minutes for you just to clear my medications…I have no issues. Or yes, I have a lot of 
issues but I parked my car outside with a parking ticket for one hour.”  (Male, 
pharmacist 4) 
4.5.1.4.3 Abscondment/Paper Work 
Furthermore, the pharmacist with the NCH went on to talk about patient numbers 
attending the clinics and the problems staff face; he felt the service did not require 
improvement. 
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“The maximum number of patients that have been attended to on a clinic day is twenty 
and least so far was four patients ----- Abscondment… non-attendance of clinic by 
registered patients… not turning up for their appointments while staff wait patiently for 
them. Em…we do have papers to stroke with the files but we take care of the patients 
who are coming. We sort of made time available to speak with the patients as far as we 
can go. So I think…I do not see anything wrong with the service.” (Male, pharmacist 1) 
4.5.1.5 Pharmacist Expectations 
Although, the first NHS pharmacist interviewed spoke about the problems staff face; he 
felt the service did not require further improvement. 
4.5.1.5.1 Managing Stable Patients 
The pharmacist with the BHH spoke of further service enhancement for stable HIV 
patients (despite some concern over social workers funding) but did question if patients 
themselves realised the high level of service they were receiving. 
“I suppose funding is always a difficulty. Err…say when we do directly employed social 
workers from…within heartlands but then social workers’ funding has been cut for HIV 
services ----- I think sometimes expectation can be a problem for the patients; the 
patients are very well looked after. I think is a very very good service…err…I think they 
don’t often realise how good that service is ----- One thing we are just starting for the 
moment is management of stable patients ----- If they are stable on treatment, rather 
than coming back to see the doctor every three or four months, they can come back to 
have their blood done and if everything is okay, we can give then give them a phone call 
to let them know that everything is okay. Then we can actually deliver or post their 
medicines. So is just mean that we can free up appointments that are needed by other 
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people and also the patients don’t need to visit quite often…quite so much so as is a 
long term life condition.” (Female, Pharmacist 3) 
4.5.1.5.2 Support Groups 
To improve on clinical service provided, the pharmacist with the SOH said they have 
begun to involve patients more in discussion around service delivery and have 
representatives from support groups present on clinic days. 
“In terms of improving our service, one of the things we started doing is not just getting 
together in terms of the professionals that run the clinics and we thinking this is best for 
the patients. More and more so we are getting the patients involved, so we have now 
held our third patients’ open forum ----- We said to them, tell us what you want. How 
would you like the service run, what areas do you think need to be improved, how can 
we get you to clinic, how could we make it a more comfortable experience for you ----- 
Another thing we have done is, rather than just having clinic, which is filled, with patients 
and staff, we have got groups…support groups such as Terrence Higgins Trusts who 
are people, also diagnosed with HIV and also on medication. Now, is easy for me to talk 
to a patient, please take these pills, I don’t have to take them. But when it comes from 
someone else who has already been through what the patient is experiencing, they can 
relate to the patient and the patient can relate to them -----That backup will help them a 
lot more rather than me using everything to let them take their tablets at home.” (Male, 
pharmacist 2) 
4.5.1.5.3 More Clinics/Pharmacist and Nurse Prescribers 
Furthermore, the pharmacist with the SOH spoke of more clinics and the ability for 
people other than doctors to be able to prescribe the ARV medicines. 
150 
 
‟In terms of service that we provide at the moment, the out of hour service, I would like 
us to increase that further. So, more evening clinics, weekend clinics, but not just clinics 
run by nursing staff, clinics run by doctors but also I want to see more pharmacists at 
clinics. The situation we have at the moment just because you have clinics running from 
say 9:00am until 5:00pm, it doesn’t mean you are not gonna get patients turning up at 
3:00pm and say they want to get medication. If a patient turns up at 3:00pm, we can’t 
do anything until we find a doctor to write prescription, however, if we have nurse 
prescribers and pharmacist prescribers, we can resolve that there and then. So this is 
what I’m pushing for, nurse prescribing, pharmacist prescribing, is already happening in 
other areas and in other centres, we need to catch up, that is the key thing that is my 
personal opinion.” (Male, pharmacist 2) 
4.5.1.5.4 Home Delivery of ARV Drugs 
To improve on clinical service provided for patients, the pharmacist with the WMH 
suggested home care service, which was yet to start; though most of the HIV patients 
had been hesitant about it because of confidentiality issues. 
“That is, now look at home care service because we haven’t got that here. But we have 
had a lot of resistances and hesitancies from patients about home care ----- They don’t 
like it…they know about it…they have heard about it, they have spoken to folks where it 
has been used; they still feel that there is issue about confidentiality or somebody 
questioning about this deliveries you are having. It might be the neighbour or sister. 
What is these deliveries you are having every two months or three months, four months, 
or somebody in the family who doesn’t know about it, saying what is this delivery. Is 
very difficult, is all shared accommodation these patients, is just about keeping it 
discreet. But they can have collection from other points we told them, they can get from 
their retail pharmacy or their GP surgery but they don’t want the GP to know…they don’t 
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want the retail pharmacist…they don’t want many people to know, they want it very 
close, sometimes some of their family members don’t know. So that is a very big issue 
that we are trying to work on how we can improve that.” (Male, pharmacist 4) 
Table 4.9: Themes and Concepts for NHS Pharmacist Interviews 
 
Concepts  Contributing Themes  
Clinical service delivery  Follows treatment guidelines (1), medicines’ history 
taking (2), patients’ orientation (1), patients’ assessment 
(1), supporting patients (2), educating, monitoring (2), 
checking the ARV drugs with each patient (1), Helping 
to advise on side effects (1), compliance and adherence 
counselling (1), Boots pharmacy dispensed ARV drugs 
(1), home delivery of ARV drugs (1), Focused on 
Individual appointments (4), classify HIV patients (2), 
patients’ feedback (1), choice of ARV drugs for patients 
(1), a point of contact 
Impressions Invaluable (1), very good service (1), good service (2), 
beneficial service (1) team work (4), committed HIV 
pharmacists (1), very integrated service (1), ARV drugs 
availability (1), few patients (1), they get a lot of time, a 
lot of input, three clinic days (1), many clinic days (2), 
evening HIV clinics (2), one to one service (1),  
Social issues  Housing issues (1), refugees, stigma (1), confidentiality 
(1), disclosure issues (2), worst cases were emigrants 
(1), curable HIV infection (1), non-acceptance of HIV 
diagnosis (1), 
Obstacles Late stage of infection presentation (1), paper work (1), 
funding cut (1), HIV patients’ expectations (1), language 
barrier (1), time management (1), abscondment (1), 
unscheduled emergency cases (1), patients’ impatience 
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(1), 
Expectations for 
improvement 
Support groups (1), out of hour service, more HIV 
pharmacists (1), HIV pharmacists and nurses’ 
prescribers (1), more HIV evening clinics (1), managing 
stable patients (1), home delivery of ARV drugs (1),  
 
4.6 Management Staff Interviews 
After the observation of patient journeys and further patient interviews, it became 
evident that it would be prudent to talk to management staff at MDH about their views of 
the HIV clinical service. 
4.6.1 Medical Record Officer’s Interview 
The interviewee (Mr C1) was the administrator in charge of HIV patients’ monitoring and 
management (PMM) unit. His interview was hand written by the interviewer which was 
based on the choice the interviewee made. Whilst being interviewed, his assistant, Mr 
C2, joined us. At this point there was no opportunity to ask him to leave. During the 
interview with Mr C1, Mr C2, did make comments and are reflected in the transcript 
(Appendix 5.5.1.1) excerpts. 
The record officers did say that the HIV patient’s journey at MDH was straightforward 
and patients were adequately informed about HIV patients’ activities within MDH at the 
beginning of their registration. 
“Is a smooth journey where new patients are directed to heart to heart for counselling. 
The first point of call is heart to heart, where the patients are properly counselled on HIV 
before HIV test is carried out and if found positive, they are properly counselled again 
with emphasis on complete treatment for HIV infection. Then individual patients are 
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advised on voluntary consent to HIV treatment before being sent to the PMM section to 
be registered as one of HIV positive patient at the facility. When a patient decides to be 
assessing HIV service in the hospital, such a patient goes to PMM office on a Monday 
and his or her details are recorded in an individual medical record by a professional 
record officer. From there, the patient is sent to consult a HIV trained medical doctor 
who will assess the patient on his or her next direction of treatment. A medical doctor 
will then send such a patient to the medical laboratory for investigation using the clinical 
evaluation form. Mainly to determine the CD4 count cells this is usually used to place a 
patient on ART (antiretroviral). Also body vital organs are monitored prior to starting 
patients on ART. Patients whose CD4 count cells are more than 350 and are not 
manifesting any sign or symptom of HIV are simply put on Septrin® for two weeks and 
under constant monitoring. Some patients that come with signs and symptoms of HIV 
such as rashes, wasted muscles, etc to the hospital are directly placed on ART without 
assessing their CD4 count cells initially. So, also patients that their CD4 count cells are 
250 or less are placed on ART immediately if they can tolerate it. Subsequently, 
appointments are given to patients by doctors at short intervals initially for two weeks, 
monthly or bi-monthly then tri-monthly and later on prolonged when patients respond 
positively to ART. There are set down standards for opening procedures which are 
usually followed -----The counsellors at the heart to heart unit tell them about their 
movements in the hospital. The counsellors take new patients around the hospital 
compound to get them familiarised with the units.” 
They also said HIV patients were given block appointments on clinic days and to report 
at 07:00. They further said that they had regular meetings with other staff about service 
provision and respond accordingly within their powers. 
“We give them block appointment time to 07:00. Initially it was 08:00 but the patients 
started coming late….sometimes later than 10:00 making the doctors to stay till late, 
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then we shifted the time backward to 07:00 ----- We do not give any patient appointment 
to come and sleep in the hospital ----- We were told that the waiting area to collect 
medicines (pharmacy) was not comfortable so we had to renovate and extended it. It is 
now comfortable ----- Usually during our weekly meetings, staff members from different 
units discuss about different observations they have made and we critically look at 
them… And if possible implement them.” 
They said that the main constraint they had, was to do with patients who did not keep to 
the appointment dates but simply turned up at the clinic whenever they wanted and then 
overcrowded the clinic. Hence, they made the medical doctors and pharmacists to work 
until late and or some patients were sent away by the pharmacists, which could have 
led to drug resistance. 
“Patients do not keep to their regular appointment days and so over congest other 
patients’ appointment days, thereby making it difficult for all staff members. Sometimes 
medical doctors stay till 16:00 and that will make the pharmacists to leave the hospital 
after 18:00. And some days, pharmacists send patients away to come back next day 
and that may make some patients to miss their doses which may lead to drug 
resistance.” 
They suggested reducing the number of patients to be seen on a clinic day to achieve 
quality clinical service provision. 
‟The most important improvement is to streamline the number of patients that can 
consult medical doctors in a day in order to provide quality service. It is better to provide 
quality service for 50 patients in a clinic day than to provide substandard service for 150 
patients. Sometimes the doctors get exhausted and when they continued with fillings of 
forms which involve ticking of boxes, they do tick the wrong ones. Even in pharmacy 
where we still lack adequate number of staff. Sometimes, pharmacists come to help 
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(volunteer pharmacists) with few minutes’ instructions, at the end of the day, mistakes 
do take place. We see these mistakes all the time, probably the staff that made the 
mistake had gone away; drugs have been dispensed for patients without recording them 
or recorded in the wrong folder. Patients have died due to drug reaction and nobody 
took it up or bordered to find out how they died. All these can be traced to over burden 
at work, so is better to go for quality work not quantity.” 
4.6.2 Senior Medical Officer’s Interview 
The medical officer in-charge of the clinical service for HIV patients at the hospital was 
also interviewed (Appendix 5.5.1.2). 
Although, he acknowledged that there were some hindrances, he said the patient’s 
journey at MDH was up to standard because the hospital had a blueprint on how HIV 
patients went about receiving their clinical services at the hospital. 
“My views are …on HIV patients’ journey in Maitama hospital is that, indeed, we have a 
developed blueprint of how our patients flow should be from one service point to the 
other. For now, I will say…the patient journey in the hospital is average because there 
are encumbrances here and there due to some sort of delays at the service delivery 
point as patients move from one point to the other. So, on a general note; I will say the 
patients’ journey in Maitama District Hospital is…by my assessment is…on the average 
----- Usually at the point of registering them before they commence ART, we educate 
and counselled them all on what to do and where to go to for subsequent services. So, 
they are aware that from the HCT (HIV Counselling and Testing) unit where the test is 
done, they move to the PMM where they are registered. At the PMM, they are also 
educated on where to go to for clinicians to see them. From the clinicians they move to 
the lab for their tests and then to the pharmacy and back to the PMM. So they are 
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aware of where to go to at any given time when they come to err…err…explore or 
assess our services at any facility.” 
He emphasised the fact that HIV patients waited for long period at the hospital to be 
provided with clinical services. 
“There are feedbacks at every point especially at the clinic and most especially at the 
pharmacy. These are two points where our patients have some forms of delays 
because they spend quality time waiting especially at the pharmacy to collect drugs. 
They also spend some quality time though not as bad as they do in pharmacy at the 
clinic to see the doctors because of the…the ratio, patients’ doctors’ ratio is very …very 
high. So there are…. feedbacks we get back from patients. Sometimes they come to the 
medical record and they will tell them that their folders cannot be traced, you know. So 
patients sometimes go through frustrations because of assessing services ----- Well, I 
wouldn’t say exactly of how much time a patient is supposed to spend but to the best of 
my knowledge, I know that patients come sometimes as early as 05:00 to the hospital to 
take their turns. And such patients sometimes stay in the hospital till about 
16:00…17:00 before they leave. So, you can imagine somebody coming to the hospital 
to assess services when he or she needs to come to the hospital early enough to get 
access to the service. That does not still serve the patient, the patient end up spending 
the whole day before she goes through all the service delivery points for that day. On 
the average, the patient can stay err…an average of eight to ten hours before they 
access services…before they leave the hospital; that is the turnaround time. Ideally, in a 
normal setting, a patient should not spend more than one to two hours to access those 
services, so they spend quiet a long time…longer than expected here ----- Some 
(patients) come the previous nights to stay and queue up early to be able to assess 
services because they did that to avoid delays. But I think that has not even helped 
them…at all, you know.” 
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He said that the hospital’s main constraint was low staffing. Hence, he suggested that 
more staff should be employed whenever the authority so wished, more space should 
be created and staff attitude to work should change for better.     
“The major constraint has been that of manpower. The hospital staff see what they are 
doing as additional work in addition to their routine job. But I want to align myself with 
some of the complaints they made in terms of manpower because on an average clinic 
day, we have about a 180 (hundred and eighty) patients to be seen by three to four 
doctors. So you can imagine how much time the doctors will need to see these numbers 
of patients. Secondly, at the pharmacy, there is only one resident pharmacist stationed 
at the pharmacy and there are volunteers that come and go at wills. Now the delay in 
the pharmacy is further complicated with the number of tools…they need to fill, the 
workbook, the patients prescription book that need to be fully signed by the pharmacist 
and endorsed by the patient. And all these things contribute to the delays. The bottom 
line is …Manpower is very very inadequate especially at the pharmacy unit. I have 
made personal efforts to visit the Administration of the FCT to recruit more Manpower to 
the facility because of the patients on the ground but up till now, we are still waiting but 
nothing has been done about it. Well…the basic improvements I think that can improve 
the patients’ journey in Maitama District Hospital are first of all we need to improve the 
manpower base of the workers. Space is a …another major constraint because the 
patients are seen in just two consulting rooms at the clinic. The space is quiet 
inadequate but most importantly manpower needs to be improved upon. And then the 
workers in the facility need to err…develop ownership of the programme. They need to 
see what they do as their routine job because they draw a dividing line between HIV 
management and other activities. So they need to improve on the number of the facility, 
they need to improve on the infrastructure in terms of space and the attitude of the 
workers towards the job will also have to change. I am sure with these three 
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err…factors, err…err…solutions in place, patients journeys in the hospital will grossly 
improve.” 
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4.7 Reflection 
4.7.1 Why I decided to carry out this project and my anxiety prior 
to data collection 
In 1990, when I became aware of HIV/AIDS, I remember vividly, people in my vicinity 
(also in hospitals) in Nigeria, including close relations infected with HIV/AIDS who have 
died. Throughout the duration of their illness, most of them refused to disclose their 
HIV/AIDS status to others even after their diagnosis by the doctors. None of those 
people wanted to be referred to as an HIV/AIDS patient. Even though, the type of OIs 
especially wasted muscles, skin rashes, frequent coughs, and oral thrush they got was 
obvious to others (including lay people) that they had HIV/AIDs but still did not want to 
admit their status to others. Why they choose not to tell people is open to conjecture but 
as possibly due to stigma, fear of being rejected or abandoned by friends and relations. 
Some of my friends and family also refused medical treatment because they preferred 
traditional therapy since some of them actually referred to HIV/AIDs as devilish infected 
illness. 
One example that springs to mind was a woman, younger than me, who was well 
known to me and lived with her parent’s in the next house to my mother, who fell ill in 
1994. When I visited my mother in 1994, she took me to the woman’s house to wish her 
well from her illness but to my greatest surprise, I saw an emaciated (all her ribs were 
conspicuously displayed) individual with only her head unaffected. She spoke aloud 
while we greeted and her mother said that that was the work of their enemies. I then 
ended my visit to their house, speechless and thought about her throughout that day, 
she later died that year. 
Also, I once visited a HIV/AIDS patient (who was a junior administrative officer attached 
to pharmacy unit) on admission at ADH after one Sunday mass. His skin was covered 
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with rashes and he told me that he did not know how he contracted ‘that sickness’. He 
later discharged himself (ran away from the hospital) from the hospital, refused taking 
his medications and died afterwards. 
These are some of the recollections and descriptions of people infected with HIV/AIDS I 
have seen. 
During my training as an undergraduate pharmacist, I became more aware of HIV/AIDS 
during ward rounds and one day, vowed to myself that I would find out from HIV/AIDS 
patients themselves their experiences and what exactly made them feel that way. 
I had further opportunities to come in to contact with HIV patients whilst studying for my 
master’s degree programme (2006 - 2007) in England. I identified one patient through 
their profiles, as part of my clinical ward rounds, was HIV positive. She had an African 
background and was advised by her employers to see her GP after an unresponsive to 
treatment cough and unexplained weight loss for months, after a holiday to her country 
of origin. I visited her about four times before she was discharged from the hospital and 
on each of those times, she was in good spirit. She chatted and communicated well with 
by every HCP that saw her over that period. Apart from her stay in low air pressured 
room in the ward during the procedure which was followed to make her diagnosis, 
everything went well (similar to in-patients with other infections) with her hospital stay. 
When she left the hospital, her CD4 cells count was high, so she was not prescribed 
ARV drugs but was asked to come back for her CD4 cells count after some months. 
However, she was treated for chest infection, oral thrush and other OIs that were 
manifested and she left the hospital, a more confident person. Her case uplifted my 
interest to further find out about the management of HIV/AIDS in the UK and as a 
clinical pharmacist who had practised in Nigeria; wish to find ways of improving 
management of HIV/AIDS patients in Nigeria. 
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So, HIV/AIDS patients’ thinking toward me and their responses to the interviews were 
my innermost anxiety prior to data collection in Nigeria, because from my previous 
experiences, HIV/AIDS patients in Nigeria neither agreed that they were ill nor wanted 
to talk about the ill health. However, the patients honoured the invitation to be 
interviewed except for few cases that declined, though, it might have been different in 
the rural area where patients are directly identified to individual family units, to avoid 
stigma being attached to their family.  
4.7.2 Limitations 
We wanted to conduct this study in more than one hospital in Abuja for comparative 
purpose; however, data were only collected at MDH. It was not feasible to collect 
qualitative data by one researcher through interviews in more than one hospital within 
this study period. Also, our aims were to use first person information gathering for 
validity and reliability because GT methodology was applied, thus, we could not include 
more researchers. Furthermore, focus groups were considered (chapter 2 under data 
collection) but deemed an inappropriate methodology given the patient population and 
the aims and objectives of the study. Besides, HIV/AIDS is a topic that HIV patients 
were not willing to discuss their experiences openly to the hearings of others around 
them. 
During phase 1 of data collection it became apparent quickly that English was not 
necessarily the first language of all interviewees and the researcher had to adapt 
language to fit with each individual participant, e.g. Pidgin English. While in Nigeria for 
data collection, my supervisors were in the UK, so, poor internet service in Nigeria and 
some hiccups with telephone communication delayed data collection and discussion 
about the study. 
162 
 
Some male patient interviewees said during the interviews that they contracted HIV 
form women (their wives or girlfriends) and I could see them struggling with those 
statements through their body language. That gave me the impression that male 
interviewers would have been more appropriate to interview the males than female 
interviewers would. 
It was very thoughtful of the researchers to have agreed to interview all patients 
involved with this study at the hospital where they attended for health and safety 
reasons. Also, not many of the interviewees would have agreed to come for interviews 
outside their appointment dates since that involved extra spending for transport and 
time taken.   
Verbatim writing (jotting) of interviews directly would be preferred with future interviews 
than relying more on voice recorder using dry batteries because I experienced 
disappointments with the dry cell batteries running out. 
The patients’ interviews were all conducted in one of the offices at APU since that was 
the most appropriate room made available during both phases of data collection. I wish 
it was in a different area of the hospital outside ARV pharmacy unit for interviewing 
patients so that the interviewees would not have associated me with pharmacy staff and 
probably, reserved their observations about ARV pharmacy staff. 
Also, on a personal note, I would have been better off if my immediate family members 
lived with me while carrying out this study in the city where the university that approved 
the study is situated to avoid being away from my immediate family members whom I 
missed a lot throughout my being away from home. However, my immediate family 
members would have competed for the limited time I used for this study if they lived with 
me 24/7 which might have prolonged my study period. 
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5. CHAPTER FIVE - DISCUSSION 
5.0 Introduction 
This study involved interviews with adult patients who were infected with HIV and 
attending the HIV Clinic at the MDH, in Abuja, Nigeria. In addition, hospital pharmacists 
and hospital administrators involved in the management and care of these patients were 
interviewed at the hospital in order to ascertain the role/potential role of pharmacy in the 
management of these patients, and to identify opportunities and strategies whereby 
service provision could be improved. Also, for purposes of comparison, pharmacists 
specialising in HIV working for the NHS in the UK were interviewed. 
Following systematic, re-iterative analysis, and coding, of patient interviews five major 
contributing concepts have emerged (Table 4.2 and Table 4.4) that shape patients’ day-
to-day experiences of living with HIV/AIDS and may have bearing on their approach to 
their management of their situation and the provision of services by the hospital. This 
study also addressed the hospital management of HIV adult outpatients from both the 
staff and the patient perspectives. The results suggest that the lived experiences of HIV 
patients are complex, and affect not only themselves, both physically, psychologically 
and socially, but also those people who care for them. It must be made clear that some 
of the patients interviewed constantly struggled to reconcile the reality of living with HIV. 
For example, in terms of the diagnosis, the fifth patient interviewed spoke of PLHA 
having psychological problems whilst patient 35 said that as each day passes, 
HIV/AIDS patients feel more sorry for themselves.  
With regard to living with HIV, patients spoke of difficulties with both the availability of 
ARV drugs and of their adherence to ARV protocols. Some spoke about their anxiety at 
having to take their ARV drugs on a daily basis mostly at 12 hourly intervals, which they 
had to remember at the right times. Also, they said that they usually took the ARV drugs 
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with food, however they were concerned that the type of food may have a bearing on 
the effectiveness of their ARV drugs; more nutritious foods that were perceived as being 
able to boost their immune system. This perception around taking the correct sought of 
food may lead to adherence problems as noted by Musumari et al [239] who found that 
uncertainty about food was the most common concern that emerged, both as a day-to-
day obstacle to ART adherence, and as one of the main reasons for patients 
discontinuing ART. 
5.1 Patient Interviews 
Twenty-five HIV patients were interviewed in the first phase of the study and ten in the 
second phase. The age of the respondents interviewed ranged from 21 to 59 years 
which falls within the prime of their working lives, and reproductive age adults. After 
analysis of all 35 patient interviews, five concepts were identified that influenced how 
they accessed hospital services. These were: 
• Faith; 
• Hospital Journey; 
• Social Issues; 
• Obstacles; and,  
• Patient Expectations for Service Provision. 
5.1.1 Faith 
Faith was mentioned in the majority of patient interviews, both in terms of their religious 
faith and faith in the medicines working. Mention of religious faith was not too surprising 
given that religion (regardless of which followed) plays a central part in the lives of 
Nigerian people. Attendance at churches or mosques is commonplace; to such an 
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extent that it can cause severe traffic congestion forcing major roads to close during 
prayer hours on Fridays (Muslims) and Sundays (Christians). Every Nigerian is likely to 
believe in God or something (spirit of their forefathers). Thus, prayer is used for many 
things, such as asking for good health to wanting good governance without going out on 
voting days to elect good leaders. However, the professed advantage of spiritual 
options as to treatment could precede more patients on ART to interrupt treatment as 
argued by Roura et al [116]. 
Faith in God and in ART helped patients to cope with the situation they found 
themselves in and continue to live a normal life as possible. This is consistent with 
findings from a study in the UK where Anderson et al [240] acknowledged faith as one 
of the main coping strategies among the Caribbean PLHA resident at South London. 
Also, in the US, Trevino et al [241] confirmed that amongst African-American and 
Caucasian HIV/AIDS patients, positive religious coping was associated with positive 
outcomes. In another study, in South Africa, Gilbert and Walker [242] stated that 
patients pledged to adhere to ART since they see the ARVs as lifesaving. Furthermore, 
the patients were grateful to God, especially after recovery from the initial signs and 
symptoms of HIV as most patients were very ill prior to medical intervention and whilst 
being interviewed spoke about their fears of thinking they were going to die. This later 
perception is similar to findings from another study in the UK where Anderson et al [243] 
found that one of the things Caribbean PLHA in London associated the infection with 
was immediate death, ‘as the known self was going to die’. 
Faith in God was also captured in some of the patients’ transcripts as a reflection of the 
two major religions in Nigeria. Some Christian patient interviewees declared that their 
faith was being tested with HIV infection and God could heal them if He so wished. This 
is consistent with a study carried out in Kinshasa, Democratic Republic of Congo where 
Maman et al [113] found that HIV-positive Christian women who were pregnant or had 
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recently given birth trusted that God has the power to cure their infection. Furthermore, 
Dalmida et al [244] found that amongst African-American Christian women with 
HIV/AIDS, there was a strong connection to God as some of them stated that HIV 
brought them closer to God. 
While Muslim patient interviewees assumed that it was the will of God for them to 
become infected with HIV and one of them (Male, patient 18), further said that his 
infection could be a punishment from God for his vindictiveness. This is consistent with 
findings from a study in Tanzania where Zou et al [114] found that shame-related HIV 
stigma is strongly linked with religious beliefs such as the belief that HIV is a  
punishment from God or PLHA have not lived righteously. Similarly, Dilger [245] found 
that some of his interviewees acknowledged that HIV was a “punishment of God”. Also, 
in Cross River, Nigeria, Ucheaga and Hartwig [246] found that most religious group 
representatives described HIV/AIDS as ‘a punishment from God’ or ‘Allah’ (Islamic 
name of God). Whilst, Tocco [115] in another study, acknowledged that in Kano, 
Nigeria, passages from Islamic books were regularly cited by both HIV/AIDS patients 
and HCPs when talking about their belief that ‘Allah sends a cure to human beings for 
every disease’. 
Many interviewees on receiving the diagnosis, had a bleak outlook on their own 
prognosis, but after medical counselling and starting courses of ARV drugs (where 
patients had seen improvements in their symptoms) were more optimistic about their 
future. Some patients still believed that they would obtain complete healing miraculously 
(through faith in God or Holy Grail) one day with, or without, the use of ARV drugs if 
they were happy and courageous. This is similar to a study in Tanzania where Roura et 
al [116] found that FLs believed that prayers could potentially cure HIV ‘completely’, but 
also encouraged ART usage because God had ‘only a part to play’. Some patients saw 
HIV infection as a challenge, in the sense that their faith may be, being tested. For 
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example, that the devil might be testing their faith, to see if people infected with HIV will 
continue to serve their Almighty God or run to other gods because of their afflictions. 
However, most patients believed that God could take away the challenge at any time if 
He so wished. For example, an interviewee (patient 13) said, he skipped doses of his 
ARV drugs for one week because a pastor said a healing prayer with him or worst still, 
some PLHA refused treatments since they believe that God can heal them of HIV one 
day. 
5.1.2 Hospital Journey 
The patients spoke openly about being delayed at the hospital on clinic days. Hence, 
some patients developed the habit of arriving at the hospital the night before their 
appointment in order to beat the queues in an attempt to speed their journey through 
the hospital. The delays made the patient journey more complicated and adversely 
affected patients’ experiences. Long waiting times (and thus loss of income) has been 
reported by Hardon et al [104] as a main contributing barrier to optimal ART adherence 
in Uganda, Tanzania and Botswana.  
Some patients interviewed also said it was stressful for them to get their CD4 cell count 
checked, because the unit limited the number of patients to 50 per day, even though the 
number of patients attending on clinic days far exceeded this number. As a result 
patients had, on occasion, to wait for weeks to have their CD4 cells count checked. This 
inevitably involves more patient return visits to the hospital, with the associated financial 
expense. This patient limit was confirmed by one of the laboratory scientists at the unit 
who stated that the machine at the lab could only process 50 specimens per day. This 
has obvious clinical consequences as doctors will continue to manage their patients 
without having real knowledge of the patients’ current CD4 cell count. 
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Patients had varying experiences with regard to how staff treated them. Most patients 
said the staff provided good services, were caring and attended to the patients well, 
although some stated that some staff were ‘uncaring and unapproachable’ which is 
consistent with a study in Uganda by Duff et al [247] who established from HIV infected 
pregnant women that staff upset them by shouting at them and embarrassing them in 
the presence of other patients with questions such as ‘Did I give you AIDS?. However, 
the majority of patients at MDH said the staff provided good services, were caring, 
good, nice, encouraging and attended to the patients well, which is also consistent with 
findings by Wouters et al [248] in South Africa where the authors found high levels of 
patient satisfaction with ART-related services. 
However, based on the facial expressions of some interviewees and coupled with some 
conflicting statements they made, more patients were critical of staff but would not say 
this because of social norms as poor service provision affected their daily lives. 
Furthermore, Olowookere et al [249] in a recent study carried out in Nigeria, stated that 
the majority of PLHA were satisfied with their medical care, however the authors  
suggested that more needs to be done to reduce patient waiting time preceding medical 
services. 
5.1.3 Social Issues 
5.1.3.1 Awareness of HIV 
Some HIV patients interviewed were aware of the infection; awareness about HIV and 
its transmission was evident, ranging from some individuals being well informed to 
those with little information about HIV/AIDS. Those patients who were well aware of HIV 
claimed they got their knowledge through attending seminars on HIV/AIDS, listening to 
the radio, reading newspapers, watching televisions, browsing the internet, information 
from friends and/or relations. This is consistent with findings from a study carried out in 
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Nigeria where Oboh and Tsue [250] established that the major and regularly available 
sources of HIV/AIDS information to the rural farmers in Vandekiya local area of Benue 
state were radio, friends and neighbour. Also, lliyasu et al [251] carried out a study in 
Kano State, Nigeria and established that more than half of the HIV patients had 
adequate knowledge of HIV/AIDS. 
Ignorance of patients surrounding their condition also affected their care. For example 
some patients assumed that, with time, their CD4 cells count will become normal and 
therefore they would be free of HIV. 
5.1.3.2 Poor Health 
Obviously, the patients were in poor health (manifested various OIs) prior to their 
diagnosis of HIV at MDH, thus, they acknowledged that HIV/AIDS is both a sickness, 
and a challenge. This might also be related to the education they get from HCPs such 
as pharmacists who counselled them that HIV infection is not a death sentence, but 
they should accept it as other chronic illnesses. Furthermore, one patient (patient 19) 
said HIV patients are better off than diabetic patients who have restriction of what to eat 
and drink whilst another (patient 32) said HIV does not show on the patients’ faces. This 
statement from patient 32, even though said in a lightly tone, poses a real danger to the 
society, and one difficult issue around HIV/AIDS to tackle as stated by the third 
pharmacist interviewed. So, HIV/AIDS patients can easily pass the virus to 
unsuspecting persons, as the virus cannot be detected by just looking at someone’s 
face. 
5.1.3.3 Stigma/Discrimination 
Patients spoke of disclosure or lack of it; whether to family, friends, co-workers or 
people in general. Stigma, scandal, discrimination and societal pressure were all factors 
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that contributed to the person revealing (or not revealing) their HIV status - a finding 
seen in other studies [58,107,109,111,118,252]. Some patients did disclose their HIV 
status to friends and family members, whilst others did not, not even to their immediate 
partners. Those that had disclosed to immediate family spoke of gaining good moral 
and material (such as money) support from them. For example, the first patient 
interviewed affirmed that her sister had been responsible for her upkeep after her 
husband died from HIV/AIDS. Also, similar findings were reported in Uyo, Nigeria where 
most patients stated that their family members accepted, cared and supported them 
after disclosure [253]. 
There were some instances where disclosure had a negative effect. A case in point was 
seen with patient 19 who said that after she told her fiancé, the marriage was called off. 
Also, patient 29 said her boyfriend abandoned her after he was convinced that she was 
HIV positive. 
Patients also did not want to be known to have HIV for fear of losing their job. For 
example, people in Abuja are aware that HIV clinics are held on Wednesdays. Habitual 
staff absenteeism from work (on Wednesdays) is therefore associated with HIV 
infection. In general, HIV patients dreaded being identified as having HIV by co-workers, 
employers, neighbours, friends and family members because of the social 
consequences. Such consequences in Nigerian society include social exclusion by 
neighbours (for example instructing their children never to play or even go near the 
children of the infected person) and being essentially unemployable. These 
observations are consistent with those found in other studies [254,255]. For example, 
the second patient interviewee said he lost his job because he was visiting the hospital 
frequently, which made his boss request for his medical report. He was sacked after his 
employer saw his medical report, which showed that he was HIV positive. This is 
despite the Nigerian government having laws protecting the rights of HIV patients from 
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losing their jobs [256]. The stark reality in Nigerian society is that the family will fail to 
have a regular income, which could lead them to borrow or beg to survive since there is 
no state benefit system in Nigeria. The spiral of decline will continue, which could result 
in children removed from schools, (since the family will not be able to meet school 
expenses), homelessness, and so on – an example of social drift theory [257]. 
Poverty worsens some patients’ experiences of clinical services. Poor patients had 
trouble getting to the hospital on clinic days, due to lack of money for transport; 
exemplified by patient 16 who was given money by someone to transport himself to the 
hospital. Also, poorer patients worried about, and found it difficult to purchase medicines 
that were out of stock at the APU (medicine supply at APU was free), for example, the 
out of stock medicines mainly for OIs such as Septrin® or multivitamin. 
5.1.4 Obstacles 
Patients had to cope with three main obstacles at MDH whilst accessing care. These 
were: patient numbers; staff levels; and medicine shortages. 
5.1.4.1 Patient Numbers 
Typically, large numbers (>180) of patients attended MDH on clinic days. It is highly 
likely that these patient numbers contributed to the delays, which were experienced by 
both patients and staff. As the patients did not receive clinical service from the clinic on 
time, so, also the staff who attended to them did not leave the hospital on time 
especially pharmacists who were about the last HCPs that attended to patients before 
their exit from the hospital. Critically, the numbers of patients that attended the HIV 
clinic at MDH were sources of stress for the patients themselves and for the staff who 
attended to them; again consistent with findings from a similar study carried out by 
Hardon et al [104]. HIV clinical service is meant to be a personal (one on one) and 
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stepwise service at MDH but when faced with too many patients the probability is that 
the service will be compromised. So, the patients continued to bear the burden and, as 
is the case in Nigeria, some patients ‘suffered in silence’.  
As a consequence of the large numbers of patients, both human and material resources 
were insufficient to serve every patient promptly and fully. Thus, ARV drugs were 
rationed, CD4 cells count could not be checked at the appropriate time, and staff did 
ask some patients to go home and come back another day, as confirmed by both 
patient and pharmacist interviewees (patient 15, 31 and pharmacist 6). 
5.1.4.2 Staff levels 
Staff levels were inadequate to serve the number of patients that attended the clinic, 
especially the pharmacy staff. At the MRU, which is the first point of contact for patients 
on clinic day, the situation was chaotic, mainly because of under staffing. However, the 
situation was made worse by the system employed in allocation of patient 
files/appointments and attending to those unannounced/unscheduled patients.  
A maximum of four and minimum of two doctors were seen at the HIV clinic during this 
study period. However, a maximum of two pharmacists were at the APU. The under 
staffing at the APU was compounded by the fact that they not only had clinic day 
patients to attend to but returning patients to collect outstanding balances of ARV 
medicines from previous rationing. The perception (from both patient and staff 
interviewees) is staff at MDH were not enough to provide a clinical service for the large 
number of patients that attended. 
5.1.4.3 Medicines 
HIV patients experienced rationing of ARV drugs and unavailability of other medicines 
such as Septrin®, leading to incomplete dispensing of their prescriptions on clinic days. 
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Rationing of medicines seemed to be directly associated with the number of patients in 
attendance and the fact that their next appointment at the hospital was in 3 months’ 
time; this created a classic supply and demand problem as patient 13 acknowledged in 
their interview. Instead of three months’ supply, one month was dispensed, thus 
requiring patients to return to the pharmacy for more refills. The implication of this is that 
those patients who could not return at the appropriate times (no transport, no money, 
fear of losing their jobs, as discussed previously) for a refill of ARV drugs, may miss 
taking some doses, and this will have a negative clinical consequence, such as 
developing viral resistance; ultimately make the medicines less effective and bringing 
about a deterioration in their health. A similar problem was described by Pasquet et al 
[258] who suggested that out of stock related ART discontinuations had a negative 
impact on patients’ retention and death. For those patients that could attend, additional 
time will have to be taken off work to visit the hospital putting greater financial strain on 
patients due to transport costs and loss of earnings. 
5.1.4.4 Other Obstacles 
Amongst other obstacles some patients identified at MDH whilst accessing care are 
briefly discussed below. 
Some patients spoke about patients getting preferential treatment, on clinic days. A 
common norm in Nigeria is that those patients who are related to any HCP may never 
queue up to take his or her turn, since the relation will hasten his or her hospital journey. 
This obviously means that this ‘queue jumping’ compounded the waiting of those 
patients without a relation to speed their hospital journey. 
Several patients spoke about the lack of a separate private space within the hospital for 
HIV/AIDS patients to avoid their being identified. The perception is that when the 
accommodation was being constructed, the authority might not have thought of the 
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number of patients that attended ARV clinic at MDH, thus, it is not the best 
accommodation for them. 
Finally, one patient (patient 21) complained about the continuous daily use of ARV 
drugs as she said, ARV drugs are not food that is eaten every day. Also, another patient 
(patient 13) spoke out of context, identifying the corruption in the Nigerian government 
as being responsible for the unavailability of ARV drugs in hospitals. 
5.1.5 Patient Expectations 
HIV patients interviewed described their expectations about the sort of HIV services 
they expected to be provided by MDH. Broadly, these fell in to two areas, Medicines 
and Service Provision Improvement. 
5.1.5.1 Medicines 
The patients expected a regular and sufficient supply of ARV drugs and other 
medicines. From a clinical perspective, this would enable them to take complete doses 
of the prescribed ARV drugs at the right time, but from the patients viewpoint, it would 
allow them to visit the hospital less frequently; thus, they would need to take less time 
off away from their day-to-day activities and reduce the chance of other people 
suspecting them of being HIV positive. Also, some patients wished, for the purpose of 
convenience, that the dosing of their ARV medicines could be formulated in such a way 
so that they could take them less frequently, for example once daily, once weekly or 
even once monthly. 
During the second phase of patient interviews, it became apparent that Septrin® was 
regularly out of stock, thus, the patients expected that it should be regularly available 
during their clinic days to avoid having to pay from their pockets to purchase it outside 
the APU. 
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5.1.5.2 Service Provision Improvement 
Interviewees suggested a number of ways in which service provision for HIV/AIDS at 
MDH could be improved: more staff should be employed; staff, who will be caring 
towards patients and the authority should increase staff salaries to motivate them. The 
patients also wanted better facilities with greater privacy.   
However, some staff informed the researcher that if the patients are provided with a 
different secluded area within the hospital, then, it will seem as if it is discrimination 
against the HIV/AIDS patients. Patients wanted some changes made for example; 
handling of patient MRs at the MRU and increasing patient numbers/day for CD4 
checking  in the Laboratory unit for ease of service. They also wished for more clinic 
days, such that clinic days will be increased from currently one (for experienced stable 
patients) to about four. Also, more HCPs volunteers should be encouraged to 
participate in providing clinical service for HIV/AIDS patients. Furthermore, Nigerian 
president (government) needs to make more contribution into HIV/AIDS service such as 
increase their funding towards ARV drugs. 
5.2 Patient’s Journey 
Observations of the ‘patient journey’ through the hospital system on clinic days gave an 
insight into the management protocols applied by the hospital, and sought to identify 
areas where the patients experienced delays (Tables 4.6, 4.7 and Figures 4.1, 4.2). Ten 
patients were shadowed during their clinic days to understand better the identified 
concept theme of the patients’ hospital journey derived through analysis of the patient 
interviews. 
From the researcher’s observation, delays were noted at each of the four major units. 
The time spent, on average, was longest at the APU and shortest at the vital signs 
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measurement unit. The short time spent at the vital signs unit was probably down to this 
being the first place patients went to after receiving their medical record – in other words 
waiting time delays could not occur, and secondly the procedures performed (blood 
pressure, weight, and body temperature) were simple and quick to perform. The vital 
signs measurement unit had two staff (both permanent and student nurses) on each 
clinic day, allowing them to ’process’ two patients at once. Interaction between the 
patients and nurses was also observed to be minimal. The results of each patient’s 
measurements were not always recorded in their medical folder; occasionally they were 
recorded on plain paper. In contrast, the medical records of patients were required by 
staff at APU before dispensing took place. Unfortunately for patients their medical 
record did not necessarily ‘follow’ them. After seeing the doctor, the patient went to the 
APU and took a seat and waited for their prescription. Standard practice by medical 
record staff was to collect patient records in batches from the doctors. This meant that a 
person seen first by the doctor would have to wait much longer than those seen 
immediately prior to the records being collected and given to the APU. This lead to long 
delays for many patients.  
In addition, pharmacists endeavoured to spend time with each patient in educating and 
counselling them on their medicines, which led to more time being spent at the APU. 
The fact is that patients spent little time receiving clinical services but a lot of time 
waiting to receive them. After the collection of folders by patients from medical record 
staff, they waited to be called forward for vital signs measurement, after the vital signs 
measurement, they waited for more time to consult doctors, and after the consultation 
with doctors, they waited for more time to see the pharmacist. For example, patient 4 
spent 18 hours 56 minutes at MDH on one clinic day. However, only 2 minutes was 
spent at the vital signs measurement unit, 8 minutes was spent in consultation with the 
doctor and 86 minutes was spent at the APU; yet most of the APU time was in fact 
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spent waiting and not with the pharmacist. However, Okoli and Cleary [126] found that 
patients spent average of under four hours at a clinic located at Enugu State, South-
Eastern Nigeria during their monthly appointments. Furthermore, Hardon et al [104] 
found in Botswana that PLHA spent between 4 and 12 hours to receive services at the 
clinics. 
Some patients who were shadowed confirmed that they arrived at the hospital the 
previous evening preceding their appointment and slept in the hospital’s waiting area in 
an attempt to avoid delays. Additionally, some patients attended MDH from bordering 
states like Nasarawa and Niger, and it could be assumed that because of the distance 
from Abuja that this also might tempt people to arrive at the hospital early. 
Regardless of when the patient arrived at the hospital, the transit of the medical record 
appeared to be a constant source of delays. On occasion, the medical record could not 
be found at the MRU when the patient first registered. This led to the patient either 
being sent for vital signs without their records or a delay whilst it was found. The records 
seemed to be transported around the various clinics by MR staff and not by the patient. 
The greatest delay was seen whilst records were with the doctors yet the patient was 
waiting for their medication at the APU. Pharmacy staff would dispense medication in 
order that the MR staff deposited the record, although this may not have been the order 
they were seen by doctors. This led to ‘queue jumping’ and excessive delays for some. 
At the end of each patient’s visit to the hospital, patient folders were left mainly at the 
last unit visited (usually APU) or taken back to the MRU by their staff. Thus, it was 
assumed that the MR staff would collect all the folders that were not returned to their 
office and file them appropriately. However, some folders were never returned to the 
MRU because the last unit where the patient left the folder had not finished extracting 
the record they wanted or the folder was taken to the MRU, but not filed appropriately. 
The system of patient records and patient movement seems to be at fault.  
178 
 
5.3 Nigerian Pharmacist Interviews  
Again, after systematically reading and re-reading the Nigerian hospital pharmacists’ 
interview transcripts, the pharmacists’ interviews have been analysed and categorised 
into five concepts based on contributing themes (Table 4.8). Hence, discussion of the 
interviews will be based on the concepts and contributing themes that shaped 
pharmacists’ day-to-day experiences of providing clinical service for HIV/AIDS patients. 
These were: 
• Clinical service delivery; 
• Pharmacists’ impressions of HIV clinical service; 
• Social issues; 
• Obstacles; and, 
• Pharmacist expectations on how to improve clinical service delivery. 
5.3.1 Clinical Service Delivery 
The pharmacists usually started with fact finding with the patient; they wanted to confirm 
if the patients knew and used their ARV medicines according to prescription 
instructions. Pharmacists wanted to know if the patient had experienced side effects or 
had any other complaints about any of their medicines so that they could provide 
counselling and/or advice for patients who needed them. These verification processes 
were similar to those applied in a South African hospital [77]. The pharmacists also 
wanted to know if the patients knew their close relations’ HIV status which enabled them 
to educate patients on how to protect and prevent themselves and their loved ones from 
becoming re-infected or infected with HIV.  
The pharmacists advised patients on confiding in close relatives to gain support, 
however, from the patients’ interviews, most patients said that they did not disclose their 
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status to anyone. They dispensed, most times, only half the quantity of prescribed ARV 
drugs because of inadequate availability of ARV medicines. The pharmacists focused 
on educating patients on the importance of ARV adherence, especially on how to avoid 
viral resistance. Pharmacists established with the patient that the medicines would not 
work if they were not taken properly. They seemed to believe that patients were 
generally good at adhering to their medication regimens as evidenced by steady 
improvements in their CD4 counts and improved health status.  
HIV outpatients at MDH were given and provided preferential (distinct from patients with 
other illnesses) clinical service face to face with pharmacists that was based on 
treatment guidelines formulated by the Nigerian FMoH [259]. This is consistent with a 
survey carried out in Abuja by Zungu et al [132] who confirmed that pharmacists were 
the most frequent HCPs who consulted the NATG at the hospitals. The pharmacists 
believed they provided a complete clinical pharmaceutical care service; identifying the 
right patient, establishing with the patient, the patients understanding of their medicines, 
vetted the prescriptions, liaised with the HIV doctors for those patients that needed 
further clinical attention. The pharmacists also filled the patients’ prescriptions with the 
quantity of available ARV drugs, which were documented by the pharmacists. The 
pharmacists also educated the patients on HIV/AIDS and the drugs, with emphasis on 
ARV drugs dosing frequency to avoid ARV drug resistance. 
5.3.2 Impression of Clinical Services provided 
One Nigerian hospital pharmacist spoke confidently about their formal training that 
enabled them to attend to HIV/AIDS patients. They were also satisfied with the clinical 
service they provided to patients and described the service provided as a success, 
citing the reduction in the death rate from HIV/AIDS in Nigeria; an observation 
consistent with findings by Odafe et al [196] who acknowledged lower death rates in a 
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study. Most pharmacists interviewed believed that the majority of patients complied with 
their prescriptions. This perception is supported by a study conducted by Ware et al 
[106] in SSA, where ART adherence was found to be high among PLHA, as those 
infected wanted to prove to family members and those who cared for them that they 
were willing to stay alive. The pharmacists also said that they derived joy from doing a 
great job as they positively contributed to someone else’s life, even though they 
believed they could provide more clinical services with more staff. 
5.3.3 Social Issues 
Most of the pharmacists asserted that there was increased public awareness about 
HIV/AIDS in Nigeria (and patients also mentioned this during their interviews). One 
pharmacist said that hospital staff (trained councillors) followed up on those patients 
that did not come for their appointments, although none of the patients interviewed 
made mention of the tracking system. This follow-up protocol demonstrates that the 
hospital wanted to ensure HIV/AIDS patients received regular treatment. The 
pharmacists also confirmed the involvement of NGOs in HIV/AIDS service in Nigeria 
[260] as the patients articulated in their interviews that NGOs and USAID have been 
supportive towards HIV service in areas of ARV drugs and some logistics supplies 
[169]. 
The pharmacists acknowledged that fear of stigmatisation inhibited patient disclosure to 
family members or the wider community knowing about their status. They observed 
patients leaving the APU and discarding packaging and inserts to hide the identity of the 
medicines they had received. They also spoke of patients being effectively ostracised 
from the family due to their positive status. Also, as the fifth pharmacist interviewed 
articulated, some patients come from Enugu to received treatment at MDH, a fact 
confirmed by the fifth patient interviewed, that he helped another patient to received 
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ARV drugs to enable him go back to Benue. A patient also said that each time he saw a 
nurse that he knows at MDH, he framed up a story for her or hid from her so that she 
would not know the reasons that brought  him to the hospital. So, it was something of 
joy for some patients to receive treatments away from environments where people can 
recognise their faces which will lead to scandal and discrimination or stigma. 
Although pharmacists spoke of an increase in the general public’s awareness of HIV, 
they still thought that ignorance was one of the reasons why some patients did not 
receive medical treatment early enough citing patients that had visited herbalists or faith 
healers (who failed them) before they accessed the hospital for medical treatment. 
5.3.4 Obstacles 
The pharmacists did identify certain obstacles they came across whilst providing clinical 
services. Principally these were work environment and issues of how the running of the 
clinic days affect pharmacy and patient obstacles inhibiting delivery of pharmaceutical 
care. 
5.3.4.1 Work Environment and Issues of how the Running of the Clinic 
Days Affect Pharmacy 
The pharmacists said the APU had few staff to attend to the large number of patients, 
especially trained pharmacists, to provide a pharmaceutical service. This increased their 
workload, which proved challenging and ultimately made them spend less time with 
each patient, even though they wanted to spend more time with the patients to educate 
them on HIV/AIDS. Despite pharmacists spending less time with patients, they tended 
to work late to attend to all patients. Consequently, this was stressful for both patients 
and staff.  
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The pharmacists had to manage with a shortage of medicines, which they rationed for 
patients because the medicines in stock were not enough to be dispensed for every 
patient according to their prescriptions. Almost all patients complained about not been 
able to get their medicines completed at a single visit to APU and the pharmacists were 
not comfortable when patients brought prescriptions that they were not able to dispense 
completely. Patients were prescribed three months of ARV medicines but were 
dispensed, at most, two months.  
The pharmacists said they had to manage within a non-conducive working environment. 
For example, having to put up with electricity outages, whereby air conditioners could 
not work, resulting in a hot working environment. The working space itself was cramped, 
with not enough shelf space for the medicines resulting in them placed on the floor. 
5.3.4.2 Patient Obstacles Inhibiting Delivery of Clinical Services 
One pharmacist also had issue with the Pidgin English spoken by many patients 
because she was brought up and schooled outside Nigeria. Some of the pharmacists 
observed that some patients did not know their ARV drugs mainly because they 
concealed the ARV drugs immediately after they had been dispensed. Similarly, 
patients were in a hurry to take their leave from the hospital such that most of them, as 
the second pharmacist interviewee said, did not wish to be saddled with counselling on 
HIV/AIDS. Rather, they wanted to get their medicines and leave the hospital. Probably, 
this is because they had already been at the hospital too long and wanted to return to 
work as quickly as possible, as many will not have gained permission from their working 
place to attend the clinic. 
Some patients also received and answered telephone calls while being attended to at 
MDH (the researcher witnessed the patients’ telephone exchanges) which could have 
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affected and made such patients to have divided attention towards pharmacists’ 
counselling. 
5.3.5 Pharmacist Expectations on how to improve Clinical 
Service Delivery 
Pharmacists thought that more staff needed to be employed across the service, 
especially pharmacists. More pharmacists would allow the APU to remain permanently 
open with permanent staff members. Besides extra staff, they wanted adequate working 
tools, such as computers and software for data entry since they record all dispensed 
prescriptions as well as making necessary notes in their files. They wished to have 
enough medicines to enable them to complete the dispensing of prescriptions, so 
avoiding the potential of patients to not go without taking their medicines. Of course the 
complete supply of medicines would minimise refill prescriptions and help decrease 
their workload. They wished electricity outages to be minimised, even though this was a 
nationwide issue. Pharmacists had mixed views on the number of clinic days; some 
wanted them to increase, whilst others were content for them to remain the same; the 
latter point being based on the staff being unable to cope with the workload. 
They also wished the authority would improve staff incentives such as pay extra salary 
for staff that work to provide HIV service because they still carried out other schedules 
within the hospital when they were not attending to HIV patients.  
5.4 NHS Pharmacist Interviews 
Four NHS HIV pharmacists were interviewed to find out how they managed HIV 
outpatients. Subsequently, after systematically reading and re-reading the NHS HIV 
pharmacists’ interview transcripts, the pharmacists’ interviews have been analysed and 
categorised into five concepts based on contributing themes (Table 4.9) identified. 
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Thus, discussion of the interviews will be based on the concepts and contributing 
themes that shaped the pharmacists’ day-to-day experiences of providing clinical 
service for HIV/AIDS patients. These were: 
• Clinical service delivery; 
• Pharmacists’ impressions of HIV clinical service; 
• Social issues; 
• Obstacles; and,  
• Pharmacist Expectations on how to improve Clinical Service Delivery. 
5.4.1 Clinical service delivery 
All four pharmacists interviewed said the management of HIV outpatients usually started 
with categorising their patients based on their CD4 cell count. Grouping of patients was 
to enable the pharmacists to identify those patients that needed a specialist service, and 
when to start them on ARV drugs. The pharmacists provided a one-on-one clinical 
service to each HIV patient, this included: counselling and education of patients on 
everything they needed to know about HIV/AIDS and their ARV drugs; vetting their 
prescriptions prior to dispensing and in some cases, arrangement of home delivery of 
ARV drugs. Also, the pharmacists worked together with other HCPs at the same 
location to provide seamless clinical services for HIV patients which is similar to a 
description in an article by Hill [261]. 
The pharmacists said that they followed treatment guidelines for HIV/AIDS (e.g. the 
British HIV Association, BHIVA) for clinical service delivery. The pharmacists also said 
that they provided all the vital information needed to help the patients live positively with 
HIV/AIDS. The pharmacists also sought for patient feedback on the clinical service 
provided to enable the hospitals to improve on the service provided. 
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5.4.2 Impression of Clinical Services Provided 
The pharmacists said that they provided good clinical services and that they were 
personally committed to the job. They saw patients individually but worked as a team to 
provide an integrated clinical service. There was good availability of ARV drugs, and 
every patient was dispensed their medications in full. Furthermore, clinics were offered 
frequently, with six (including Saturday at SOH) clinic days per week, which included 
evening clinics at some hospitals like BHH and SOH. 
5.4.3 Social Issues 
The pharmacists said that some of the patients were refugees who lived in shared 
houses and thus confidentiality was important to them with regard their HIV status. 
Thus, such patients made careful decisions about home delivery of ARV drugs to avoid 
flat mates or neighbours from noticing contents of the delivery. They also said that some 
patients had issues with stigma, which affected their decision to disclose their status to 
others. Furthermore, the NHS pharmacists said that some patients believed that HIV is 
curable. Also, the NHS pharmacists said that some patients refused to accept that they 
tested positive to HIV/AIDS after the doctor’s diagnosis and so, turned down treatment 
for HIV. 
5.4.4 Obstacles 
The NHS HIV pharmacists did talk about some obstacles they came across whilst they 
provided clinical services. One of them spoke about paper work involved which they 
processed and were needed for good record keeping. They also talked about those 
patients who presented to hospitals at late stage of HIV infection, which made treatment 
difficult, and how such patients needed consultants’ services. They talked about 
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patients who did not return to the hospital for their treatment, prompting the staff to track 
them. They spoke about pressure on their time to fulfil all their obligations, which 
included activities other than caring for HIV patients. Furthermore, they spoke about 
high patient expectation towards HIV clinical services, such that the patients wanted to 
be given more privileges, for example coming to the HIV clinic at unscheduled times. 
Language was a barrier, since some patients were not native English speakers. The 
NHS pharmacists spoke about patients’ being in the hurry to leave hospitals on their 
appointment days such that some patients made mentioned of their parking tickets 
running out. Such patients were likely to be amongst those patients who did not disclose 
their HIV status to anybody, so wanted to meet up with other appointments such as 
office duties as usual. After commending the NHS for providing a good service for 
HIV/AIDS patients, one NHS pharmacist did talk about PCT (Primary Care Trusts) 
funding cuts to some HIV services, which may affect the way the staff are able to 
provide clinical service for HIV patients in the future. 
5.4.5 Pharmacist Expectations on how to improve Clinical 
Service Delivery 
The pharmacists did not have much to talk about regarding service improvements as all 
generally felt that NHS was providing a good service for HIV patients. In fact, one of the 
four NHS pharmacists had no suggestions for improvement since he was satisfied with 
the service provided. The other three talked about support groups for people living with 
HIV, who would, from time to time attend forums with HIV patients and speak openly 
about HIV to reduce the stigma attached to HIV/AIDS. They wanted more HIV 
pharmacists to be employed. Suggestions were raised on giving pharmacists (and HIV 
nurses) prescribing rights, which they felt would reduce congestion in the clinic, or able 
to provide treatment to patients when doctors were not readily available. They felt that 
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more evening clinics would be helpful since they found evening clinics useful for 
working patients or patients who, due to stigma, do not like day time clinic hours. They 
wished that they could manage stable HIV patients via the telephone so that 
appointments could be freed up and used by other patients; this would also help to 
reduce patient visits to the hospital. Also, they wished to see the home delivery service 
expanded.  
5.5 The Hospital Administrator Interviews 
The administrators (represented by two medical records staff and a senior medical 
doctor) interviewed acknowledged that HIV patients experienced delays at MDH and 
that the patient:staff ratio was high and thus, staff were overworked. Acknowledgement 
of patient delays has been identified by all groups; patients, pharmacists and the 
administrators. The administrators gave further clarity about the clinic day set-up and 
running. Patients were given block (same appointment times for all patients) 
appointments, which required every patient to report at the hospital for 08:00 on a clinic 
day. Thus, the block appointment system was a major reason why delays were 
observed at the MRU, as they struggled to cope with the large number of patients on 
clinic days with a limited staff resource. 
Administrators also stated that some patients did not turn up for their appointments 
without notifying the hospital, whilst others came to the clinic on days that they were not 
given appointments. This led to a chaotic administrative system which manifested in 
further patient delays. Administrators suggested that the authority needed to: employ 
more staff, notably, pharmacists and doctors; reduce clinic day patients’ numbers; 
improve the staff work environment; and have electronic recording of patients’ data. 
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5.6 Key Issues that Emerged 
The key issues that emerged from data collected will be discussed based on similarities 
and differences between NHS HIV, and Nigerian pharmacists’ interviews, and overall 
ideas from the study results. 
5.6.1 Main Similarities and Differences that Emerged from NHS 
HIV and Nigerian Pharmacist Interviews 
Some similarities and differences emerged from interviews of the NHS and Nigerian 
pharmacists. 
5.6.1.1 Clinical Service Delivery 
Fundamentally, they both tried to provide the same type of service that was modelled on 
pharmaceutical care but routine feedback from patients on the service is gained by NHS 
pharmacists whereas in Nigeria, this is an aspiration. 
5.6.1.2 Pharmacist Impressions of Service Provision 
Both felt that they were providing a good service to their patients and the impression 
from both sets of pharmacists is that they cared about what they did and derived 
satisfaction from seeing their patients get better. 
The way in which they interacted with other HCPs did vary, in that NHS pharmacists 
were ‘closer to the doctors’ and had a more integrated approach to overall healthcare of 
the patient rather than a  separate temporary (‘silo’) approach in Nigeria. Pharmacists in 
the UK enjoyed greater resource to provide services such as medicines and greater 
number of clinic days. 
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5.6.1.3 Social Issues Associated with Service Provision 
Stigmatisation surrounding the diagnosis of HIV was something expressed in both the 
UK and Nigeria and one which impacted on service delivery. In Nigeria, this was more 
acute and made worse by repeat visits to the hospital to access services leading to 
greater opportunity for others to guess the patients reasons for visiting the hospital. 
Although, disclosure of status was something that UK HIV patients feared, the social 
impact with regard to financial security was of less importance given the UK state 
benefit system as opposed to Nigeria where knowledge of HIV status could lead to job 
loss and financial insecurity. 
The level of discrimination in Nigeria also appears to have a greater impact on HIV 
patients. It is not untypical for social exclusion from family, friends and the wider 
community – something rarely obvious in the UK. 
5.6.1.4 Obstacles encountered while providing Service 
Patients’ failing to attend scheduled appointments was seen in both Nigeria and the 
UK– in both settings mechanisms were in place to try and ‘track’ these patients. The 
issue of ‘not enough time’ was again common to both settings; however, the context of 
this time was different. In Nigeria, it was the overwhelming numbers which made basic 
delivery of pharmaceutical care difficult whereas in the UK, it was more to do with not 
being able to provide additional services above and beyond what was expected and 
managing a high patient expectation. The expectation in Nigeria from the patient was 
low – being seen and getting enough free medicine appeared to be key. 
5.6.1.5 Expectations for Improvement of Service Provision 
Service improvements were very different between the two groups. Nigerian 
pharmacists requirements were basic – more staff, better facilities and reliable power 
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supply. NHS pharmacists in contrast were looking to provide further services to patients 
and create a higher profile role for themselves, e.g. prescribing. 
5.6.2 Overall Ideas that Emerged from the Study Results 
This section completes the description of this study and the results as important issues 
that emerged from the study have been presented. The preceding chapters have talked 
about experiences of patients living with HIV/AIDS, pharmacists and administrators 
experiences of attending to HIV/AIDS outpatients at MDH, and how NHS HIV 
pharmacists managed HIV outpatients. Participants in the study have described living 
with HIV/AIDS as challenging because what it brings about include stigma, 
discrimination, loss of source of income and/or positively, increased their faith in God. 
5.6.2.1 Faith  
Faith was very important to the majority of the patients interviewed as they explicitly 
expressed that faith in God and ART helped them to cope with the diagnosis and also, 
most of them were optimistic and hoped that one day, God will cure them completely 
from HIV infection. Some patients also advised that they (patients) needed to pray to 
God for staff to double their efforts in finding a cure for the infection. Though, the 
pharmacists and management staff did not express their opinions about faith as regards 
provision of clinical services for patients. However, the Nigerian pharmacists were 
aware that the patients have strong views about their individual religion which could 
influence how they utilised the ART. The pharmacists were aware that patients moved 
from one church to another, had visited spiritual healers and other places in search of 
spiritual healing without success prior to coming to MDH. 
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5.6.2.2 Patient Delays 
In this study, almost every HIV patient interviewed bemoaned the recurrent delays 
experienced when they went to receive clinical services and yet, their ratings of service 
at MDH were satisfactory. These delays were confirmed by interviewed pharmacists 
and administrators which they both attributed mainly to large numbers of patients and 
inadequate staff.  These delays were also observed by the researcher when shadowing 
patients on the ‘journey’ through the hospital. 
Delays were greatest at the APU. Patients were attended to by few pharmacists, patient 
medical records appeared in batches creating delays for many and prompt service for 
the very few. This coupled with repeat visits by patients requiring re-supply of half-filled 
prescriptions all contributed to delay. From the researchers’ perspective, it was 
distressing to observe two pharmacists attempting to provide clinical services for over 
180 patients at the APU in one day. This high intensity of workload does place pressure 
on pharmacist staff and increases the risks of mistakes happening; mistakes were 
observed by the medical record staff when records were checked. Patients, pharmacists 
and administrators all stated that the APU was understaffed, and thus, all felt that more 
staff needed to be employed to ease delay and congestion. 
5.6.2.3 Employ More Staff 
The researcher observed a maximum (minimum of two) of four doctors, two 
pharmacists and other HCPs (nurses, MR staff, Laboratory scientists) attended to over 
180 HIV patients on a clinic days. The patient:staff ratio and subsequent HCP workload 
was something that all interviewees commented on, and unsurprisingly recommended 
that more staff should be employed. At every unit of MDH that provided HIV services, 
there was shortage of staff, which was most acute at the APU and acknowledged by the 
hospital administrator. This is consistent with a recent study from Mozambique by 
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Lambdin et al [262] which revealed that high pharmacy workload led to patients’ loss to 
follow-up. However, Africa as a continent has a severe shortage of pharmacists so there 
is no quick fix in employing more staff ‘just like that’. 
5.6.2.4 Stigma and Discrimination 
Stigma remains a major issue associated with a diagnosis of HIV/AIDS. As the then UN 
Secretary-General, Ban Ki-Moon stated in 2008 at the 17th International AIDS 
Conference in Mexico City:  
‘Stigma remains the single most important barrier to public action. It is the main reason 
too many people are afraid to see a doctor to determine whether they have the disease, 
or to seek treatment if so. It helps make AIDS the silent killer, because people fear the 
social disgrace of speaking about it, or taking easily available precautions. Stigma is a 
chief reason the AIDS epidemic continues to devastate societies around the world.’ 
[263]. 
This sentiment holds true in this study. In Nigeria where social norms and cultural 
practice dictate behaviour, then, stigma associated with HIV/AIDs does lead to 
discrimination that can effectively see lives ruined. 
Raising public awareness and demystifying widely held beliefs is one way in which 
stigma can be tackled and authors such as Babalola et al [264] suggested that media-
based HIV programmes should be intensified in Nigeria to battle HIV/AIDS related 
stigma. This stigma and discrimination however is not just a public issue in Nigeria, as 
highlighted by Reis et al [265], discrimination also needs to be tackled with healthcare 
workers themselves. 
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5.6.2.5 Increase Clinic Days 
The numbers of patients attending the clinic day at MDH are too great and all parties 
concerned thought that additional clinic days would be a potential solution to better 
managing the number of patients and allow staff to ‘cope’ and provide better services. 
The overall view of this study findings with emphasise on pharmacist contribution into 
HIV/AIDS management at MDH is summarised in the diagram below (Figure 5.1). 
 
Figure 5.1: Schematic View of this Study Findings Connecting Faith and 
Pharmacists Counselling Roles at MDH  
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6. CHAPTER SIX - RECOMMENDATIONS AND 
CONCLUSION 
6.0 Introduction 
This study has identified a number of concepts that are pertinent to the management 
of HIV/AIDS patients at MDH, and to the promotion of a ‘fit for purpose’ pharmacy 
service to support these patients. The study has identified twenty-three 
recommendations as elucidated below and are further synthesised into six potential 
areas for implementation and changes to the working practices within the hospital 
that would result in improvements to the service provision at MDH. 
6.1 Recommendations for Pharmacists to Effect Changes 
The Nigerian interviewees, particularly patients have spoken about the obstacles to 
service provision and of their expectations for the HIV service provision at MDH. 
However, whilst all expectations cannot be addressed immediately, a number stood 
out as requiring immediate attention, and possible ways by which pharmacy and 
pharmacists can intervene to resolve them are explored below. 
6.1.1 Faith 
Faith came out powerfully in the majority of patient interviews, as they expressed 
their beliefs and the effects that these beliefs had on their approach to their HIV 
therapy. Pharmacists were aware of the patients’ beliefs in God as they have alluded 
to patients seeking for help from pastors, churches and other places like traditional 
healers prior to their coming into the hospital. However, whilst pharmacists cannot, 
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and should not seek to alter these spiritual beliefs, an awareness of such patient-held 
beliefs may well serve to increase the effectiveness of patient counselling sessions.  
6.1.1.1 Recommendation One 
The pharmacists should consider customising patient education and counselling on 
ART, so that counselling recognises individual patient’s religious beliefs to encourage 
the patients to connect their religious beliefs to their ART appropriately. 
6.1.1.2 Recommendation Two 
The pharmacists should advise the hospital authorities to contact the two main 
religious worship places in Abuja; being the National Christian Centre and Nigerian 
National Mosque, to seek the support of their leaders on educating their worshippers, 
about the importance of adherence to ART while still trusting God or Allah. 
6.1.1.3 How to accomplish recommendations one and two 
A one day seminar by religious leaders and pharmacists should be organised to 
explore the views of the various religious groups to ensure that pharmacist 
counsellors are aware of the various views of both Islam and Christianity about 
clinical therapy. An emphasis on the exact phrases that pharmacists could use during 
their counselling sessions would enable them to counsel patients appropriately on 
the usage of ART. Furthermore, Church leaders and Imams should be encouraged to 
include positive views concerning ART in their preaching.  
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6.1.2 Delays 
Delays in the patient journey as an obstacle to service provision emerged as a 
dominant theme across the three groups of interviewees in Nigeria. Such delays led 
to patient dissatisfaction and often a failure to provide an effective service. 
6.1.2.1 Recommendation Three 
The number of clinic days for HIV/AIDS patients should be increased from one to 
two. This would serve a number of advantages, firstly a reduction in the number of 
patients attending on a given day from 180 to 90 would relieve the strain on 
overworked resources and second, the movement away from the concept of the 
Wednesday clinic being the HIV clinic would reduce some of the social problems for 
the patient, such as stigma.  
6.1.2.2 Recommendation Four 
The pharmacists should be on permanent positions at the APU without carrying out 
other duties such as call duties at any other pharmacy units within or outside the 
hospital. This would allow for a more dedicated and contiguous service provision. 
6.1.2.3 Recommendation Five 
Patients attending the APU for repeat prescriptions should be timed to visit the 
pharmacy before the normal clinic times. Thus, pharmacy staff should be required to 
report to the APU from 08:00 each clinic day, so that they can attend to patients on 
repeat prescriptions. These would include patients whose ARV medicines were 
incompletely dispensed at previous visits to the APU. 
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6.1.2.4 Recommendation Six 
The responsibility for the refilling of repeat prescription on non-clinic days should be 
transferred to the main pharmacy unit, thus enabling repeat patients to collect their 
prescriptions on non-clinic days and so further reduce the workload on the APU on 
clinic days. 
6.1.2.5 Recommendation Seven 
The availability of HIV/AIDS clinics should be extended to weekend clinics as 
provided in the NHS in the UK, thus enabling patients who are in full time 
employment to attend clinics without requiring work leave. This would further reduce 
the fear of exposure in these patients as they would not have to request leave from 
their employers. Such clinics may well require shorter hours (10:00-16:00) to serve 
smaller number of patients attending.  
6.1.2.6 Recommendation Eight 
Hospital management should be advised to make changes to the working practices 
at the MRU; particularly, changes to the method of having to wait for ten or more 
patients to finish consulting with doctors before their MRs are taken to other units, 
especially to APU for service provision. There is no need for the first patient on the 
queue to wait for more other patients’ MRs to be filled by doctors before his or her 
MRs are taken to APU in bulk. If each patients MR could be transferred immediately 
with the patient, unnecessary delays would be avoided and the flow of work through 
the APU would be streamlined.  
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6.1.2.7 Recommendation Nine 
Hospital management should consider the introduction of an electronic MR system 
allowing for the fast transfer of patient data between hospital units. Such a system 
would further reduce delays, reduce waiting times at the APU and greatly improve 
not only the actual service provision for the patients, but also improve their 
perceptions of the service and the hospital. 
6.1.2.8 Recommendation Ten 
The pharmacists should advise the management on the number of patients that can 
feasibly be attended to at the APU on clinic days, so that the patient numbers can be 
streamlined to between 50 and 100 on a clinic day. A reduction in the number of 
patients attending on a given clinic day would have the effect of reducing the 
patient:staff ratio towards those values reported by NHS pharmacists as being 
desirable for the provision of a good service.  
6.1.2.9 Recommendation Eleven 
Pharmacists working in the APU should reduce the number of paper-based 
recordings carried out for each patient both during the patient visit and after they 
have left the APU. This would reduce the administrative workload on the pharmacists 
and greatly increase their availability for patient counselling concerning ART.   
6.1.2.10 How to accomplish recommendations three through eleven 
Implementation of the recommendations three to eleven will require a complete 
rethink on the delivery strategy for the provision of HIV/AIDS services to patients 
attending MDH. Thus, although they may be pharmacy-led, they will require input 
from hospital management and other clinical units providing input to the patient 
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journey through the hospital. It is unlikely that these wide-ranging recommendations 
could be implemented at a stroke, but a revisit on the management strategies for the 
handling of patient medication records and the timing and frequency of clinic days 
would enable the provision of a much-improved service. The implementation of an 
electronic patient record system may well have wider implications across the hospital 
but, if only implemented in the HIV/AIDS clinics would greatly improve the patient 
experience. 
To be successful, these changes will require complete dedication from all staff 
involved in the clinic especially pharmacists, to put in more time, and MRU staff will 
need to address the pharmacy-led suggestions for service improvement. As for the 
electronic MR system, its implementation may not be immediate but let the 
management be aware of the importance for the patients for future considerations. 
6.1.3 Stigma 
The stigma or shame associated with HIV and/or ART is conspicuously evident 
amongst all patients as they themselves spoke about it and pharmacists were also 
aware of patients stigmatising themselves. 
6.1.3.1 Recommendation Twelve 
Pharmacists should increase their efforts to both encourage and to educate patients 
during their counselling sessions, especially on the disadvantages of self-
stigmatisation and on how to manage their disease with ART. Such encouragement 
and increased understanding of the clinical status of HIV/AIDS and its management 
with ART would lead to improvements in patient adherence and more positive clinical 
outcomes. 
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6.1.3.2 Recommendation Thirteen 
The number of HIV/AIDS clinics held at MDH should be increased. There is 
considerable speculation amongst patients that many people in Abuja are aware of 
HIV clinics at MDH being held on Wednesdays. Patients perceive this association as 
greatly increasing the chances of employers and family members concluding their 
HIV status from the fact that they attend hospital on Wednesday. Thus, the 
timetabling of clinic days at MDH throughout the week would greatly reduce the 
patients’ perceptions of this association being made by employers and family, and so 
reduce their perceived risk of being identified as HIV/AIDS patients.  
6.1.3.3 Recommendation Fourteen 
There should be an increased awareness campaign on the stigma associated with 
HIV/AIDS throughout the catchment area of the hospital. Pharmacists should raise 
this issue with hospital management through their monthly reports and so, enable the 
management to emphasise the benefits of prevention of HIV stigma. 
6.1.3.4 How to accomplish recommendations twelve through 
fourteen 
The increase in the number of clinic days and their rescheduling to occur possibly 
daily throughout the week and at weekends will require a major undertaking by both 
management and by pharmacy staff. Changes in the working practices of both 
groups must be addressed to provide a wider-availability of patient service, the 
overall benefits of which will be a more patient-focussed service with lower levels of 
stigmatisation for patients and their families. In addition, the pharmacists will need to 
draft appropriate messages or slogans that may be used by management in an 
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attempt to change in the patients’ experiences as regards HIV stigma for the 
campaign.  
6.1.4 Staff:Patient Ratio 
Shortage of staff and the ratio between numbers of staff and numbers of patients 
emerged as one of the dominant themes across the three groups of interviewees at 
MDH and as one of the most important issues identified in this study. Whilst the 
majority of interviewees thought that employing more staff would solve the problem, 
this is unlikely to be an available option. Therefore, explorations on the working 
practices of staff at MDH may serve to redress the balance.  
6.1.4.1 Recommendation Fifteen 
The physical dispensing of prescriptions at the APU should be delegated to suitably-
trained technical staff, with only the final check being carried out by a qualified 
pharmacist. Such a development would allow greater flexibility on pharmacist 
workloads, improved patient counselling times and the delivery of the final 
prescription as part of the counselling process. This latter implementation may serve 
to promote patient adherence as counselling by the pharmacists may be directed at 
each medication as it is presented to the patient.  
6.1.4.2 Recommendation Sixteen 
With pharmacists and technicians on duty, clinic days should be increased from two 
clinic days in a week to at least four. To learn from the NHS, HIV clinics have enough 
clinic days for HIV patients, thus; HIV patients attending NHS clinics had more 
options of when to attend clinics, thereby, reducing the number of patients on a clinic 
day. 
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6.1.4.3 Recommendation Seventeen 
The pharmacists could solicit for more volunteering pharmacists on behalf of MDH 
from academic and private sectors to help them out on clinic days. 
6.1.4.4 How to accomplish recommendations fifteen through 
seventeen 
The change in working practice outlined above requires the transfer of a suitably 
qualified technician into the APU. Such an individual may well come from existing 
staff in the main pharmacy. One Pharmacy technician from the main pharmacy unit 
can be moved to the APU with authorisation from the HOD of pharmacy. Depending 
on the skill set of the individual moving to the APU, dispensing training may need to 
be given to ensure an adequate level of expertise for prescription dispensing.  
It is acknowledged that the APU relies on a number of volunteer staff, both 
pharmacists and non-pharmacists, and the recruitment of a suitably-qualified 
technician from outside the MDH staff pool may be an option. Pharmacists should 
contact other pharmaceutical establishments for more volunteers. 
6.1.5 Accommodation 
The APU is under spaced; three temporary rooms, with one or two desk top 
computers, four tables and chairs, dispensary accessories and ART drugs on the 
tables, shelves and floor. It was evident that when MDH was planned or built, there 
was no plan for the inclusion of APU. However, relatively small changes to the 
accommodation provided to the APU by the hospital authorities may well serve to 
improve service provision to patients. 
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6.1.5.1 Recommendation Eighteen 
Hospital management should look to the provision of an improved APU facility. Whilst 
a larger, purpose-built provision would be the aim, changes to the structural provision 
of the existing facility would still improve the situation. Pharmacists should make 
suggestions to the authorities for a bigger and more permanent APU provision with 
increased temperature-controlled shelving for storage of ART drugs; improved 
counselling facilities; private cubicles with sufficient tables and chairs to provide 
greater levels of patient confidentiality and more computers with internet access.  
6.1.5.2 Recommendation Nineteen 
Management should provide a small generator system to cover regular power 
outages at the APU. This would ensure continuity of appropriate storage conditions 
for ART drugs and so greatly improve the supply chain. A further advantage of such 
an installation would be the maintenance of a comfortable environment for both 
patients and pharmacy staff.  
6.1.5.3 How to accomplish recommendations eighteen and nineteen 
Whilst it is acknowledged that these two recommendations may not be immediate 
feasibilities, due to issues around funding, their highlighting in this report serves to 
identify the priority that pharmacy would place on these provisions to enable the 
development of an improved service to patients. Their possible implantation should 
be the subject of an appropriate cost-benefit analysis 
6.1.6 Shortage of ART 
Shortage of ART emerged as a dominant theme across the three groups of 
interviewees at MDH and thus, one of the most important issues identified in this 
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study. Also, hospital pharmacists’ principal roles revolve around medicines, which 
make it very difficult for them to work efficiently without the availability of suitable 
medicines. Again, it is acknowledged that these ART drugs are expensive, and that 
monies for their provision are limited, there do exist mechanisms by which drug 
supplies may be obtained from other sources. Thus, many drugs are supplied by 
local pharmacies in response to requests from the hospital. 
6.1.6.1 Recommendation Twenty 
Pharmacists should develop a more focussed strategy to solicit for ART and other 
medicines from community pharmacies; possibly by involving their colleagues during 
general monthly meetings for pharmacists in Abuja and through formal letters from 
MDH.  
6.1.6.2 Recommendation Twenty-one 
The pharmacists can also approach and solicit for donations of ART and other 
medicines for the patients through distinguished and well to do individuals and 
organisations around or outside Maitama district such as pharmaceutical companies 
in Nigeria, for example, Emzor Pharmaceuticals.  
6.1.6.3 Recommendation Twenty-two 
The hospital should ensure that the APU receives information as to patient numbers 
attending clinic days well in advance of the event. It is important for the pharmacists 
to be informed about an approximate number of patients attending next clinic day 
from the MRU so that they can make adequate preparation as regards quantity of 
ART in stock to reduce patients’ repeat visits to the clinic. 
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6.1.6.4 Recommendation Twenty-three 
The pharmacists can put more pressure on the authorities to re-enforce their efforts 
in advising the MFCTA on the needs to increase the budget for health by adding 
more funding specifically into provision of ART to avoid further catastrophes from HIV 
infection in Abuja. 
6.1.6.5 How to accomplish recommendations twenty through 
twenty-three 
When pharmacists attend their meetings, they should be able to make constant and 
consistent appeals to other pharmacists for ART donations. The pharmacists should 
be able to find out the number of patients scheduled for next clinic day from the 
MRU. Also, there should be constant reminder of the management at the end of 
every month as they make their end-of-month reports on service provision about 
more funding for ART. 
This study has investigated the current provision of HIV/AIDS services to patients 
attending clinics at the MDH in Abuja, Nigeria. Twenty three recommendations have 
been made that would, if implemented in total, dramatically improve the pharmacy-
based provision of services to this group of patients. It should be noted that many of 
these recommendations do not require massive financial input, but are based on 
appreciation of the patients’ perspectives of their disease management and proposed 
changes to the working practices of the MDH in provision of pharmacy services to its 
patients. 
6.2 Proposed Implementations 
The six major potential areas for implementation and changes to the working 
practices within MDH are: 
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1. The influence of ‘faith’; 
2. Restructuring of the staffing provision in the APU; 
3. Employment of technical helps in the APU; 
4. Increased number of clinic days; 
5. Changes to working practices covering patient records; and 
6. Increased efforts to secure more availability of ARTs. 
6.2.1 Faith  
Faith needs to be recognised, accepted and used as a “tool” in the counselling of 
patients on ART adherence in APU. Thus, the pharmacists should consider 
customising patient education and counselling on ART, so that counselling 
recognises an individual patient’s religious beliefs to encourage the patients to 
connect their religious beliefs to their ART appropriately. Also, the pharmacists 
should advise the hospital authorities to contact the two main religious worship 
places in Abuja; being the National Christian Centre and Nigerian National Mosque, 
to seek the support of their leaders on educating their worshippers, about the 
importance of adherence to ART while still trusting God or Allah. 
6.2.2 Pharmacist Staff Restructuring 
This study has shown that a continuity of pharmacist provision at the APU would 
result in an improved level of service to patients. Therefore, a pharmacist should be 
placed on permanent position at the APU without carrying out other duties such as 
call duties at any other pharmacy units within or outside the hospital. This would 
allow for a more dedicated and contiguous service provision. However, this may well 
necessitate a review of overall pharmacist provision in the hospital. 
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6.2.3 Technician Restructuring 
The physical dispensing of prescriptions at the APU should be delegated to suitably-
trained technical staff, with only the final check being carried out by a qualified 
pharmacist. Such a development would allow greater flexibility on pharmacist 
workloads, improved patient counselling times and the delivery of the final 
prescription as part of the counselling process. This latter implementation may serve 
to promote patient adherence as counselling by the pharmacists may be directed at 
each medication as it is presented to the patient.  
6.2.4 Increased Clinic Days 
One of the major barriers to service provision identified in this study is the large 
numbers of returning patients attending on the Wednesday clinic day. In addition, the 
identification of the Wednesday clinic as the ‘HIV/AIDS clinic’ raises problems of 
stigma and other social implications for the patients.  
With pharmacists and technicians on duty, clinic days should be increased to two 
clinic days per week for returning patients. This would not only reduce the workload 
on pharmacists and technicians on an individual clinic day, but also serve to lessen 
any sociological problems associated with the single clinic day. 
To learn from the NHS, HIV clinics have enough clinic days for HIV patients, thus; 
HIV patients attending NHS clinics had more options of when to attend clinics, 
thereby, reducing the number of patients on a clinic day. 
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6.2.5 Changes to Working Practices 
This study has shown that current working practices, particularly with reference to 
patient records, results in intermittent delivery of patient records to the pharmacy and 
subsequent long delays for patients waiting for their medication. 
Hospital management should be advised to make changes to the working practices 
at the MRU; particularly, changes to the method of having to wait for ten or more 
patients to finish consulting with doctors before their MRs are taken to other units, 
especially to APU for service provision. There is no need for the first patient on the 
queue to wait for more other patients’ MRs to be filled by doctors before his or her 
MRs are taken to APU in bulk. If each patients MR could be transferred immediately 
with the patient, unnecessary delays would be avoided and the flow of work through 
the APU would be streamlined.  
6.2.6 Pharmacy should Solicit for more ART  
The availability of ART at the hospital is limited, often resulting in patients having to 
return several times in order to receive their full prescription. The presence of a 
dedicated pharmacist at the APU would, in collaboration with the Chief Pharmacist, 
enable the development of a more focussed strategy to solicit for ART and other 
medicines from community pharmacies; possibly by involving their colleagues during 
general monthly meetings for pharmacists in Abuja and through formal letters from 
MDH.  
The pharmacists can also approach and solicit for donations of ART and other 
medicines for the patients through distinguished and well to do individuals and 
organisations around or outside Maitama district. 
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6.3 Theoretical and Practical Contribution of Thesis 
This thesis contributes valuable knowledge to our understanding of the role(s) of 
pharmacy in the management of HIV patients, especially in the Nigerian setting. It 
provides new knowledge about the experiences of HIV patients and their impact on 
the provision of clinical services. The thesis also makes several important 
contributions to theory which includes:  
Firstly, the thesis identifies that faith has a central role in patient experiences of living 
with HIV, second; it proposes that religious faith is utilised as a tool and incorporated 
into pharmacy counselling to connect patients to their ART. Third, it recognises how 
delays at the hospital on clinic days affect patient experiences. Fourth, it identifies 
that social stigma and discrimination have strong influences on patients and their 
interactions with HIV services, with the populace linking every Wednesday to HIV 
clinic day at MDH and restricts home delivery of ART in the UK. Finally, pharmacists 
in Nigeria and the UK views of clinical services for HIV patients have been explored 
in this thesis. 
6.4 Conclusion  
This thesis has detailed HIV patient, pharmacist and management staff views on the 
management of HIV patients at MDH, and elucidated the patient journey on clinic 
days. In addition, pharmacy management of HIV patients at UK NHS hospitals was 
explored. Although this study has been exploratory in nature, it has contributed 
substantial new knowledge into an under researched area such as contribution of 
pharmacy in the management of HIV and opened the door for further exciting 
research in this domain. Whilst most of findings obtained in this study are consistent 
with the literature, certain factors such as; shortage of staff, ART shortage, delays, 
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inadequate accommodation, few clinic days and stigma that impinge on the quality of 
clinical services provided for patients in Nigeria have been identified. Consequently, 
suggestions on how pharmacy can contribute to improve the service provision for 
HIV patients at MDH have been made and implementations of these suggestions 
could improve the patients’ experiences at MDH. 
6.5 Recommendations for Future Work 
The focus of recommendations for future work is on two areas of significance 
identified from this study and these are: 
1. Adherence; and  
2. Surveys in other prototype hospitals in Abuja and Nigeria. 
6.5.1 Adherence 
The Nigerian pharmacists interviewed had said that every patient testified to the fact 
that ARV drugs were properly taken according to their prescriptions. However, the 
pharmacists did not trust that the patients took their ART according to prescriptions, 
though, most pharmacists, generally, agreed that there was a good level of ARV 
drugs compliance by the patients. Furthermore, some patients stated that they had 
some tablets (ARV medicines) remaining, so did not come to the clinic as scheduled 
or had exhausted all their medications prior to their hospital visits. Therefore, it would 
be appropriate in future to find out how HIV patients at MDH view the importance of 
ARV drugs adherence and to what degree adherence is maintained in order to help 
the patients avoid viral resistance to ARV drugs. This could be done through 
structured interviews using purposive sampling and responses from the interviews 
will be used for formulating questionnaires with closed ended questions for a 
quantitative study. 
212 
 
6.5.2 Surveys in other Prototype hospitals in Abuja and Nigeria 
The findings of this study at MDH identify a number of areas of concern and have 
identified possible implementations to improve service provision. However, it is 
important to identify whether, or not, these observations are peculiar to MDH, or 
typical of service provision at other hospital sites throughout Abuja, in the first 
instance, and Nigeria as a whole. Thus, further studies should be carried out at other, 
similar hospitals in Abuja and Nigeria to elucidate the overalls scale of the problems 
in order to further identify strategies for improvements in the service to HIV/AIDS 
patients in Nigeria. 
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Appendices 
Please note that appendices are on the accompanying CD ROM, and only interview 
prime questions are attached to the appendices below.  
 
Appendix 1 Research Ethics Committee Approval from MDH 
Appendix 2 Notification Letter to MDH of the Researcher’s Arrival for the First Phase 
of Data Collection 
Appendix 3 Approval from Federal Capital Territory Health Research Ethics 
Committee 
Appendix 4 Participant Letters 
Appendix 4.1 Letter of Invitation for Participants 
Appendix 4.2 Participant Information Sheet for Patients 
Appendix 4.3 General Consent Form for Participants 
Appendix 4.4 Questions for Phase 1 Patient Interviews 
Prime questions 
1. Can you tell me what is it like living with HIV? 
2. What are the worries that come to mind when you think of medical treatment for 
HIV? 
3. Can you tell me your views on receiving clinical services for HIV infection?  
4. What improvements do you think could be made to the way you receive your 
clinical services? 
Appendix 4.4.1 First Phase Patient Interview Transcripts  
Appendix 4.4.1.1 Patient 1 Interview Transcript 
Appendix 4.4.1.2 Patient 2 Interview Transcript 
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Appendix 4.4.1.3 Patient 3 Interview Transcript 
Appendix 4.4.1.4 Patient 4 Interview Transcript 
Appendix 4.4.1.5 Patient 5 Interview Transcript 
Appendix 4.4.1.6 Patient 6 Interview Transcript 
Appendix 4.4.1.7 Patient 7 Interview Transcript 
Appendix 4.4.1.8 Patient 8 Interview Transcript 
Appendix 4.4.1.9 Patient 9 Interview Transcript 
Appendix 4.4.1.10 Patient 10 Interview Transcript 
Appendix 4.4.1.11 Patient 11 Interview Transcript 
Appendix 4.4.1.12 Patient 12 Interview Transcript 
Appendix 4.4.1.13 Patient 13 Interview Transcript 
Appendix 4.4.1.14 Patient 14 Interview Transcript 
Appendix 4.4.1.15 Patient 15 Interview Transcript 
Appendix 4.4.1.16 Patient 16 Interview Transcript 
Appendix 4.4.1.17 Patient 17 Interview Transcript 
Appendix 4.4.1.18 Patient 18 Interview Transcript 
Appendix 4.4.1.19 Patient 19 Interview Transcript 
Appendix 4.4.1.20 Patient 20 Interview Transcript 
Appendix 4.4.1.21 Patient 21 Interview Transcript 
Appendix 4.4.1.22 Patient 22 Interview Transcript 
Appendix 4.4.1.23 Patient 23 Interview Transcript 
Appendix 4.4.1.24 Patient 24 Interview Transcript 
Appendix 4.4.1.25 Patient 25 Interview Transcript 
Appendix 4.4.2 Participant Information Sheet for Hospital Pharmacists 
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Appendix 4.4.3 Questions for Nigerian Hospital Pharmacist Interviews 
Prime questions 
1. Can you tell me your views on providing clinical services for HIV infected adults in 
your hospital? 
2. Can you describe to me how you manage a typical patient in your HIV clinic?  
3. What are the difficulties with providing clinical services for HIV infected adult 
patients?  
4. What improvements do you think could be made to the way you deliver your 
clinical service?  
Appendix 4.4.4 Nigerian pharmacists Interview Transcripts 
Appendix 4.4.4.1 Pharmacist 1 interview Transcript 
Appendix 4.4.4.2 Pharmacist 2 Interview Transcript 
Appendix 4.4.4.3 Pharmacist 3 Interview Transcript 
Appendix 4.4.4.4 Pharmacist 4 Interview Transcript 
Appendix 4.4.4.5 Pharmacist 5 Interview Transcript 
Appendix 4.4.4.6 Pharmacist 6 Interview Transcript 
Appendix 4.4.4.7 Pharmacist 7 Interview Transcript 
Appendix 4.4.4.8 Pharmacist 8 Interview Transcript 
Appendix 4.4.4.9 Pharmacist 9 Interview Transcript 
Appendix 4.4.4.10 Pharmacist 10 Interview Transcript 
Appendix 5 Second Phase of Data Collection 
Appendix 5.1 Notification Letter to MDH of the researcher’s Arrival for Second Phase 
of Data Collection 
Appendix 5.2 Questions for Phase 2 Patient Interviews 
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Prime questions 
1. Can you tell me what is it like living with HIV? U fit tell me how ebe and how u feel 
as u don know say you are HIV positive? 
2. Can you tell me any worries or fears you have concerning HIV treatment in this 
hospital? u fit tell me any wahala  u get  4 the HIV medicine wey them don give 
you in this hospital 
3. Can you tell me your views on receiving clinical services for HIV infection? U fit 
tell me your mind for the HIV treatment you don get?  
4. What improvements do you think could be made to the way you receive your 
clinical services? Wetin u think wey fit improve the treatment you dey get? 
 Appendix 5.2.1 Second Phase of Patient Interview Transcripts  
Appendix 5.2.1.1 Patient 26 Interview Transcript 
Appendix 5.2.1.2 Patient 27 Interview Transcript  
Appendix 5.2.1.3 Patient 28 Interview Transcript 
Appendix 5.2.1.4 Patient 29 Interview Transcript 
Appendix 5.2.1.5 Patient 30 Interview Transcript 
Appendix 5.2.1.6 Patient 31 Interview Transcript 
Appendix 5.2.1.7 Patient 32 Interview Transcript 
Appendix 5.2.1.8 Patient 33 Interview Transcript 
Appendix 5.2.1.9 Patient 34 Interview Transcript 
Appendix 5.2.1.10 Patient 35 Interview Transcript 
Appendix 5.3 Consent Form for Patient Shadow 
Appendix 5.3.1 Observation of Patient’s Journey 
Appendix 5.3.1.1 Patient 1 Shadowed 
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Appendix 5.3.1.2 Patient 2 Shadowed 
Appendix 5.3.1.3 Patient 3 Shadowed 
Appendix 5.3.1.4 Patient 4 Shadowed 
Appendix 5.3.1.5 Patient 5 Shadowed 
Appendix 5.3.1.6 Patient 6 Shadowed 
Appendix 5.3.1.7 Patient 7 Shadowed 
Appendix 5.3.1.8 Patient 8 Shadowed 
Appendix 5.3.1.9 Patient 9 Shadowed 
Appendix 5.3.1.10 Patient 10 Shadowed 
Appendix 5.4 Participant Information Sheet for Hospital Administrators 
Appendix 5.5 Questions for Administrator Interviews 
Prime Questions 
1. What are your views on HIV patient journey in this hospital? 
2. Are the patients aware of their journey in this hospital? 
3. Are there feedbacks about patients’ journey in this hospital? 
4. Who made those feedbacks? 
5. When were there made? 
6. What are your constraints in this area of patients’ journey? 
7. What improvements do you think could be made to the patients’ journey? 
 
Appendix 5.5.1 Administrator Interview Transcripts 
Appendix 5.5.1.1 Medical Record Staff Interview Transcript 
Appendix 5.5.1.2 Senior Medical Officer (doctor) Interview Transcript 
Appendix 5.6.1 NHS HIV Pharmacist Interview Transcripts 
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Appendix 5.6.1.1 NHS Pharmacist 1-DP-at WNH Interview Transcript 
Appendix 5.6.1.2 NHS Pharmacist 2-SS-at SOH Interview Transcript 
Appendix 5.6.1.3 NHS Pharmacist 3-GH-at BHH Interview Transcript 
Appendix 5.6.1.4 NHS Pharmacist 4-RB-at WMH Interview Transcript 
